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ABSTRACT OF THE DISSERTATION
Understanding and exploiting protein allostery and dynamics using molecular simulations
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Protein conformational landscapes contain much of the functionally relevant information that
is useful for understanding biological processes at the chemical scale. Understanding and map-
ping out these conformational landscapes can provide valuable insight into protein behaviors
and biological phenomena, and has relevance to the process of therapeutic design.
While structural biology methods have been transformative in studying protein dynamics, they
are limited by technical limitations and have inherent resolution limits. Molecular dynamics
(MD) simulations are a powerful tool for exploring conformational landscapes, and provide
atomic-scale information that is useful in understanding protein behaviors. With recent ad-
vances in generating datasets of large timescale simulations (using Folding@home) and pow-
erful methods to interpret conformational landscapes such as Markov State Models (MSMs), it
is now possible to study complex biological phenomena and long-timescale processes. How-
ever, inferring communication between residues across long distances, referred to as allosteric
communication, remains a challenge.
Allostery is a ubiquitious biological phenomena by which two distant regions of a protein are
coupled to one another over large distances. Allosteric coupling is the mechanism through
which events in one region (such as ligand binding) alter the conformation or dynamics of
another region (ie. large conformational domain motions). For example, allostery plays a
critical role in cellular signaling, such as in the transfer of a signal from outside the cell to
cytosolic proteins for generating a cellular response.
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While many methods have made tremendous progress in inferring and measuring allosteric
communication using structures or molecular simulations, they rely on a structural view of
allostery and do not account for the role of conformational entropy. Furthermore, it remains a
challenge to interpret allosteric coupling in large, complex biomolecules relevant to physiology
and disease.
In this thesis, I present a method to measure the Correlation of All Rotameric and Dynami-
cal States (CARDS) which is used to construct and interpret allosteric networks in biological
systems. CARDS allows us to infer allostery both via concerted changes in protein structure
and in correlated changes in conformational entropy (dynamic allostery). CARDS does so by
parsing trajectories into dynamical states which reflect whether a residue is locally ordered (ie.
stable in a single rotameric basin) or disordered (ie. rapidly hopping between rotamers).
Here I explain the CARDS methodology (chapter 2) and demonstrate applications to a variety
of disease-relevant systems. In particular, I apply CARDS and other sophisticated computa-
tional methods to understand the process of G protein activation (chapter 3), a protein whose
mutations are linked to cancers such as uveal melanoma. I further demonstrate the utility of
CARDS in the study a potentially druggable pocket in the ebolavirus protein VP35 (chapter
4). The analyses and models constructed in this work are supported by experimental test-
ing. Lastly, I demonstrate how integrating MD with experiments, sometimes with the help
of citizen-scientists around the world, can provide unique insight into biological systems and
identify potentially useful targets. In particular, I highlight our recent effort converting Fold-
ing@home into an exascale computer platform to hunt for potentially druggable pockets in the




1.1 Protein conformational landscapes encode functional in-
formation.
Proteins are the machines that power cellular function and life. They allow us to see, smell,
think, and carry out many of the basic functions required for us to live. However, when they
malfunction or misbehave (usually through mutation), they can also result in diseases like can-
cer or heart disease among others. Proteins are also utilized by viruses and bacteria to infect
host cells, replicate, or even break down the drugs we use to stop them.
Understanding protein behaviors relevant to health and disease depends on being able to model
them in atomic detail. Atomistic scale motions allows us to infer things like mechanisms,
thermodynamic profiles, and kinetic rates. This level of detail can provide predictive models
and explanations for why certain mutations may cause disease, which can be useful for tar-
geting proteins using drug design methods. Furthermore, knowledge of chemical interactions
allows us to design chemical groups against pockets that would jam them open [4]. Atomic-
scale knowledge may even provide guiding principles upon which proteins can be designed to
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perform novel functions, which has implications for therapeutic design and industrial applica-
tions [5].
Structural biology methods have been transformative in allowing us to learn about the struc-
ture of proteins and their behaviors. The first view of protein structures was done using X-Ray
crystallography [6]. However, static structures do not provide a complete picture of protein
function. These static structures may not be able to provide information about a proteins stabil-
ity [7], ligand affinities or specificities [8], or how different mutations could impact function [9].
Indeed, it has been often observed that crystal structures of the same protein families are too
similar to explain the difference in their measured physiological parameters [10].
As the atoms of a protein move around relative to one another, a protein is able to shift be-
tween an enormous number of different structures. Even small proteins of <100 amino acids
have ∼200 rotatable bonds along their backbone, granting access to more than 1060 backbone
conformations [11]. Many of these structures however are never accessed by the protein in
physiologically relevant timescales. Of the fraction that are accessed however, some of them
may have relevance to a protein’s mechanism and biophysical behavior. Each of these struc-
tures that a protein may shape-shift into has an associated energy that characterizes intra-protein
and protein-environment interactions. Given that the probability of a protein adopting any one
structure is proportional to the exponential of that structures energy, we are able to characterize
how likely a protein is to adopt some states over others. The phase space of a protein’s energies
(or probabilities) and their corresponding structures are often referred to as an “energy land-
scape”, with most likely states (such as those observed by crystallography) are named “ground”
states due to being energy minima.
From these ground states, a protein can also transition into less likely “excited” states, some
of which may contain key functional information. These states can be characterized using
a plethora of methods. Nuclear Magnetic Resonance (NMR) and Hydrogen-Deuterium Ex-
change (HDX) have provided unique functional insight into the conformational heterogeneity
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a protein can have [12, 13]. Work on DHFR has been critical in understanding the complete
catalytic cycle and the residue level configurations (and dynamics) [14]. NMR experiments on
DHFR that was arrested in one stage of its catalytic cycle provided evidence that DHFR was
also adopting stages in the latter part of its cycle [14]. Mutational experiments also put forth a
correlation between dynamics and catalytic ability [13–15]. Powerful combinations of NMR,
crystallography, and computer simulations have rationalized cofactor- and mutational-effects
on kinases [16,17]. With advances in structural methods, it is even possible to resolve structural
information about excited states [14,15]. Other electron paramagnetic resonance (EPR) experi-
ments have granted unique insight into the conformational distributions of proteins [18]. NMR
also has the additional power to measure the degree of conformational entropy of residues [19].
Recently, Cryo-EM structures of even large complexes have revealed the degree of conforma-
tional heterogeneity in physiologically relevant systems [20–23]. However, it is important to
note that each of these methods have tradeoffs due to resolution limits, labelling strategies that
may perturb the system, or technical limitations (system size, material requirements, etc.). Al-
together, this large body of work studying excited states of folded proteins suggests that the
equilibrium motions of a protein may encode all of its functionally relevant states.
Molecular dynamics (MD) simulations have the potential to provide atomistic detail to explain
complex biological processes. These simulations compute the movements of atoms over time
by integrating Newton’s laws of motion over each atom. Thus, MD acts as a “computational
microscope”, allowing us to observe the different conformations a protein adopts [24, 25]. A
perfect simulation would completely describe a protein’s thermodynamic and kinetic behaviors
at equilibrium. However, there are major limitations: (i) The accuracy of atomic parameters
(aka ”force fields”) that are used to describe atomic interaction (A topic that is discussed exten-
sively elsewhere [26]). (ii) Simulations take femtosecond-sized timesteps, making it expensive
to gather data at biologically relevant timescales (microsecond to milliseconds). (iii) Inter-
preting large datasets with thousands of unique structures to generate biologically meaningful
predictions remains a daunting task.
3
1.2 The Folding@home platform allows access to protein mo-
tions at biologically relevant timescales.
1.2.1 Folding@home distributes simulations across thousands of comput-
ers at once.
A myriad of methods have been developed to improve sampling of protein motions out to bio-
logically relevant timescales [27–30]. However, many perturb the thermodynamics or kinetics
of a system, in turn biasing the predictions these simulations make. The advent of GPUs pro-
vided access to longer timescales, but they are bounded by an upper limit of parallelism in
computing architectures [31–34]. Recently, novel adaptive sampling techniques have allowed
for the mapping of slower motions [35] but may require system-specific knowledge or an order
parameter of relevance. Specialized hardware has also been developed [36] that allowed com-
putational biophysicsts to study processes at unprecedented timescales. However, utilizing and
maintaining this kind of specialized hardware can be a costly endeavor.
To sample unbiased simulations at biologically relevant timescales using commodity hardware,
the Folding@home platform was developed in 2000 [37]. Folding@home, headquartered at
the Bowman lab at WUSTL, is a distributed computing network that runs MD simulations
on donated computing power thanks to thousands of citizen-scientists who download the app
onto their hardware. Folding@home runs trajectories as small “work units” that are smaller
simulations on the order of nanoseconds. The starting file for a work-unit is generated server-
side, which is sent to a client computer somewhere in the world (Fig. 1.1). The client then runs
the work-unit and returns it. This is used to generate the subsequent work-unit (representing the
next chunk of time in a simulation). Afterwards, work units are stitched together to generate
a single trajectory. Folding@home allows for the generation of a datasets containing hundreds
of trajectories that, in aggregate, capture a large amount of a protein’s energy landscape. These
datasets are so large that interpreting them presents a unique “big data” challenge, and requires
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the development of new methods and software [38, 39].
Figure 1.1: Folding@home distributes work units worldwide to run simulations A. Workflow
schematic detailing the steps a citizen-scientist’s computer (”client”, green) takes to receive,
run, and return a work-unit successfully by communicating with the Assignment Server (blue)
and the Work server (yellow). B. Heatmap of completed work-units returned from each country
in the world in a representative 48-hour period. The number of returned work units is indicated
by the color scale (right).
1.2.2 Markov State Models allow for the construction of unified models
from large simulation datasets.
Markov state models (MSMs) are network representations of a protein’s free-energy landscape,
providing map representations of protein conformational space with thermodynamic and ki-
netic properties taken from equilibrium simulations (Fig. 1.2). Rather than depending on a
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single long simulation that explores multiple states sequentially, MSMs are capable of stitch-
ing together multiple short trajectories into a single unified landscape. Thus MSMs capture
slow events, and their intermediates, far beyond the reach of any individual simulation. Thanks
to distributed networks like Folding@home, gathering large numbers of short trajectories is
tractable in a reasonable time-frame. Many reviews have been dedicated to providing accessi-
ble and in-depth explanations of MSM technology [38, 40, 41].
Figure 1.2: Diagram highlighting the conversion of a simulation dataset into a Markov State
Model (MSM). Simulation trajectories (left) are parsed into discrete states on a per-frame basis
(red, blue, green, yellow), and estimation methods are used to convert the trajectories into a
MSM (right). The spheres radii is proportional to the population of that state, while arrow
thickness denotes transition probability.
MSMs require two components to describe the dynamics of a biomolecular system: (i): A
discretization of a high dimensional state space into n conformational states, and (ii) A model
of the stochastic transitions between each states, represented as a Transition Matrix P. The
probability of transitioning from state i to state j (Pij) is:
Pij(τ) = Prob(xt+τ ∈ Sj|xt ∈ Si) (1.1)
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where τ is a lag-time parameter across which transitions between states are observed, and Si is
state i and Sj refers to state j. These transition matrices P give rise to a stationary distribution
π as a result of the eigenvalue equation:
πTP = πT (1.2)
where T represents a single time-step. In an MSM, the stationary distribution π represents the
equilibrium probabilities for each state. Therefore, assuming sufficient statistics are collected
to observe transitions between states, MSMs are able to appropriately capture the equilibrium
thermodynamic and kinetic behaviors of a system. It is important to note that the underlying
assumption behind MSM construction is that the discretized dynamics of biomolecules is mem-
oryless (aka Markovian). That is, the probability of a transition from state i to state j at time t
is only dependent on state i and not any of the previously visited states.
For any constructed MSM, the Markovian assumption is tested by looking at implied timescales
plots of a Markov State Model. That is, for a given state decomposition, the molecular relax-





These timescales ti are plotted for a series of lag-times τ (C.8). If the timescales remain rel-
atively unchanged for a series of τ values and higher, then the models constructed for those
values of τ can be considered Markovian. The values of Pij can then be estimated using a
variety of estimation methods [40, 42].
A critical component of high-quality MSM construction is the features selected in the dis-
cretization of state space. It is important to balance statistical error against systematic bias
when choosing, as narrow features ranges may result in poor statistics, while broadly-ranged
features may have large systematic errors due to convolution of multiple motions into a single
state. Choice of appropriate feature can challenging due to the sheer size of simulation datasets
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and the system-specific knowledge often need to identify appropriate features.
While methods such as PCA might provide some degree of feature-reduction, a major break-
through in simulation featurization was the use of time-lagged independent component analysis
(tICA) [43], which transforms input coordinates to identify the rarest (which are assumed to be
the slowest) motions. For protein folding simulations, this provides excellent dimensionality
reduction, since the slowest coordinate is often the rarest and most valuable [44, 45]. How-
ever, in simulations of folded proteins the rarest motions observed may be less interesting or
artifacts of sampling due to the simulation size. Much success has previously been seen using
geometric features, such as cartesian coordinates or dihedral angles [46–48]. Other features
such as solvent accessible surface area (SASA) or ligand-residence-time have also been useful
for construction of predictive MSMs [48, 49].
Once appropriate features are selected, there are a myriad of approaches to cluster them into
discrete states. One major method is a hybrid k-centers/k-medoids approach [50, 51]. In brief,
for every pair of features a distance metric, such as the Root Mean Square Deviation (RMSD)
is computed. The k-centers algorithm then (i) chooses an initial cluster center either as a
predetermined point or randomly, and then all points are assigned to this initial cluster. (ii) The
distance between every point and its assigned cluster center is then computed. (iii) The point
with the largest distance to the assigned cluster center is then labelled as a new cluster center.
(iv) The distances between all points and all cluster centers are recalculated, and points are
reassigned to their closest cluster center based on these new labels. Steps (ii− iv) are repeated
until the maximum distance from any point to its assigned cluster center goes below a specified
threshold, or a maximum number of cluster centers is reached.
To refine the cluster center assignments, and ensure that the “center” of each cluster is truly
equidistant from all assigned points, a k-medoids algorithm known as Partitioning around
Medoids (PAM) [51] is used. PAM proceeds by iterating through each cluster and choosing
a new center from one of the currently assigned points. All points across all states are then
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reassigned based on this new proposed cluster center. From this proposed center, a ”cost”
is calculated (i.e. the sum of distances from each point to their respective center), and the
proposed center placement is accepted if the cost is minimized. Once states are discretized,
clustered, assigned across a simulation trajectory, the transition probability matrix is estimated.
As mentioned above, the matrix of transitions between states is counted based on some lag time
τ .
One simple approach to estimate transitions is to count the number of transitions from states i
to j between all states, and divide by the number of states i observed. To maintain ergodicity,
some methods only estimate over the largest connected subset of states [52] or using maximum
likelihood estimators that respect detailed balance [53]. One method to estimate transition





where Cij is the observed number of transitions from state i to state j, and Cji represents
the number of transitions in the reverse direction. Subsequent row normalization is used to










whereCtransposeij is the averaged number of transitions between states i and state j, andC
transpose
k,j
is the number of transitions between states k and j. Recent success has been observed by sim-
ply adding a pseudocount C̃ to serve as an estimate of the system in absence of data [42, 54].





where N is the number of states.
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1.2.3 The scalable power of Folding@home has generated insights into
protein behaviors.
There are many success stories that have come out of the usage of the Folding@home plat-
form such as the observation of a millisecond-timescale folding event in 2010 [46]. Markov
state models have been shown to quantitatively agree with experimental measurements [40,55].
Particularly, there is excellent agreement between microsecond-scale simulations and the prop-
erties of systems measured with NMR and room-temperature crystallography [56, 57]. Fur-
thermore, simulations have been able to interpret the impact of mutations on diseases such
as phenylketonuria [58] and characterize the landscapes of a myriad of targets [59]. Fold-
ing@home and MSMs have allowed for the assessment of families of protein homologs [10].
Folding@home has also made significant progress in developing and supplementing experi-
mental work with predictive models. For example, Folding@home data was used to identify
novel cryptic pockets in TEM-1 β-lactmase [49], the enzyme most directly involved in an-
tibiotic breakdown and microbial resistance. Indeed, accounting for the dynamics within the
active site of TEM-1 β-lactamase substantially improved the predictive ability of modern vir-
tual screening technologies [9]. Similar approaches have yielded valuable insights into the pH
dependence of protein-protein interactions [60], and other biological phenomena.
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1.3 Allosteric communication is critical for protein function,
but difficult to infer.
1.3.1 Allosteric communication is universal and critical for biological func-
tion.
One cellular phenomena existing at long-timescales is communication between distant struc-
tural elements of a protein. This behavior, referred to as allostery [61], was first recognized in
hemoglobin [62] where the binding of oxygen to a single subunit increases the oxygen affinity
within the other three subunits. Since then, the importance of allostery has been recognized in
a myriad of cellular functions, such as transcription factors [63, 64] or cellular signaling [65].
A well-studied protein (and drug target) with allosteric behavior is the G protein coupled re-
ceptor, which transmits information from outside the cell to inside based on a stimulus. This
stimulus can be anything from ligand binding [66] to membrane deformations [67]. Structural
methods revealed rearrangements of transmembrane helices that convert the GPCR into an “ac-
tive” form [68]. However, recent data of different GPCR-Gα complexes have highlighted the
conformational heterogeneity in the allostery and activation of GPCRs [20–23].
The idea that a protein’s conformational landscape can impact its allosteric behavior leads one
to speculate if all proteins have some degree of allosteric coupling [69]. Indeed, the ubiquity
of allostery has been acknowledged in studies of natural and directed evolution [70,71], where
mutations distant from the active site can impact measured properties. Given the potentially
universal nature of allostery, it is worth speculating if mutations and ligands work by tapping
into existing allosteric networks to modulate the distributions of a protein’s of structures and
dynamics [41]. Thus, understanding allosteric coupling in proteins could present new oppor-
tunities for modulating biological processes, designing therapeutics, or even designing new
proteins.
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Mounting evidence highlights the value in leveraging allostery to modulate protein function.
There are a multitude of biological systems where allostery is leveraged to inhibit or activate
protein-protein interactions, and so it may be possible to identify small molecules that could
achieve the same objective of modulating protein behaviors. An allosteric drug that could
modulate protein behaviors could play a huge role in restoring lost functions or reducing over-
active protein behaviors. However, modern drug-design methods often require the presence
of a cavity (or “pocket”) to successfully design small molecule hits. Many surfaces involved
in protein-protein interactions are often too flat for a small molecule to bind tightly [72], and
targeting known ligand binding sites of critical signaling proteins like GPCRs creates the risk
of off-target effects. Identifying distant pockets that are not as conserved between homologs
could be a means to achieve specificity [73].
Hidden allosteric sites known as ‘cryptic pockets’ could be promising targets for drug design
methods. The shape-shifting nature of proteins implies the existence of states that contain new
pockets that are not observed in existing experimental structures. The hidden pockets may also
be cryptic allosteric sites that are connected to key functional sites via the underlying allosteric
network of a protein [74]. Successful methods have emerged to identify novel allosteric sites,
some of which have been verified by experiments [49]. Indeed, the value of cryptic pockets
has been supported by the discovery of small molecule inhibitors that are shown to bind an
allosteric pocket and modulate a protein’s function [9, 75–77]. Computer simulations provide
promising avenues to hunt and target cryptic pockets, an effort which has yielded promising
results [78, 79], but it remains a challenge to apply these approaches to a wide variety of sys-
tems. Furthermore, the discovery of a distant pocket in a protein does not imply it is “useful”
as a drug target, because it is difficult to measure the degree of coupling between the cryptic
pocket and a protein’s functional regions (like active site). Understanding the communication
between a cryptic pocket to functional regions of a protein could further supplement drug de-
sign strategies. However, obtaining a complete picture of the allosteric network of a protein is
often difficult.
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1.3.2 Inferring allosteric communication in proteins remains a non-trivial
task.
Methods for inferring allostery typically rely on observing concerted structural changes. A
system with two distant sites may jump between alternative configurations in some coupled
fashion. That is, the structure of site A may be coupled to the configuration of site B, and
vice versa. This extreme example of conformational selection could be inferred by comparing
structures of proteins before and after some perturbation to one of the sites is introduced (such
as ligand binding). Indeed, crystallography and HDX methods have proved useful in revealing
residues involved in allosteric networks of TIM-barrels and their catalytic domains [80]. Mul-
tiple NMR methods have also proven useful in studying the nature of allosteric communication
between proteins [81].
Likewise, computational methods measure concerted structural changes using a variety of met-
rics on a myriad protein features. Some methods utilize sequence coevolution to group proteins
regions into “sectors” that are coupled to one another [82]. Recent work has highlighted that
molecular simulations can capture atomistically detailed pictures of allosteric coupling between
sites. The underlying assumption that a proteins functional states are encoded in the equilibrium
simulations implies that observing correlated motions in MD simulations would be representa-
tive of the degree of coupling between residues. Indeed, a number of algorithms use a myriad
of features and metrics to quantify coupling [83,84]. Some features used could be the backbone
Cα atoms of proteins, and measuring the degree of covariance in pairs of Cα atoms [85]. Other
methods utilize mutual information methods on dihedral angles to quantify how much better
one residue’s dihedral angle predicts the dihedral angle of another residue [86]. However, there
has been growing recognition that allostery via concerted structural changes is not the only
mechanism through which two sites may be coupled.
In recent years the role of conformational entropy in allosteric communication has been increas-
ingly acknowledged. The importance of conformational entropy was first described theoreti-
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cally in 1984 by Cooper and Dryden [87]. Since then experimental evidence for this “dynamical
allostery” has grown. Particularly, NMR data demonstrated two sites on a transcription factor
were coupled with no discernible structural changes [88]. Furthermore, intrinsically disordered
regions can also play a role in allosteric coupling, as normally ordered regions of a protein may
transition locally into higher-entropy excited states that rapidly hop between multiple ther-
modynamic minima. This flattening of the effective free energy surface for a set of residues
distinguishes dynamic allostery from the previously discussed mechanism of concerted struc-
tural changes. More recently, it has become apparent that to understand a protein’s allosteric
network, it is important to observe both concerted structural changes and altered conforma-
tional entropy [89]. The ability to construct allosteric networks, by measuring both structure
and disorder, has the potential to explain the mechanism of coupling in many complex biologi-
cal process and may present opportunities to identify promising druggable pockets and the role
they play in modulating protein function.
1.4 Scope of thesis.
It remains a critical challenge to understand allostery to completely describe biological be-
havior. The potential power of MD simulations to explain complex biological processes in
atomistic detail presents a promising avenue to achieve these goals, but the tools to do so re-
main limited in scope, and generating simulation datasets that capture slow allosteric processes
remains difficult. This thesis describes an approach to understand allosteric communication and
the conformational landscape of proteins, and leverages these insights towards understanding
fundamental biological phenomena or supplementing drug design efforts.
In this thesis I will describe a method to infer allosteric coupling in MD simulations via both
concerted structural changes and conformational entropy. This will be done by measuring the
Correlation of All Rotameric and Dynamical States (CARDS) – a novel method presented in
chapter 2. This algorithm builds upon previous works that infer allostery through structural
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changes by capturing allostery through changes in conformational entropy. It parses dihedrals
into dynamical states, capturing whether a rotamer is ordered (remaining in a single basin) or
disordered (rapidly hopping between basis). We then describe our framework to measure cou-
pling between every pair of residues by computing communication between rotameric states,
between dynamical states, as well as cross-correlations. We apply the CARDS methods to a
system with known dynamic allostery, the Catabolite Activator Protein (CAP), a transcription
factor whose allosteric behavior was previously measured in NMR and ITC studies.
Chapter 3 describes the application of CARDS and other MD/MSM methods to a known al-
losteric system of importance, the heterotrimeric G proteins. Heterotrimeric G proteins are
molecular switches that regulate everything including vision, smell, and neurotransmission.
Malfunctions in G protein activation are implicated in cancers such as uveal melanoma. While
considerable work has characterized G protein thermodynamics and kinetics, a complete mech-
anism of activation remains unclear including the allosteric network coupling the receptor and
nucleotide binding sites. Here we describe in atomistic detail for the first time a complete mech-
anism of G protein activation, GDP release, and the conformational and dynamical changes
driving this process.
Chapter 4 describes the discovery of a hidden cryptic pocket in the previously ‘undruggable’
ebolavirus protein VP35. The seeding strategy described in chapter 3 is applied to the RNA-
binding VP35 protein. A cryptic pocket is identified from a Folding@home dataset, and
CARDS identifies the degree of coupling between the cryptic pocket and residues important
for Protein-Protein and Protein-Nucleic-Acid interactions (PPIs and PNIs, respectively). The
existence of this cryptic pocket is supported using experiments, and the functional importance
of this distant allosteric site is solidified using experimental techniques that observe VP35 in-
hibition after pocket-open state is stabilized.
Chapters 5 and 6 describe recent efforts utilizing Folding@home to study SARS-CoV-2, the
virus behind the COVID19 pandemic. In chapter 5, we rapidly generate conformations of
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the Nucleocapsid protein folded domains, and integrate them with Monte Carlo simulations
and experiments. This study shows that the Nucleocapsid protein is dynamic, disordered, and
undergoes Liquid Liquid Phase Separation (LLPS) behavior. Folding@home simulations of the
folded domain are used to seed Monte Carlo simulations of the intrinsically disordered regions
of the Nucleocapsid protein, obtaining a complete picture of the free energy landscape; a feat
which would not have been achieved using a single method. These simulations are integrated
with experimental data to describe a model explaining how the N protein may package the
genome.
In Chapter 6, I describe a recent effort where Folding@home shifted focus to simulating po-
tential drug targets in the proteome of the SARS-CoV-2 virus, the cause of the COVID19
pandemic. Many citizen-scientists around the world rallied together, downloading the Fold-
ing@home app and running simulations of almost every possible protein from SARS-CoV-
2. This effort generated a historic 0.1 seconds of equilibrium simulation data using Fold-
ing@home. Included is a description of how, through generations donations and partnerships,
Folding@home surpassed the exascale barrier in computing speed, a feat never before achieved
in human history. We utilize this monumental computational power to study how the viral
Spike protein uses conformational masking to evade an immune response, and identify cryp-
tic pockets that are not present in existing experimental snapshots. The data generated by
Folding@home presents new potential targets for drug design efforts, and new structural and
mechanistic insights that may supplement the design of therapeutics.
Chapter 7 demonstrates how MD simulations can be integrated with standard structural bi-
ology techniques to explain mechanisms of antibiotic resistance. The cefotaximase enzyme
CTXM is responsible for the breakdown of many modern cephalosporins, which can result
in microbial resistance and sustained infections. With each new drug generated, such as Cef-
tazidime (CAZ), CTXM has been shown to accrue mutations that grant it enhanced resistance
profiles. This chapter will focus on two mutations, D240G and P167S. Counter-intuitively,
these mutations are not additive in their behavior, and the presence of both mutations abrogates
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the CAZ resistance profile in CTXM. Combining MD and crystallographic methods, along
with biochemical approaches, we describe how these mutations alter the acyl-enzyme complex
and modulate a key-region in CTXM known as the Ω-loop. We show that while each mutation
uniquely modulates the Ω-loop to better accomdate CAZ, both mutations revert the conforma-
tional behavior of the Ω-loop back to its non-resistant state. This study demonstrates the unique
ability of combining MD with structural biology methods to better understand fundamental be-
haviors and biological phenomena.
Lastly, in chapter 8 I summarize the main advancements presented within this thesis. This
chapter further explores the general implications of these findings and how allosteric cou-
pling may be a universal phenomena. I expand by discussing future projects, discussing fu-
ture promising questions, and speculate on the prospect of further integrating simulations with




Quantifying allosteric communication via
both concerted structural changes and
conformational disorder
The work in this chapter is published in: Singh, S., and Bowman, G.R., Quantifying al-
losteric communication via both concerted structural changes and conformational disorder
with CARDS. Journal of Chemical Theory and Computation. 13:1507-1517, 2017. PMID:
28282132., Copyright 2018 American Chemical Society [90]
2.1 Abstract
Allosteric (i.e. long-range) communication within proteins is crucial for many biological pro-
cesses, such as the activation of signaling cascades in response to specific stimuli. However,
the physical basis for this communication remains unclear. Existing computational methods for
identifying allostery focus on the role of concerted structural changes, but recent experimental
work demonstrates that disorder is also an important factor. Here, we introduce the Correla-
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tion of All Rotameric and Dynamical States (CARDS) framework for quantifying correlations
between both the structure and disorder of different regions of a protein. To quantify disorder,
we draw inspiration from methods for quantifying “dynamic heterogeneity” from chemical
physics to classify segments of a dihedral’s time evolution as being in either ordered or disor-
dered regimes. To demonstrate the utility of this approach, we apply CARDS to the Catabo-
lite Activator Protein (CAP), a transcriptional activator that is regulated by Cyclic Adenosine
MonoPhosphate (cAMP) binding. We find that CARDS captures allosteric communication
between the two cAMP-Binding Domains (CBDs). Importantly, CARDS reveals that this cou-
pling is dominated by disorder-mediated correlations, consistent with NMR experiments that
establish allosteric coupling between the CBDs occurs without a concerted structural change.
CARDS also recapitulates an enhanced role for disorder in the communication between the
DNA-Binding Domains (DBDs) and CBDs in the S62F variant of CAP. Finally, we demon-
strate that using CARDS to find communication hotspots identifies regions of CAP that are
in allosteric communication without foreknowledge of their identities. Therefore, we expect
CARDS to be of great utility for both understanding and predicting allostery.
2.2 Introduction
Despite its fundamental importance, understanding of the physical mechanisms of allosteric
communication remains incomplete. For example, significant effort has gone into studying
how G-Protein Coupled Receptors (GPCRs) allosterically transmit extracellular signals to in-
tracellular binding partners [91]. However, understanding of this process is still insufficient for
the routine design of drugs that allosterically modulate GPCRs [92].
Models of allostery have typically focused on concerted structural changes [93]. For example,
the classic induced fit model postulates that ligand binding to one subunit of a protein causes
a conformational change in other subunits [94, 95]. The conformational selection model also
focuses on structural changes, positing that ligand binding to one subunit stabilizes an alter-
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native (but pre-existing) structure of other subunits [96]. Extensive work establishes there is
often a role for conformational selection [97], though there is clearly a continuum between
extreme versions of induced-fit and conformational selection [98–100]. This conclusion im-
plies allostery can be inferred from proteins’ equilibrium fluctuations even in the absence of an
allosteric perturbation. Inspired by this implication, numerous methods have been developed
to infer allosteric communication from structural fluctuations observed in molecular simula-
tions [83, 85, 86, 101–119].
While concerted structural changes are clearly important for allostery, there is mounting evi-
dence that conformational disorder has an important role to play, and can even lead to allosteric
communication in the absence of concerted structural ,transitions [64, 93, 120–125]. The im-
portance of allostery without conformational change first appeared in a model where ligand
binding perturbs the entropy of a distant site rather than its preferred structure [87]. Since then,
NMR and ITC experiments on Catabolite Activator Protein (CAP) have established allosteric
communication without conformational change exists in nature [19,88,126]. CAP is a homod-
imeric transcription factor whose DNA-binding affinity increases upon binding of cAMP to the
cAMP-Binding Domains (CBDs) [127, 128]. In wild-type CAP, cAMP binding allosterically
induces the DNA-Binding Domains (DBDs) to swivel around the central hinge region into a
DNA-binding conformation (Fig. 2.1) [129, 130]. There is also negative coupling between the
two CBDs [127, 128, 131]. A combination of NMR and ITC measurements reveal that binding
of cAMP to one CBD reduces the cAMP-binding affinity of the second CBD without changing
its structure [88, 131]. Additional experiments reveal that binding of cAMP activates the S62F
variant of CAP without causing a conformational change in the hinge or DBDs [63, 132].
While the importance of disorder is gaining widespread acceptance, the field lacks systematic
methods for identifying allosteric communication in the absence of conformational change.
For example, NMR has yet to uncover how these signals are transmitted. COREX/BEST
[121, 133, 134], other coarse-grained models [107], and normal modes [135] provide valuable
insights but miss essential subtleties, such as important side-chain motions. Using molecular
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Figure 2.1: Structures of CAP in apo and holo forms. A. Structure of apo-CAP, with cAMP-
binding domains (CBDs) and DNA-binding domains (DBDs) indicated by brackets. Residues
that make up the hinge region are colored in red. B. Structure of holo-CAP with cAMP ligands
(spheres) bound to the CBD regions. The same hinge residues are colored in red.
dynamics simulations to measure the mutual information between the orientations of different
dihedral angles captures the reduction in uncertainty (measured with an entropy metric) about
the structure of one dihedral given knowledge of another [86, 108, 109], but does not capture
phenomena like changes in the rotameric state of one dihedral increasing the conformational
heterogeneity of a distant site. Approaches for inferring allosteric coupling from sequence co-
variation [82, 136] are agnostic to the mechanism underlying this communication and cannot
explain how it occurs. A method for identifying timing correlations has promise for captur-
ing disorder-mediated coupling [89]. For example, application of this approach to side-chain
degrees of freedom in CAP successfully identified hotspots for allosteric communication. It
also demonstrated that disorder-mediated correlations give rise to long-range communication,
while purely structural correlations are limited to short-ranged communication. However, tim-
ing correlations do not integrate structural and dynamical correlations into a holistic measure
of communication that can capture the continuum of possibilities between purely structural and
purely disorder-mediated coupling.
Here, we introduce the CARDS (Correlation of all Rotameric and Dynamical States) methodol-
ogy for quantifying the roles of both concerted structural changes and conformational disorder.
CARDS is based on our observation that a single degree of freedom (e.g. a dihedral angle) can
transition between “ordered” regimes, wherein it undergoes small fluctuations within a single
22
structural state, and “disordered” regimes wherein it undergoes bursts of transitions between
different structural states (Fig. 2.2). Similar “dynamic heterogeneity” [137–139] has been ob-
served in the physics of glasses, where it has been shown that a single degree of freedom’s
local environment can either facilitate dynamics by flattening out the effective free energy sur-
face that degree of freedom experiences or freeze out dynamics [140–142]. CARDS identifies
ordered and disordered regimes based on two kinetic signatures: the average time a degree of
freedom persists within a structural state and the typical timescale for transitions between struc-
tural states. For many dihedrals, we observe that the typical time that elapses between structural
transitions, which is dominated by segments of a trajectory in disordered regimes, is orders of
magnitude smaller than the typical persistence time in a state. Based on these kinetic signa-
tures, CARDS assigns segments of trajectories to dynamical states (i.e. ordered and disordered
regimes). CARDS then quantifies correlations between the structural and dynamical states of
different dihedrals. Specifically, we employ the mutual information to assess how much bet-
ter one can predict the structural and dynamical states of one dihedral given knowledge of the
structural and dynamical states of another dihedral. To demonstrate the utility of CARDS, we
assess whether it can identify allosteric communication in the absence of concerted structural
changes observed in CAP.
2.3 Theory and methods
CARDS captures all forms of correlated fluctuations, including concerted structural changes,
correlations between the conformational disorder of different degrees of freedom, and corre-
lations between the structure of one degree of freedom and the conformational disorder of
another. As in other recent work, we focus on dihedral angles, as they are natural degrees of
freedom for describing protein structure and dynamics and are easily decomposed into a small
number of rotameric states [86, 109].
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Figure 2.2: Workflow for identifying ordered and disordered regimes. A. An example of the
time-evolution of a χ1 angle. The core of each rotameric state is shaded green and the buffer
zones between them are white. B. Assignment of each snapshot in the trajectory to rotameric
states. C. Transition indicator function identifying where the dihedral changes states. Examples
of ordered (τord) and disordered (τdis) times are labeled. D. Assignment of each snapshot in the
trajectory to dynamical states (e.g. ordered and disordered regimes).
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2.3.1 Molecular Dynamics simulations
We ran three 500 ns simulations with our previously published protocol [9] (see SI for details).
Briefly, we placed PDB ID 4N9H [130] in a dodecahedron box and solvated it with TIP3P
explicit solvent [143] extending 1 nm beyond the protein in any dimension. We used PyMOL
[144] to mutate Ser62 to Phe to create a starting structure for the S62F variant. For each
system, we ran simulations with the Gromacs software package [145] using the Amber03 force
field [146]. This combination of software and parameters was selected because it has proven
reliable in our past studies of both protein folding [55] and structural fluctuations within folded
proteins [9,56,147]. As described in the Results section, our microsecond timescale simulations
are sufficient to recapitulate much of what is known from experiments about allostery in CAP.
The correlation coefficient between the couplings obtained from any individual simulation and
the combination of three simulations is 0.64±0.02, suggesting that hundreds of nanoseconds of
simulation may be sufficient to discover gross patterns of communication but are insufficient to
obtain converged results. The correlation coefficient between the coupling obtained from any
pair of simulations and the combination of three simulations is 0.79±0.02, suggesting that 1-1.5
microseconds of simulation give more reproducible results. Taken together with our past work,
we conclude that a few microseconds of simulation are adequate to demonstrate the utility of
our new method and, likely, to gain valuable insights into many systems.
2.3.2 Assignment of dihedrals to rotameric states
Dihedral angles were calculated with MDTraj [148] and assigned to discrete rotameric states
(e.g. gauche+, gauche-, and trans for most χ angles and cis or trans states for backbone di-
hedrals). Transition-Based Assignment (TBA) is used to distinguish lasting transitions from
transient fluctuations [149–152]. TBA prevents over-counting of transitions (e.g. due to fluctu-
ations at a barrier peak where a simulation repeatedly crosses a hard cutoff between rotameric
states) by defining a core region within each rotameric state and buffer zones between them. A
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dihedral is only considered to have changed rotameric states if it transitions from the core of
one state to the core of another state, passing completely through the buffer zone between cores
(Fig. 2.2A and 2.2B). A dihedral that starts in one core, enters a buffer zone, and then returns
to its initial core is said to have remained in the initial rotameric state. We define the core of
a rotameric state as a region of width W centered between the boundaries between rotamers.
We present results using a core width of 90°, but our results are robust to variations in the core
width ranging from 60° to 90° (Fig. A.1A)
2.3.3 Assignment of snapshots to dynamical states
CARDS assigns snapshots to ordered and disordered regimes based on two variables that de-
scribe the dynamics of the trajectory: the mean ordered time (τord) and mean disordered time
(τdis). An ordered time (τord) is the time from any time-point to the next time where a transi-
tion occurs and a disordered time (τdis) is the time between two consecutive transitions (Fig.
2.2C). These times are called persistence and exchange times in the condensed matter physics
literature [141, 142, 153]. For many dihedrals, we observe that 〈τdis〉  〈τord〉 because (〈τdis〉)
is dominated by the short times between transitions in disordered regimes, whereas 〈τord〉 is
heavily influenced by the lengthy times without any transitions in ordered regimes. To calcu-
late these times, CARDS first identifies the time points where a dihedral transitions between
two different rotameric states (Fig. 2.2C), referred to as the transition indicator function. The
method then extract the complete set of τdis and τord values in the trajectory. Next, CARDS
classifies each segment of a trajectory between two consecutive transitions as being in an or-
dered or disordered regime based on whether the length of the segment t between the transi-
tions is more consistent with the distribution of ordered or disordered times (Fig. 2.2D). We
find that transitions within ordered and disordered regimes are roughly Poisson processes with
different characteristic times (〈τord〉 and〈τdis〉, respectively), see Fig. A.2. Therefore, CARDS
determines if a segment of a trajectory of length t between two consecutive transitions is more
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where Pdis is the probability the segment is disordered and Pord is the probability it is ordered.
Taking inspiration from the interpretation of Bayes factors [154], CARDS classifies a segment
of a trajectory as being disordered if L > 3.0, otherwise the trajectory segment is classified
as being in an ordered regime. Our results are robust to varying this cutoff from 1.5 to 5 (Fig.
A.1B).
2.3.4 Calculation of structural, disorder-mediated, and holistic correla-
tions
The primary objective of CARDS is to calculate the total correlation between different dihe-
drals, including both their rotameric state and dynamical state (e.g. whether the dihedral is
in an ordered or disordered regime at a given time). Towards this end, we define the holistic
correlation (IH) between dihedrals X and Y as
IH(X, Y ) = Iss(X, Y ) + Idd(X, Y ) + Ids(X, Y ) + Isd(X, Y ) (2.2)
where Iss(X, Y ) is the normalized mutual information between the structure (i.e. rotameric
state) of dihedral X and the structure of dihedral Y , Isd(X, Y ) is the normalized mutual infor-
mation between the structure of dihedral X and the dynamical state of dihedral Y , Ids(X, Y ) is
the normalized mutual information between the dynamical state of dihedral X and the structure
of dihedral Y, and Idd(X, Y ) is the normalized mutual information between the dynamical state
of dihedral X and the dynamical state of dihedral Y . The mutual information (I) is:









where x ∈ X refers to the set of possible states that dihedralX can adopt, p(x) is the probability
that dihedral X adopts state x, and p(x, y) is the joint probability that dihedral X adopts state
x and dihedral Y adopts state y. We define the normalized mutual information (I(X, Y )) as




where C(X, Y ) is the maximum possible mutual information between two dihedrals, called the
channel capacity [155]. Using this normalized mutual information allows for a direct compari-
son between the different components of the holistic correlation by correcting for the fact that
the largest possible mutual information between different types of dihedrals will vary based
on how many different states there are. For example, a side-chain dihedral has three possible
rotameric states but only two possible dynamical states, so structural correlations (Iss) can be
as large as log(3) while the correlations between dynamical states (Idd) can only reach as high
as log(2).
In addition to the above, we define the disorder-mediated correlation (IDM ) as all forms of
correlation between two dihedrals that rely, at least in part, on disorder (Isd + Ids + Idd). This
construct is useful for assessing the importance of disorder relative to existing methods based
purely on concerted structural changes (Iss). We use bootstrapping to measure the uncertainty
in our estimates of all the components of the holistic correlation to ensure any comparisons
we make are statistically sound. Specifically, we draw 20 random samples of our trajectories,
with replacement, and calculate the structural and disorder-mediated correlations between all
pairs of residues. We conclude that disorder-mediated communication dominates if the aver-
age disorder-mediated communication minus the standard deviation across all our bootstrap
samples is greater than the mean structural correlation plus the standard deviation.
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2.3.5 Calculation of net communication to a target site
We are often interested in calculating how much influence a particular residue has over another
site, such as an active site or ligand-binding site. To calculate the communication between a
reference residue and some target site, we take the average mutual information between two
sets of dihedrals: 1) all dihedrals in the reference residue and its nearest neighbors and 2) all
dihedrals in the target site. We define the nearest neighbors of a reference residue as all residues
with atoms that fall within 3 Å of any atom in the reference residue. Varying this cutoff does
not alter our results (Fig. A.1C). Including both a reference residue and its nearest neighbors
accounts for the fact that mutating the reference residue will directly change the environment
of all neighboring residues.
2.3.6 Calculation of global communication
In addition to identifying residues that have strong correlations to a specific target site, it would
also be valuable to identify residues that generally appear to play an important role in allosteric
networks. Towards this end, we define the global communication strength of a residue as the
sum of its holistic correlations to all other residues. For these calculations, we also include
neighboring residues, as in our calculation of the net communication to a target site.
2.4 Results and discussion
2.4.1 Many dihedrals have the potential for disorder-mediated commu-
nication
For a dihedral to have ordered and disordered regimes, 〈τord〉 must be significantly larger than
〈τdis〉. We reasoned that determining if 〈τord〉 ≥ 3× 〈τdis〉 is a reasonable heuristic for iden-
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tifying dihedrals with separable ordered and disordered regimes based on the likelihood ratio
defined in Eq. 2.1. Dihedrals that do not meet this criterion are classified as entirely being in
ordered regimes and, therefore, are only capable of having structural correlations with other
dihedrals.
Based on the criterion defined above, we find that 556 of the 1584 dihedrals in CAP have sepa-
rable ordered and disordered regimes and, therefore, are capable of disorder-mediated commu-
nication with other dihedrals (Fig. A.3). Mapping these dihedrals to the apo structure of CAP
highlights a number of interesting patterns (Fig. 2.3). First of all, CARDS reveals that many
side-chain dihedrals buried in CAP’s core are capable of disorder-mediated communication.
This finding helps to rectify the apparent contradiction between the common physical intuition
that proteins’ cores should be rigid due to their tight packing and the observation that there
is substantial conformational heterogeneity within proteins’ cores [57, 156]. That is, dihedrals
within a protein’s core are commonly locked in a single rotameric state for extended periods of
time but rare fluctuations create room for conformational changes. Backbone dihedrals that are
capable of disorder-mediated communication tend to reside on the protein’s surface. Notably,
a number of these backbone dihedrals are in β-sheets that contact cAMP. However, there are
also backbone dihedrals within the core that are capable of disorder-mediated communication.
For example, we find backbone dihedrals within the central hinge region that are capable of
disorder-mediated communication. This observation is noteworthy because the hinge region
undergoes a large conformational change upon activation of CAP (Fig. 2.1) [63, 131, 132]. We
find that similar patterns emerge when we vary the cutoff for determining whether a dihedral
has separable ordered and disordered regimes (Fig. A.4). In the future it will be interesting to
examine whether separate proteins, or homologous members of a family, have similar propor-
tions and patterns of dihedrals that are separable into ordered and disordered regimes. How-
ever, given the opportunity to only analyze a limited number of sufficiently sampled datasets
so far [?, 10, 48].
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Figure 2.3: Residues whose dihedrals are capable of disorder-mediated communication. A.
Residues with at least one backbone dihedral that is capable of disorder-mediated communi-
cation (orange). B. Residues with at least one side-chain dihedral that is capable of disorder-
mediated communication (green).
2.4.2 Disorder-mediated correlations dominate communication between
the CBDs
Given experimental evidence for allosteric communication between the CBDs without a con-
certed structural change [63], we expect the disorder-mediated component of the holistic cor-
relation between these sites to be larger than the purely structural component. To test this
prediction, we simulated apo CAP for 1.5 µs and calculated the net communication of every
residue to one of the cAMP-binding sites. Specifically, we defined the target site as all residues
with heavy atoms within 6Åof one of the two cAMP molecules in the holo crystal structure
(PDB ID 1CGP) [129]. The residues in this target site are 30, 36, 49, 61-62, 64, 69-86, and 99
from chain A and residues 122-129 from chain B.
As predicted, CARDS successfully identifies that there is communication between the two
CBDs. Fig. 2.4A shows the holistic correlations to a single cAMP-binding site. Unsurprisingly,
the residues with the strongest correlations to this set of residues reside within the same CBD.
However, there is also strong communication between the target site and residues lining the
other cAMP-binding pocket. There are also strong correlations on the central hinge region
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and the interface between the CBDs and DBDs that may be responsible for allosteric coupling
between these domains.
To determine the relative importance of disorder-mediated communication and purely struc-
tural correlations, we broke the holistic communication into structural and disorder-mediated
components. Furthermore, we used bootstrapping to estimate the uncertainty in each of these
components.
Figure 2.4: Communication to a single CBD. A. Holistic mutual information (IH) of each
residue to the residues lining a single cAMP-binding pocket (shown in sticks). B. Residues
whose communication to the cAMP-binding pocket is dominated by disorder-mediated com-
munication (orange sticks). Residues lining the target cAMP-binding pocket are in blue sticks.
Identifying residues where disorder-mediated communication to the target cAMP-binding site
is larger than purely structural correlations automatically identifies a number of residues in the
second cAMP-binding site (Fig. 2.4B, Fig. A.5). This finding demonstrates that CARDS reca-
pitulates the experimental finding that communication betwen the two CBDs does not primarily
occur through concerted structural changes [63]. CARDS also identifies disorder-dominated
communication within a single CBD. Furthermore, the Pearson correlation coefficient between
structural and disorder-mediated communication is 0.44. This result indicates there are some
similarities between patterns of allosteric coupling that could be observed by focusing entirely
on structural correlations and those identified by CARDS, but that considering disorder pro-
vides additional information.
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2.4.3 Disorder-mediated communication is enhanced in the S62F variant
The S62F variant of CAP is still activated by cAMP binding [63,132,157,158]. However, NMR
studies have revealed that the conformation of the DBDs does not change upon cAMP binding.
Rather, NMR and ITC experiments suggest an important role for conformational entropy, with
the DBDs only changing conformation in the presence of both cAMP and DNA [63, 132].
Therefore, we expect an increase in disorder-mediated communication between the CBDs and
DBDs in the S62F variant, compared to wild-type CAP.
To determine the effect of the S62F variant, we also ran 1.5 µs of simulation of this variant.
Then we calculated the holistic communication to a single cAMP-binding site, as described for
wild-type CAP.
As expected, we observe significant increases in disorder-mediated communication between
the target CBD and the DBDs. There are particularly large increases in disorder-mediated cor-
relations in regions of known importance for CAP activation, such as the central hinge region
and along the interfaces between the CBDs and DBDs (Fig. 2.5A). At the same time, there are
some decreases in disorder-mediated communication within the CBDs. There are also changes
in purely structural correlations. These changes often follow the same qualitative trends as the
changes in disorder-mediated communication. However, the magnitudes of any increases in
purely structural correlations are considerably smaller than the increases in disorder-mediated
correlations. Furthermore, reductions in structural correlations are often larger than any de-
creases in disorder-mediated communication.
2.4.4 Side-chain-side-chain and backbone-side-chain correlations domi-
nate allosteric communication in CAP
To begin understanding the relative importance of different types of degrees of freedom, we
plotted the matrix of correlations between every pair of dihedrals (Fig. 2.6A). The upper trian-
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Figure 2.5: Change in coupling to a single CBD pocket upon the S62F mutation. A. Change in
disorder-mediated communication of each residue to the single cAMP-binding pocket depicted
in Fig. 2.4. B. Change in structural communication of each residue to the same cAMP-binding
pocket. Red indicates increased communication in S62F compared to wild-type, and blue indi-
cates decreased communication.
gle represents purely structural correlations, while the lower triangle represents purely disorder-
mediated correlations. Side-chain and backbone dihedrals are also grouped together to enable
comparisons between the relative strengths of backbone-backbone, backbone-side-chain and
side-chain-side-chain correlations. Inspection of the matrix of all pairwise correlations im-
mediately reveals that side-chain-side-chain correlations dominate allosteric communication in
CAP. This observation is consistent with previous reports that side-chain degrees of freedom
are more variable than the backbone [57, 156, 159–165]. Backbone-backbone correlations are
far rarer, and we find that disorder-mediated correlations between backbone dihedrals are more
common than structural correlations. We also find a small number of backbone dihedrals that
appear to be hubs of communication that are coupled to the side-chains of a large fraction of
the residues in CAP. These hubs appear as lines in the backbone-side-chain quadrants of the
matrix in Fig. 2.6A. Mapping the strongest (top 5%) backbone hubs to the structure reveals
that they cluster in two regions: the phosphate-binding cassette (PBC) of each CBD and the
interface between the CBDs and DBDs, including the central hinge (Fig. 2.6B). Using an even
stricter cutoff (top 2%) only identifies residues along the CBD-DBD interface and within the
central hinge (Fig. A.6), further emphasizing their importance in the allosteric network. This
result suggests that perturbations to these functionally important regions (e.g. cAMP binding)
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can influence the behavior of the entire protein, and vice versa.
It is also possible that the assumed Poissonian distribution of dihedral timescales may impact
the degree of measured communication. While these are long-tailed distributions, it is not clear
if they are truly Poissonian, and proving this behavior may prove a non-trivial task. While we
already observe that our measurements are robust to the choice of Likelihood Ratio cutoff (Fig-
ure A.1). It will be worth exploring whether or not other exponential distributions can be used
to more appropriately model the probability of being ordered or disordered when computing a
likelihood ratio.
More importantly, using a different binning strategy than 3-state or 2-state designations can
improve measurements of allosteric coupling. These rotameric state designations are based on
classic alkane stereochemistry, and assume flat prior. Given the chemical diversity of amino
acids, it is possible that some dihedrals will never explore all rotameric states. For example a
phenylalanine χ2 will not explore all three possible rotameric states due to the aromatic ring on
the sidechain. One possible avenue to improve the measurement of dihedral communication is
to incorporate established rotamer libraries into the rotameric state decomposition [166, 167].
Using library-based designations,and their standard error measurements to define buffer region
widths, would correct the currently-used flat prior. This would increase the reliability of mea-
surement of dihedral communication while still allowing us to assess the role of side-chain di-
hedrals against backbone dihedrals in communication. However, it is important to note that the
current binning strategy being used is robust when assessed with metrics such as bootstrapping
or Excess Mutual Information. Excess Mutual Information has been shown as a robust way
of detecting noise in measuring allosteric communication, and major dihedral communication
patterns are still evident after this correction [47]. Consistently, we observe that communica-
tion measurements remain significant (ie. not within error of zero) (see Appendix B and Figure
A.1). It is worth noting that utilizing this naı̈ve, residue-independent binning system is already
capable of making measurable predictions of protein allostery [48, 54].
35
Figure 2.6: Hubs of backbone-side-chain communication in wild-type CAP. A. Mutual infor-
mation between every pair of dihedrals in wild-type CAP. The upper triangle of the matrix
(above the green diagonal) represents structural communication and the lower triangle (below
the green diagonal) represents disorder-mediated communication. The pink and cyan squares
encompass the regions of the matrix that capture backbone-side-chain communication that is
mediated by disorder-mediated and structural coupling, respectively. B. Structure of wild type
CAP highlighting the residues that are the strongest hubs (top 5%) of backbone-side-chain
communication (red sticks).
2.4.5 Locating communication hotspots identifies key functional sites
The coincidence of backbone dihedrals that are hubs of communication and key functional sites
suggests that CARDS may be capable of predicting the locations of such sites. Indeed, if evo-
lution has selected for communication between particular sites, then one might expect residues
in these sites to have stronger coupling to other regions of a protein than typical residues.
To detect strongly communicating residues, we ranked each residue based on the sum of its
correlations to all other residues in the protein. This measure of global communication will
highlight two types of hotspots: 1) hubs with correlations to many residues and 2) residues that
have strong correlations to a few residues.
Coloring each residue in the apo structure according to its global communication highlights
that the central hinge region and the helices between the two cAMP-binding sites are key me-
diators of allosteric communication in CAP (Fig. 2.7). There are also hotspot residues in
other parts of the cAMP-binding sites and along the interfaces between the CBDs and DBDs.
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These are precisely the regions that were identified by assessing communication to a single
cAMP-binding site, providing evidence that CARDS can indeed identify key functional sites
without foreknowledge of their locations. This conclusion is further supported by the fact that
the central hinge region has even stronger communication in the S62F variant (Fig. A.7).
Figure 2.7: Global communication strength of each residue in apo CAP.
2.5 Conclusion
CARDS provides a means to integrate concerted structural changes and disorder-mediated cor-
relations into a holistic view of allostery. Application of this approach to wild-type CAP and
the S62F variant demonstrates the method’s ability to identify allosteric coupling in the ab-
sence of concerted structural changes. Specifically, we showed that examining the coupling
of every residue to a known cAMP binding site naturally highlights regions of the protein that
are known to be impacted by cAMP binding, such as the second cAMP binding site and the
central hinge region connecting the CBDs and DBDs. Decomposing the correlations between
these sites into disorder-mediated and purely structural components demonstrates an important
role for disorder-mediated coupling in the absence of concerted structural changes. Our global
communication metric also provides a means to identify important functional sites without
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foreknowledge of their existence and locations. For example, this metric identifies the central
hinge region—which undergoes the largest conformational change upon activation—and the
cAMP binding pockets as important components of the allosteric network in CAP. Therefore,
CARDS should be a powerful means to identify allosteric networks in systems that have not
been studied as thoroughly as CAP. Taken together, we expect CARDS to be of great utility for
understanding allostery in systems where it is already known to occur, as well as for predicting
allostery in systems where it has yet to be observed.
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Chapter 3
Simulation of spontaneous G protein
activation reveals a new intermediate
driving GDP unbinding
This chapter is adapted from the following publication:
Sun, X.∗ and Singh, S.∗, Blumer, K.J., and Bowman, G.R., Simulation of spontaneous G pro-
tein activation reveals a new intermediate driving GDP unbinding. eLife, 7, October 2018,
https://doi.org/10.7554/eLife.38465.001 [48] ∗Authors contributed equally to this work
3.1 Abstract
Activation of heterotrimeric G proteins is a key step in many signaling cascades. However, a
complete mechanism for this process, which requires allosteric communication between bind-
ing sites that are ∼30 Å apart, remains elusive. We construct an atomically detailed model
of G protein activation by combining three powerful computational methods: metadynamics,
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Markov state models (MSMs), and CARDS analysis of correlated motions. We uncover a
mechanism that is consistent with a wide variety of structural and biochemical data. Surpris-
ingly, the rate-limiting step for GDP release correlates with tilting rather than translation of the
GPCR-binding helix 5. β-Strands 1-3 and helix 1 emerge as hubs in the allosteric network that
links conformational changes in the GPCR-binding site to disordering of the distal nucleotide-
binding site and consequent GDP release. Our approach and insights provide foundations for
understanding disease-implicated G protein mutants, illuminating slow events in allosteric net-
works, and examining unbinding processes with slow off-rates.
3.2 Introduction
Heterotrimeric G proteins are molecular switches that play pivotal roles in signaling processes
from vision to olfaction and neurotransmission [168–170]. By default, a G protein adopts an
inactive state in which guanosine diphosphate (GDP) binds between the Ras-like and helical
domains of the α-subunit (Gα, Fig. 3.1). A dimer consisting of the β- and γ-subunits (Gβγ)
also binds Gα. G protein-coupled receptors (GPCRs) trigger G protein activation by binding
Gα and stimulating GDP release, followed by GTP binding to Gα and dissociation of Gα from
Gβγ. Gα and βγ then interact with effectors that trigger downstream cellular responses. Gα
returns to the inactive state by hydrolyzing GTP to GDP and rebinding Gβγ. Given the central
role Gα plays, a common Gα numbering scheme (CGN) has been established to facilitate
discussion of the activation mechanisms of different Gα homologs [171]. For example, the
notation Lys52G.H1.1 indicates that Lys52 is the first residue in helix 1 (H1) of the Ras-like
domain (also called the GTPase domain, or G). S6 refers to β-strand 6 and s6h5 refers to the
loop between S6 and H5.
Strikingly, the GPCR- and nucleotide-binding sites of Gα are ∼30 Å apart (Fig. 3.1), but
the allosteric mechanism coupling these sites to evoke GDP release remains incompletely un-
derstood [169]. Biochemical and structural studies have elucidated some key steps, but the
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Figure 3.1: Structure of Gαq with key secondary structure elements labeled according to the
Common Gα Numbering (CGN) system. The coloring scheme highlights the GPCR bind-
ing interface (gray), GDP phosphate-binding regions (pink), GDP nucleotide-binding regions
(green), β-sheets (blue), and switch 2 (orange).
entire process has yet to be described in atomic detail. Early studies of Gα subunits revealed
structures of the GDP- and GTP-bound states, as well as the transition state for GTP hydrol-
ysis [172–174]. The high similarity of these structures and the binding of GDP or GTP deep
in the protein’s core suggests that activation occurs by adoption of other conformational states
that allow GDP release [175]. One intermediate in G protein activation was suggested by the
first crystal structure of a GPCR-bound G protein in which the Ras-like and helical domains of
Gα are hinged apart and GDP has dissociated [68]. Structural analysis has led to the proposal
of a universal mechanism for G protein activation [171]. In this model, GPCR binding induces
translation of H5 away from H1, which increases disorder in H1 and the P-loop (or Walker A
motif [173]) to facilitate GDP release. However, there is evidence that additional intermediates
may be involved in Gα activation [169, 174, 176, 177],and the functional importance of this
conformational ensemble has been previously suggested [178]. Furthermore, mutagenesis and
nuclear magnetic resonance (NMR) studies have suggested important roles for other structural
elements [179–181].
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Molecular dynamics simulations promise to capture the entire mechanism of G protein activa-
tion and synthesize the wealth of experimental data on this process. Methodological advances
now enable simulations to capture millisecond timescale processes for proteins with less than
100 residues [182]. For example, it is now possible to capture the binding or release of small
molecules [47, 99, 183–185] and peptides [186, 187] from small proteins. Impressive simu-
lations on the ANTON supercomputer have revealed critical conformational dynamics of G
proteins in their inactive and active states, elucidating the role of domain opening in GDP un-
binding [188, 189]. However, even this specialized hardware could not capture the entire pro-
cess of G protein activation and GDP release due to the size of the Gα subunit (>300 residues)
and the slow kinetics of GDP dissociation (∼ 10−3 min−1) [190–192].
Here, we introduce an approach to capture rare or long-timescale events, such as GDP release,
and reveal the mechanism of Gα activation. As a test of this methodology, we apply it to
Gαq, which has one of the slowest GDP release rates [190] and is frequently mutated in uveal
melanoma [193, 194]. To highlight aspects of the activation mechanism that we propose are
general to all G proteins, we focus our analysis on the behavior of secondary structure elements
and amino acids that are conserved across Gα domains. Our approach first combines two
powerful sampling methods, metadynamics [195] and Markov state models (MSMs) [196],
to observe GDP release and identify the rate-limiting step for this slow process. Then we
use our recently developed CARDS method [90], which quantifies correlations between both
the structure and disorder of different regions of a protein, to identify the allosteric network
connecting the GPCR- and nucleotide-binding sites. The resulting model is consistent with
a wealth of experimental data and leads to a number of predictions, described below. Taken
together, our results provide the most comprehensive model of G protein activation to date.
Based on this success, we expect our approach to be valuable for studying other rare events,
including conformational changes and unbinding processes.
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3.3 Results and Discussion
3.3.1 Capturing G-protein activation and GDP release in atomic detail
We reasoned that studying the mechanism of spontaneous GDP release from a truncated form
of Gαq would be representative of the mechanism of GPCR-mediated activation of the het-
erotrimeric G protein while minimizing the computational cost of our simulations. This hy-
pothesis was inspired by previous work demonstrating that a protein’s spontaneous fluctuations
are representative of the conformational changes required for the protein to perform its func-
tion [14, 97, 197]. Therefore, we hypothesized that GPCRs stabilize conformational states that
G proteins naturally, albeit infrequently, adopt in the absence of a receptor. We chose to focus
on Gα since it forms substantial interactions with GPCRs, compared to the relatively negligible
interactions between GPCRs and G protein β and γ subunits. This view is supported by the fact
that GPCRs and ‘mini’ G proteins, essentially composed of just the Ras-like domain of Gα, re-
capitulate many features of GPCR-G protein interactions [198]. We also reasoned that truncat-
ing the last five residues of Gαq would facilitate the activation process. These residues contact
Gα in some GDP-bound structures but not in GPCR-bound structures [199,200], and removing
these residues promotes GDP release due to a reduced GDP-binding affinity [201, 202]. Taken
together, such evidence suggests that the last five residues of Gαq help stabilize the inactive
state and that removing them would accelerate activation. In support of this hypothesis, we find
that the energetic barrier to GDP release is lower in metadynamics simulations of the truncated
variant than for full-length Gαq (Figure B.1). These simulations, and those described hereafter,
were initiated from an X-ray structure of the Gαq heterotrimer bound to GDP and an inhibitor
of nucleotide exchange [203]; Gβγ and the inhibitor were excluded from all simulations.
To observe G-protein activation, we developed a variant of adaptive seeding [204] capable of
capturing slow processes like ligand unbinding that are beyond reach of conventional simu-
lation methods. First, we use metadynamics [185, 195, 205] to facilitate broad sampling of
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conformational space by biasing simulations to sample conformations with different distances
between GDP and Gαq. Doing so forces GDP release to occur but provides limited mech-
anistic information because adding a biasing force can distort the system’s kinetics or cause
the simulations to sample high-energy conformations that are not representative of behavior
at thermal equilibrium. To overcome these limitations, we chose starting conformations along
release pathways observed by metadynamics as starting points for standard molecular dynam-
ics simulations, together yielding an aggregate simulation time of 122.6 µs. These simulations
should quickly relax away from high-energy conformations and provide more accurate kinet-
ics. Then we use these simulations to build an MSM (Source data 1). MSMs are adept at
extracting both thermodynamic and kinetic information from many standard simulations that,
together, cover larger regions of conformational space than any individual simulation [196].
Related approaches have successfully captured the dynamics of small model systems [206] and
RNA polymerase [207].
This protocol enabled us to capture the entire mechanism of G-protein activation, including
GDP release and the rate-limiting step for this process. Identifying the rate-limiting step for
this process is of great value because GDP release is the rate-limiting step for G-protein acti-
vation and downstream signaling. Therefore, the key structural and dynamical changes respon-
sible for activation should be apparent from the rate-limiting conformational transition for this
dissociation process.
To identify the rate-limiting step, we applied transition path theory [208,209] to find the highest
flux paths from bound structures resembling the GDP-bound crystal structure to fully dissoci-
ated conformations. Then, we identified the least probable steps along the 10 highest flux
release pathways (Figure 3.2A and Figure B.2), which represent the rate-limiting step of re-
lease. By comparing the structures before and after the rate-limiting step, we define the bound
state as all conformations where the distance from the center of mass of GDP’s phosphates to
the center of mass of three residues on H1 that contact the GDP β-phosphate (Lys52G.H1.1,
Ser53G.H1.2, and Thr54G.H1.3) is less than 8 Å. Consistent with this definition, this distance
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remains less than 8 Å throughout the entirety of 35.3 µs of GDP-bound simulations.
Figure 3.2: Structural and dynamical changes during the rate limiting step for GDP release.
A. Overlay of representative structures before (blue) and after (orange) the rate limiting step.
B. Change in conformational disorder (Shannon entropy) across the rate-limiting step, accord-
ing to the color scale on the right. C. Histograms of inter-domain distances before (top, blue)
and after (middle, orange) the rate limiting step, along with the inter-domain distance distribu-
tion after GDP is released (bottom, black). Inter-domain distance is measured using residues
analogous to those used in DEER experiments [188], Leu97H.HA.29 in the helical domain and
Glu250G.H3.4 on H3. D. Distribution of distances between Glu49G.s1h1.4 and Arg183G.hfs2.2
(left) before (blue) and after (orange) the rate-limiting step, as well as after GDP release (black).
Representative structures of the interacting residues are also shown (right).
The conformational changes we observe during the rate-limiting step are consistent with pre-
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vious structural and biochemical work. For example, we observe that the Ras-like and helical
domains separate (Figure 3.2C), as observed in DEER experiments [210] and previous simu-
lations [188]. This finding is consistent with the intuition that these domains must separate to
sterically permit GDP release, and that this separation is driven by the disruption of multiple
inter-domain interactions. For example, we note a disrupted salt bridge between K275G.s5hg.1
and D155H.hdhe.5 (Figure B.4), previously identified in structural studies [171]. Domain open-
ing is accompanied by disruption of a key salt bridge between Glu49G.s1h1.4 of the P-loop and
Arg183G.hfs2.2 of switch 1 (Figure 3.2D), as well as an increase in the disorder of many of the
surrounding residues (Figure 3.2B and Figure B.3A), consistent with the proposal that this salt
bridge stabilizes the closed, GDP-bound state [176].
While domain opening is necessary for GDP release, previous simulations suggest it is insuf-
ficient for unbinding [188]. Indeed, we also see that this opening is necessary but not suffi-
cient for GDP unbinding, as the Ras-like and helical domains often separate prior to release
(Figure 3.2C). Notably, the Ras-like and helical domains only separate by ∼10 Å during the
rate-limiting step. In contrast, these domains separate by 56 Å in the first structure of a GPCR-
G-protein complex. This result suggests that GDP release may have occurred long before a
G protein adopts the sort of widely opened conformations observed in crystallographic struc-
tures [68].
3.3.2 Tilting of H5 helps induce GDP release
We also observe less expected conformational changes associated with GDP release. The most
striking is tilting of H5 by about 26° (Figure 3.3A, and Figure B.6). We find that H5 tilting
correlates strongly with the distance between GDP and Gαq along the highest flux dissociation
pathway (Figure 3.3B and B.1). In particular, substantial tilting of H5 is coincident with the
rate-limiting step for GDP release. This tilting contrasts with X-ray structures and the universal
mechanism, in which H5 is proposed to translate along its helical axis towards the GPCR,
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initiating the process of GDP release (Figure 3.3A). During our simulations we also observe
translation of H5, but it is not correlated with the rate-limiting step of GDP release (Figure
3.3C, Figure B.7). Therefore, we are not merely missing an important role for translation due
to insufficient sampling.
The potential importance of H5 tilting is supported by other structural data. For example, a
crystal structure of rhodopsin [211] with a C-terminal fragment from H5 of Gαt shows a similar
degree of tilting (Figure 3.3A). Also, the tilt of H5 varies in crystal structures of the β2AR-Gs
complex [68], two different GLP-1 receptor-Gs complexes [176, 212], and an A2AR-mini-Gs
complex [198]. The potential relevance of tilting has also been acknowledged by a number of
recent works [68, 171, 213] including four recently published structures of receptor-G-protein
complexes across which H5 also shows a broad range of tilting and translational motion [20–
23]. Interestingly, the tilting and translation we observe falls within the observed range of tilting
and translational motions that H5 undergoes in available GPCR-G protein complex structures
[20–23, 68], providing support that conformational selection plays an important role (B.1).
Finally, H5 is translated toward the GPCR in the A2AR-mini-Gs structure but GDP remains
bound [198]. The authors of that study originally suggested that one of the mutations in mini-Gs
decouples H5 translation from GDP release. However, given that we see GDP release without
H5 translation in our simulations, it is also possible that amino acid substitutions required to
create mini-Gs instead mitigate H5 tilting. Both of these models are consistent with the fact
that some of the mutations in mini-Gs stabilize the GDP-bound state [180].
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Figure 3.3: Tilting of H5 is correlated with GDP release but translation of H5 is not. A.
Displacements of H5 relative to the GDP-bound crystal structure (blue). The three other orien-
tations of H5 come from the rate-limiting step in our model (orange), the co-crystal structure
of Gαs and β2AR (green, PDB ID 3SN6 [68]), and the co-crystal structure of a C-terminal
fragment of Gαt and rhodopsin (magenta, PDB ID 3PQR [211]). The black arrows highlight
the change in orientation of the long axis of each helix. A representative GPCR (gray) and Gα
(white) structure are shown for reference. B. GDP release distance across the highest flux path-
way, defined as the distance from the GDP β-phosphate to the center of mass between residues
Lys52G.H1.1, Ser53G.H1.2, and Thr54G.H1.3 on H1. The state marking the rate-limiting step is
highlighted by the blue dashed line. C. H5 motion across the highest flux pathway. The dis-
tances measured here representing H5 motion are taken from the same states as in B. H5 tilting
(orange) is measured by the distance between Leu349G.H5.16 and Tyr325G.S6.2. Likewise, H5
vertical motion (green) is measured by the distance between Thr334G.H5.1 and Phe341G.H5.8.
The rate-limiting step is marked with the blue dashed line, extended down from B.48
We propose that tilting of H5 is an early step in the GDP release process, which is followed by
upward translation of this helix to form a GPCR-G protein complex primed to bind GTP. This
hypothesis stems from our observation that tilting of H5 is coincident with the rate-limiting
step for GDP release, while translation of H5 only becomes stable after GDP dissociates (Fig-
ure 3.3C). This model is consistent with previous suggestions that G-protein activation occurs
through a series of sequential interactions with a GPCR [68, 169]. Another possibility is that
any displacement of H5, whether tilting or translation, may be sufficient to trigger GDP release.
3.3.3 Identification of the allosteric network that triggers GDP release
While conformational changes of H5 are important for Gα activation, other regions could also
play a role [177, 180]. However, it is not straightforward to determine what other structural
elements contribute to activation or their importance relative to H5. Our hypothesis that spon-
taneous motions of a protein encode functionally relevant conformational changes suggests that
the coupling between the GPCR- and nucleotide-binding sites of Gα should be present in sim-
ulations of the inactive protein; This provides a means to identify key elements of this allosteric
network. To test this hypothesis, we ran 35.3 µs of simulation of GDP-Gαq. Then we applied
the CARDS method [90] to detect correlations between both the structure and dynamical states
of every pair of dihedral angles. Structural states are determined by assigning dihedral angles
to the three dominant rotameric states for side-chains (gauche+, gauche-, and trans) and the
two dominant rotameric states for backbone dihedrals (cis and trans). Dynamical states are
determined by whether a dihedral angle remains in a single rotameric state (ordered) or rapidly
transitions between multiple rotameric states (disordered). These pairwise correlations serve
as a basis for quantifying the correlation of every residue to a target site, such as the GPCR-
binding site. Combining these correlations with structural and dynamical changes in our model
of GDP release provides a basis for inferring how perturbations to the GPCR-binding site are
transmitted to the nucleotide-binding site. We focus our analysis on the most direct routes
for communication between the GPCR- and nucleotide-binding sites by following correlated
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motions that emanate from structural elements that directly contact GPCRs until they reach
the GDP-binding site. There are correlations between many other elements of Gαq, including
parts of the helical domain, that branch off of this allosteric network. Such correlations may be
important for aspects of Gα function besides activation, but are beyond the scope of the present
study, which focuses on how GPCR-binding impacts nucleotide release.
To understand how H5 tilting triggers GDP release, we first identified structural elements with
strong coupling to H5 and then worked our way outward in repeated iterations until we reached
the nucleotide-binding site (Figure 3.4). This analysis reveals that tilting of H5 directly com-
municates with and impacts the conformational preferences of the s6h5 loop, which contacts
the nucleobase of GDP (Figure 3.4 and Figure 3.5). During the rate-limiting step, these contacts
are broken and there is increased disorder in the s6h5 loop, particularly Ala331 of the TCAT
motif (Figure 3.5 and Figure B.3B). The importance of the TCAT motif in our model is con-
sistent with its conservation and the fact that mutating it accelerates GDP release [214–216].
Based on our model, we propose these mutations accelerate release by weakening shape com-
plementarity with GDP.
We also observe an important role for communication from H5 to H1, consistent with the uni-
versal mechanism. In particular, H1 is strongly coupled with the s6h5 loop (Figure 3.4B),
which is sensitive to displacement of H5. In the rate-limiting step, s6h5 moves away from H1,
contributing to an increase in disorder of H1 and the P-loop (Figure B.3A and Figure B.3B).
Increased disorder in a set of residues that directly contact the GDP phosphates (Glu49G.s1h1.4,
Ser50G.s1h1.5, Gly51G.s1h1.6, Lys52G.H1.1, and Ser53G.H1.2) likely contributes to a reduced affin-
ity for GDP (Figure B.3A). Increased disorder in these residues also contributes to disruption of
the salt bridge between Glu49G.s1h1.4 of the Ras-like domain and Arg183G.hfs2.2 of the helical
domain, facilitating inter-domain separation.
We further note that the s6h5 loop impacts the nucleotide-binding site through allosteric cou-
pling with the HG helix, which also contacts GDP via Lys275G.s5hg.1 and Asp277G.HG.2 (Fig-
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Figure 3.4: Allosteric network connecting H5 motion to the nucleotide binding-site via s6h5.
CARDS data showing communication per residue to a target site (dashed box) is plotted (left)
and mapped onto the structure of Gαq (right) for (A) H5, (B) s6h5, (C) HG, (D) H1, and (E)
the P-loop. Arrows indicate regions of importance with significant communication to the target
site.
ures 3.4E and 3.6). The disorder of both of these residues increases during the rate-limiting
step, consistent with observations of increased mobility in HG upon receptor-mediated ac-
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Figure 3.5: Change in the s6h5 loop conformation across the rate-limiting step. Distribution
of distances (left) from GDP’s β-phosphate to Ala331G.s6h5.3 on the s6h5 loop before (blue)
and after (orange) the rate-limiting step, as well as after GDP release (black). Representative
structures of the s6h5 loop (right) are shown for before (top right, blue) and after (bottom right,
orange) the rate limiting step.
tivation (Oldham and Hamm, 2008). There are also correlations between the P-loop and
Lys275G.s5hg.1 on Helix G (Figure 3.4E), which result from the disruption of a key salt bridge
between Lys275G.s5hg.1 and Glu49G.s1h1.4 on the P-loop during the rate-limiting step (Figure
3.6). Lys275G.s5hg.1 is conserved across all Gα families, suggesting it plays an important role
in the stability or function of the protein. However, attempts to experimentally examine the
role of this residue by mutating Lys275G.s5hg.1 have resulted in aggregation [180]. Our simula-
tions suggest Lys275G.s5hg.1 plays an important role in stabilizing the GDP-bound state and that
breaking the salt bridge with Glu49G.s1h1.4 facilitates GDP release. This finding demonstrates
the utility of our atomistic simulations, as we can examine the role of residues that are difficult
to probe experimentally.
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Figure 3.6: Probability distributions of the distance between the side-chains of Lys275G.s5hg.1
and Glu49G.s1h1.4. Distributions were computed for the bound (blue), rate-limiting step (or-
ange), and dissociated (black) states. Representative structures (above) for the bound (left,
blue) and rate-limiting step (right, orange) are included with residues as sticks.
3.3.4 H1 and β-sheets are communication hubs
To identify other important structural elements in the allosteric network underlying G protein
activation, we followed correlated motions emanating from other sites that are known to interact
directly with GPCRs, including the hNs1 loop, the h3s5 loop, and the h4s6 loop [169]. We
find that h3s5 and h4s6 are largely isolated, suggesting they play a role in forming a stable
GPCR-G protein complex but not in the allosteric mechanism that triggers GDP release. This
finding is consistent with sequence analysis suggesting these structural elements are important
determinants of the specificity of GPCR-Gα interactions [217]. In contrast, the hNs1 loop has
strong correlations with β-strands S1-S3 (Figure 3.7). These strands, in turn, communicate
with H1, switch 1, and the P-loop.
Integrating our correlation analysis with structural insight from the rate-limiting step described
above suggests an important role for S1-S3 in a complex allosteric network that couples the
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Figure 3.7: CARDS data showing communication per residue to a target site (dashed box) is
plotted (left) and mapped onto the structure of Gαq (right) for (A) hNs1, (B) S1, (C) S3, (D)
S2, and (E) H1. Arrows indicate regions of importance with significant communication to the
target site.
GPCR- and nucleotide-binding sites (Figures 3.7 and 3.8, Figure B.8). S2 and S3 twist relative
to S1 and away from H1 (Figures 3.2A and 3.9, Figure B.10). This twisting disrupts stacking
between Phe194G.S2.6 on S2 and His63G.H1.12 on H1 and increases disorder of side-chains in
H1 (Figures 3.2B and 3.9, Figure B.3C). Increased disorder in H1 is also a crucial component
of the proposed universal mechanism, but in that model translation of H5 is the key trigger
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for changes in H1. The role for the β-sheets in our model is consistent with previous work
identifying interactions between S2 and H1 [171], NMR experiments showing chemical ex-
change in the methyls of S1-S3 upon receptor binding [179], and mutational data. In particular,
Flock et al. have previously noted the important interaction between residues Phe194G.S2.6 and
His63G.H1.12 [171].
Figure 3.8: Allosteric network connecting the GPCR- and nucleotide-binding interfaces. The
coloring scheme corresponds to that used in 3.1, highlighting the GPCR binding interface
(gray), GDP phosphate-binding regions (pink), GDP nucleotide-binding regions (green), and
the β-sheets (blue).
Figure 3.9: π–stacking between S2 and H1 is disrupted during the rate-limiting step. Distribu-
tion of the χ1 angle (bottom) of Phe194G.S2.6 on S2 before (blue) and after (orange) the rate-
limiting step, as well as after GDP release (black). Representative structures of Phe194G.S2.6
and His63G.H1.12 (top) corresponding to before and after the rate-limiting step are also shown.
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The importance of H1 and β-strands S1-S3 is underscored by mapping the global communi-
cation of every residue onto a structure of Gα (Figure B.9). The global communication of a
residue is the sum of its correlations to every other residue and is a useful metric for identifying
residues that are important players in allosteric networks [90]. Interestingly, these β-strands and
H1 have higher global communication than H5 and the s6h5 loop. This suggests that H1 and
the β-sheets integrate conformational information from multiple sources, including the hNs1
loop, and not just H5. The importance of the β-sheets and H1 for allosteric communication
is consistent with their conservation [180], which may not simply reflect the role they play in
protein folding and stability, as had been suggested previously [180, 218].
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3.3.5 GDP release alters the structure and dynamics of the Gβ-binding
site
We also find that switch 2 has strong correlations with the nucleotide-binding site, especially
switch 1 (Figure B.8). Given that switch 2 is a major component of the interface between
Gα and Gβ, this communication could enable GDP release to trigger dissociation of Gα from
Gβγ. Examining the rate-limiting step for GDP release reveals that switch 2 shifts towards the
nucleotide-binding site (Figure 3.10) and exhibits increased conformational disorder (Figure
3.2B and Figure B.3). These findings are consistent with previous kinetic studies postulating
that switch 2 dynamics are impacted prior to GDP release [219].
Figure 3.10: Switch 2 moves towards GDP across the rate-limiting step. Distance distribution
(left) of Gly207G.s3h2.1 to GDP before (blue) and after (orange) the rate-limiting step, as well
as after GDP release (black). Representative structures of Switch 2 motion are shown (right).
3.4 Conclusion
We have succeeded in simulating G protein activation, including both the allosteric coupling
between the GPCR- and nucleotide-binding sites of Gαq and consequent unbinding of GDP.
Our results reveal a previously unobserved intermediate that defines the rate-limiting step for
GDP release and, ultimately, G protein activation. Our model synthesizes a wealth of exper-
imental data and previous analyses. For example, we identify an important role for coupling
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from H5 to the s6h5 loop and H1 that is consistent with a previously proposed universal mech-
anism for G protein activation. However, we also find that this allosteric network incorporates
the hNs1 loop, β-strands S1-S3, and the HG helix. Strands S1-S3 and H1 serve as hubs in
this network, simultaneously integrating information from both H5 and the hNs1 loop. Our
observation is consistent with previous postulates that information flows from H5 and hNs1
to H1 [220]. It is important to note that our model was extracted using simulations of Gαq,
and so some correlations or changes in conformation and dynamics may apply only to Gαq.
However, by focusing our analysis on secondary structure elements and residues that are shared
across all Gα homologs, our model likely captures a universal ‘skeleton’ of changes involved
in Gα activation, expanding upon a previously proposed universal mechanism for Gα activa-
tion [171]. The consistency of our model with a wide variety of structural and biochemical data
suggests that it is a promising foundation for future efforts to understand the determinants of
GPCR-Gα interaction specificity, how mutations cause aberrant signaling and disease, and how
small molecule inhibitors modulate Gα activation. Our model also adds weight to the growing
appreciation for the fact that a protein’s spontaneous fluctuations encode considerable infor-
mation about its functional dynamics [20–23]. Construction of our model was enabled by a
powerful combination of simulation methods, namely metadynamics and MSMs. In the future,
we expect this methodology will prove valuable for understanding other slow conformational
changes and unbinding processes.
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3.5 Materials and Methods
3.5.1 Molecular dynamics simulations of GDP unbinding
System preparation
We used the crystal structure of Gα from the heterotrimeric Gαq protein (PDB entry 3AH8) as
the initial structure to set up our simulations [203]. The first 36 residues were removed prior to
simulation, as they come from Gαi, along with the Gβ and Gγ subunits which were removed
to minimize the system size and maximize our chances of observing GDP release [169].
The protein structure was solvated in a dodecahedron box of TIP3P water [143] that extended
1 nm beyond the protein in every dimension. A single Mg2+ ion was added coordinating the
phosphate groups of GDP as its presence accelerates GDP release [221]. Thereafter, Na+ and
Cl− were added to produce a neutral system at 0.15 M NaCl. The final system consists of one
GDP, one Gαq, 57 Cl−1, 64 Na+1, one Mg2+, and 18696 TIP3P water molecules, for a total of
61,893 atoms.
Molecular dynamics (MD) simulations were carried out using Gromacs [145, 222] and the
AMBER03 force field [146]. The force field parameters of GDP were obtained from the AM-
BER Parameter Database (http://research.bmh.manchester.ac.uk/bryce/amber) [223]. The sys-
tem was energy minimized with the steepest descent algorithm for 50,000 steps until the maxi-
mum force fell below 100 kJ/mol/nm using a step size of 0.02 nm and a cut-off distance of 0.9
nm for the neighbor list, electrostatic interactions and van der Waals interactions. Afterward,
the solvent was relaxed by a NVT simulation of 100 ps with the constraint of 1000 kJ/mol/nm
applied to the protein heavy atoms and 2 fs as the time step. In this relaxation simulation, the
temperature of the system is constrained to 300 K using V-rescale thermostat (with a time con-
stant of 0.1 ps) [224]. A cut-off distance of 1 nm was used for the van der Waals, short-range
electrostatic interactions. Periodic boundary conditions are applied to x, y and z directions. The
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Particle-Mesh-Ewald method is employed to recover the long-range electrostatic interactions
with 0.16 nm as the grid spacing and with a fourth order spline [225]. All the bonds connecting
to hydrogens are constrained using LINCS algorithm [226]. After the NVT relaxation, the sys-
tem further underwent an NPT simulation for one ns with the time step of 2 fs for equilibration.
The simulation parameters here are kept the same as the NVT relaxation except for the applica-
tion of Parrinello-Rahman barostat for pressure coupling [227]. After these equilibration runs,
the constraint on heavy atoms were removed for all subsequent production runs. Virtual sites
were used to allow for a 4 fs time-step [228]. We then applied a three-step protocol to simulate
GDP release.
Step one: MD simulations of the GDP-bound state
We performed 100 parallel simulations of the GDP bound state on the Folding@home [37]
distributed computing environment for an aggregate simulation time of 35.3 µs.
Step two: Metadynamics simulations
We subsequently ran metadynamics simulations [195, 229] initiated from conformations gen-
erated in step one to actively promote GDP release. Starting conformations were selected from
step one by clustering protein conformations into 625 states using a hybrid K-center/K-medoids
method [230] with a 2 Åcutoff. The 10 most populated states included conformations with large
inter-domain separation distances between the Ras-like and AH domains as measured by the
angle formed between the α-carbon atoms of Leu97H.HA.29, Asn82H.HA.14, Ile258G.H3.12, and
Glu250G.H3.4. This inter-domain angle ranged from −30° to 0°. From these states, three rep-
resentative structures were chosen with inter-domain angles of −6° (Conf. 1),−10° (Conf. 2),
and−26.6° (Conf. 3) as starting conformations for metadynamics simulations, which were run
on PLUMED [229]. We defined two collective variables for our metadynamics simulations: 1)
the distance between GDP’s phosphate groups and the backbone of Lys52G.H1.1-Thr54G.H1.3 in
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Table 3.1: Details of metadynamics simulations
Starting conformation Width of CV1 (Å) Width of CV2 (Å) Number of conformations selected
1 0.1 0.1 171
1 0.08 0.03 132
1 0.03 0.01 504
2 0.1 0.1 145
2 0.08 0.03 141
2 0.03 0.01 320
3 0.1 0.1 198
3 0.08 0.03 186
3 0.03 0.01 288
Gαq subunit (CV1), and 2) the RMSD of GDP to the starting conformation (CV2).











where t represents time, S are collective variables, ω is the energy rate and σi controls the width
of the Gaussian for the ith collective variable. Summing up the Gaussians allows us to obtain
the biased potential VG. The free energy −F (S) is derived by the assumption,
lim
t→∞
(S, t) ∼ −F (S) (3.2)
The metadynamics simulations were repeated three times for each selected representative struc-
ture using different Gaussian widths (3.1). We set the Gaussian height to 1.5 kJ/mol.
We observed the release of GDP from Gα in the metadynamics simulations and obtained the
free-energy landscape for the release. We then applied the string method [231] to detect poten-
tial release pathways and use these conformations as the seeds for simulations in step 3. We can




















































δ(zv − θv(χ))dχ (3.7)
The points determining the minimum free-energy path along the surface satisfy
0 = (Mij(z)∆F (z(α)))
⊥ (3.8)
We applied this method [232,233] to obtain a minimum free energy path, extracting 2085 con-
formations along potential GDP release pathways. Notably, we only observed the transition
from the bound state and the unbound state for one time in a single metadynamics simulation.
This implies that the predicted free-energy surface from metadynamics cannot be used to de-
scribe the release events accurately. In spite of this, we can still use the conformations along
the release pathway explored by metadynamics to seed unbiased parallel MD simulations.
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Step three: Metadynamics-seeded MD simulation of GDP release
Lastly, we carried out unbiased MD simulations initiated from the 2085 conformations obtained
from metadynamics using the Folding@home platform [37]. A total of 122.6 µs of simulation
was generated in this step. All the following analyses are based on unbiased MD simulations.
3.5.2 Identifying the allosteric network with CARDS
To determine how the GPCR- and GDP-binding regions communicate with one another, we ap-
plied the CARDS [90] methodology to simulations of the GDP-bound state of Gαq. CARDS
measures communication between every pair of dihedrals via both correlated changes in struc-
tural motions and dynamical behavior. Structural states are captured by discretizing backbone
φ and ψ dihedrals into two structural states (cis and trans), while side-chain χ angles are placed
into three states (gauche+, gauche-, and trans). Every dihedral is also parsed into dynamical
states, capturing whether the dihedral is stable in a single state (ordered), or rapidly transi-
tioning between multiple states (disordered). These dynamical states are identified using two
kinetic signatures of dihedral motion: the average time a dihedral persists in a structural state
(an ordered timescale), and the typical timescale for transitions between structural states (a dis-
ordered timescale). Parsing into dynamical states utilizes a two-step process by (i) calculating
the distribution or ordered and disordered times from the simulations and (ii) assigning each
period of time between two consecutive transitions into ordered and disordered states based on
which distribution the time between two transitions is most consistent with.
From these states, a holistic communication (IH(X, Y )) is computed for every pair of dihedrals
X and Y :
IH(X, Y ) = Iss(X, Y ) + Idd(X, Y ) + Ids(X, Y ) + Isd(X, Y ) (3.9)
where Iss(X, Y )is the normalized mutual information between the structure (i.e., rotameric
state) of dihedral X and the structure of dihedral Y , Ids(X, Y ) is the normalized mutual infor-
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mation between the structure of dihedral X and the dynamical state of dihedral Y , Isd(X, Y )
is the normalized mutual information between the dynamical state of dihedral X and the struc-
ture of dihedral Y , and Idd(X, Y ) is the normalized mutual information between the dynamical
state of dihedral X and the dynamical state of dihedral Y . The Mutual Information (I) is








where x ∈ X refers to the set of possible states that dihedralX can adopt, p(x) is the probability
that dihedral X adopts state x, and p(x, y) is the joint probability that dihedral X adopts state x
and dihedral Y adopts state y. Normalized mutual information is computed using the maximum
possible mutual information for any specific mode of communication.
From the pairwise correlation for every dihedral-pair, we extracted how much each individual
residue communicates with a target site of interest via bootstrapping with 10 random samples
with replacement. After locating the group of residues communicating most strongly with a
specific target site, we set this newly identified group as the new target site; The iteration of
this process allows us to identify a pathway of communication from one region of interest to
another. Here, we set the GPCR contact sites as our initial target sites. We then iteratively used
this approach to identify pathways connecting these contact sites with the GDP-binding site of
Gαq.
3.5.3 Markov state model construction
We clustered Gαq conformations and GDP binding states separately and combined the assign-
ments to build a Markov State Model using MSMbuilder [230, 234] and enspara [39]. First,
we clustered protein conformations into 5040 states using a hybrid k-center/k-medoids method
with 1.8 Å cutoff. Then we clustered the GDP-binding state into 321 states using the automatic
partitioning algorithm (APM) [235] with a residence time of 2 ns. By combining the assign-
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ments from protein conformations and the GDP-binding states, we obtained a total of 221,965
states. The implied timescales of this MSM show Markovian behavior with a lag time of 5
ns [236]. (Figure B.5). Analyses of distances, angles, and dihedrals of interest were carried
out using bootstrapping with ten random samples, with replacement. Results were insensitive
to varying the number of bootstrapped samples between 5 and 30. Histograms were generated
using 100 bins.
3.5.4 Quantifying conformational disorder
The disorder of every residue was measured by computing Shannon entropy [237] of each
dihedral as they are natural degrees of freedom for describing protein dynamics. Shannon





where x ∈ X refers to the set of possible states that dihedral X can adopt and p(x) is the prob-
ability that dihedral X adopts state x. Dihedral angles were calculated using MDTraj (McGib-
bon et al., 2015) and assigned to discrete rotameric states as described above using CARDS.
The entropy of a single residue was computed by summing up the entropies of its dihedrals,
and normalized by the residue’s maximum possible Shannon entropy. This maximum possible
Shannon entropy, using a flat distribution for the appropriate number of bins, is referred to as
the ’channel capacity’ and has been used to normalize other information-theoretic metrics [90].
Summing entropies within a residue establishes an upper bound on the degree of motion for a
single residue, while ignoring intra-residue correlations between dihedrals.
3.5.5 Identification of the rate-limiting step for GDP release
We used transition path theory (TPT) [208, 209] to find the highest flux paths from the bound
state to the unbound state [238]. The bound state was defined as all clusters that satisfied two
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criteria: (i) GDP is within 6 Å of the backbone atoms of Lys52G.H1.1-Thr54G.H1.1, and (ii) GDP
has an RMSD < 0.5Å to its crystallographic conformation. The unbound state was defined as
all clusters with GDP > 55Å from the binding pocket. The rate-limiting step was identified
by finding the bottleneck in the highest flux paths. To obtain this, we first calculate the flux







j , if i 6= j
0, if i = j
where q+ is the committor probability from the bound to the unbound state, and q−i is 1 − q+i ;
πi is the weighted probability, and Tij is the transition matrix. The highest flux paths can be
identified by maximizing the fluxes between the bound states and the unbound states using
c(w) = min (f+ilil+1|l = 1 . . . nw − 1) (3.12)
where il are intermediate states. From this, the slowest step was extracted as the minimum flux
step of the highest flux release pathway.
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Chapter 4
Discovery of a cryptic allosteric site in
Ebola’s ‘undruggable’ VP35 protein using
simulations and experiments
This chapter is adapted from the following publication:
Cruz, M.A.∗ and Frederick, T.E.∗, Singh, S., Vithani, N., Zimmerman, M.I., Porter, J.R., Moeder,
K.E., Amarasinghe, G.K., and Bowman, G.R., Discovery of a cryptic allosteric site in Ebola’s
’undruggable’ VP35 protein using simulations and experiments. Preprint on BioRxiv https://doi.org/10.1101/2020.02.09.940510
[54]
∗Authors contributed equally to this work
In this work, my work analyzing the allostery in VP35 and the coupling between the cryptic
pocket opening and binding interface is presented in figure 4.3 and appendix figure C.2.
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4.1 Abstract
Many proteins are classified as ‘undruggable,’ especially those that engage in protein-protein
and protein-nucleic acid interactions. Discovering ‘cryptic’ pockets that are absent in avail-
able structures but open due to protein dynamics could provide new druggable sites. Here, we
integrate simulations and experiments to search for cryptic pockets in Ebola viral protein 35
(VP35). VP35 plays essential roles in Ebola’s replication cycle, including binding the viral
RNA genome to block a host’s innate immunity. However, VP35 has so far proved undrug-
gable. Using adaptive sampling simulations and allosteric network detection algorithms, we
uncover a cryptic pocket that is allosterically coupled to VP35’s key RNA-binding interface.
Experimental tests corroborate the predicted pocket and confirm that stabilizing the open form
allosterically disrupts RNA binding. These results demonstrate simulations’ power to char-
acterize hidden conformations and dynamics, uncovering cryptic pockets and allostery that
present new therapeutic opportunities.
4.2 Introduction
Many proteins have proved so difficult to target with small molecule drugs that they are often
classified as undruggable, greatly limiting the scope of drug design efforts. In fact, up to 85%
of human proteins have been classified as undruggable because their folds are thought to lack
binding pockets where small molecules can bind with the affinity and specificity required for
drug design [239]. Many undruggable proteins predominantly participate in protein-protein
interactions (PPIs) and protein-nucleic acid interactions (PNIs) [72, 240]. In contrast to the
binding pockets that many enzymes and receptors use to bind their small molecule ligands,
the large flat interfaces involved in PPIs and PNIs do not lend themselves to forming many
favorable interactions with small drug-like molecules. As a result, PPIs and PNIs are often
considered intractable targets even when there is strong evidence that disrupting these interac-
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tions would be of great therapeutic value.
Cryptic pockets could provide new opportunities to target undruggable proteins [41, 241], but
realizing this potential remains challenging. Such pockets are absent in available experimental
structures because they only form in a subset of excited states that arise due to protein dynamics.
Cryptic sites can serve as valuable drug targets if they coincide with key functional sites, as can
cryptic allosteric sites that are coupled to distant functional sites. However, identifying cryptic
pockets remains difficult. Most known cryptic sites were only identified after the serendipitous
discovery of a small molecule that binds and stabilizes the open form of the pocket [74, 241].
Experimental techniques for intentionally identifying and targeting cryptic pockets show great
promise [77, 242, 243], but they still leverage the simultaneous discovery of ligands that bind
and stabilize the open pocket. To overcome this limitation, a number of computational methods
have been developed to identify cryptic pockets without requiring the simultaneous discovery
of small molecules that bind them [47, 49, 244–249]. These methods have proved capable of
retrodicting a number of previously identified cryptic pockets. More importantly, applications
to a few established drug targets and other enzymes have successfully identified novel cryptic
pockets that have been corroborated by subsequent experiments [49, 79, 250].
Here, we integrate atomically-detailed computer simulations and biophysical experiments to
explore the potential utility of cryptic pockets in a target that has so far proved undruggable:
the interferon inhibitory domain (IID) of Ebola viral protein 35 (VP35). Ebola virus causes
a hemorrhagic fever that is often lethal, with case fatality rates approaching 90% in past out-
breaks [251, 252]. While recent progress in vaccine development and use of biologics, such
as antibodies, for therapeutic and prophylactic purposes show promise [252], small molecule
drugs still offer many advantages, including ease of delivery, lower cost, and longer shelf life.
The 1̃20 residue IID of VP35 is a particularly appealing drug target for combating Ebola and
other viruses in the Filoviridae family given that it has a well-conserved sequence and plays
multiple essential roles in the viral lifecycle [253]. One of its primary functions is to antag-
onize a host’s innate immunity, particularly RIG-I-like receptor (RLR)-mediated detection of
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viral nucleic acids, to prevent an interferon (IFN) response and signaling of neighboring cells
to heighten their antiviral defenses [254–256]. Crystal structures have provided a foundation
for understanding much about the mechanism of VP35-mediated IFN antagonism [257, 258].
For example, they have revealed that VP35’s IID binds both the blunt ends and backbone of
double-stranded RNA (dsRNA), and that there is a PPI between these dsRNA-binding modes
(Fig. 4.1) [258]. Disrupting any of these interactions could potentially render Ebola suscepti-
ble to a host’s innate immunity. In particular, binding to dsRNA blunt ends plays a dominant
role in IFN suppression by Ebola [259]. Indeed, mutations that reduce the IID’s affinity for
dsRNA blunt ends are sufficient to mitigate IFN antagonism, ultimately attenuating Ebola’s
pathogenicity [259–262]. So, disrupting this single binding mode could dramatically reduce
the impact of an Ebola infection on the host and potentially reduce deleterious effects, includ-
ing lethality. However, both dsRNA-binding interfaces are large flat surfaces that are difficult
for small molecules to bind tightly (Fig. 4.1). As a result, [there are no approved therapies tar-
geting VP35]. Both docking and screening attempts to discover small molecules that bind these
interfaces have not yielded sufficiently strong leads to warrant clinical development [263,264].
The discovery of cryptic pockets in VP35 could provide new opportunities for drugging this
essential viral component.
Figure 4.1: Crystal structure of two copies of VP35’s IID (dark gray) bound to dsRNA (light
gray) via two flat interfaces (PDB ID 3L25). The backbone-binding interface (blue) and blunt
end-binding interface (orange) are shown as spheres to highlight that they lack deep pockets
amenable to binding small molecules.
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4.3 Results
4.3.1 Computer simulations reveal a potentially druggable cryptic pocket.
We applied our fluctuation amplification of specific traits (FAST) simulation algorithm [35]
to enhance sampling of structures with large pocket volumes that may harbor cryptic pockets.
FAST is a goal-oriented adaptive sampling algorithm that exploits Markov state model (MSM)
methods to focus computational resources on exploring regions of conformational space with
user-specified structural features. An MSM is a network model of a protein’s energy landscape
which consists of a set of structural states the protein adopts and the rates of hopping between
them [53, 265]. Adaptive sampling algorithms enable efficient construction of MSMs by iter-
atively 1) running a batch of simulations, 2) building an MSM, and 3) selecting a subset of
the states that have been identified so far as starting points for the next batch of simulations
to maximize the chances of improving the model [266, 267]. FAST selects which states to
further simulate in a manner that balances exploration/exploitation tradeoffs by considering 1)
how well each state optimizes a user defined structural criterion (in this case maximizing the
total pocket volume) and 2) the likelihood of discovering new conformational states [35]. After
running FAST, we collected additional simulation data by launching each state on the Fold-
ing@home distributed computing environment, which brings together the computing resources
of tens of thousands of citizen scientists who volunteer to run simulations on their personal
computers. Our final model has 11,891 conformational states, providing a detailed characteri-
zation of the different structures the IID adopts but making manual interpretation of the model
difficult.
To identify cryptic pockets within the large ensemble captured by our MSM, we applied our
exposons analysis pipeline [49]. An exposon is a cluster of residues that undergo cooperative
changes in their solvent exposure. Coupling between the solvent exposure of every pair of
residues is quantified using a mutual information metric, as described in Methods. Exposons
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are often associated with cryptic sites because the opening/closing of such pockets gives rise to
cooperative increases/decreases in the solvent exposure of surrounding residues. Importantly,
once an exposon has been identified, our MSM framework provides a facile means to identify
the conformational changes that give rise to that exposon.
The IID has two significant exposons, one of which corresponds to a large cryptic pocket. The
blue exposon (Fig. 4.2A and 4.2B) consists of a set of strongly-coupled residues in helix 7
and adjacent loops and secondary structure elements. Visualizing the conformational change
that gives rise to this exposon reveals a substantial displacement of helix 7, creating a large
cryptic pocket between it and the helical domain (Fig. 4.2C). A number of residues that are
displaced along with helix 7 (i.e. A306, K309, and S310) make van der Waals contacts with the
dsRNA backbone in the dsRNA-bound crystal structure [258], so targeting this cryptic pocket
could directly disrupt this binding mode. Retrospective analysis of other validated drug targets
suggests cryptic sites created by the movement of secondary structure elements, such as the
displacement of helix 7, are often druggable [268]. The potential druggability of this cryptic site
is also supported by application of the FTMap algorithm [269, 270], which predicts a number
of hotspots within the pocket where small molecules could form a variety of energetically-
favorable interactions (C.1). Unfortunately, disrupting backbone binding is of less therapeutic
utility than disrupting blunt end binding and it is unknown whether the contacts between A306,
K309, and S310 are essential for backbone binding. Therefore, it is unclear from this analysis
alone whether drugging this newly discovered cryptic pocket would be useful.
The second exposon (orange in Fig. 4.2) encompasses portions of both dsRNA-binding in-
terfaces, but it does not correspond to a cryptic pocket. This exposon includes residues that
bind dsRNA’s backbone (i.e. S272) and residues that interact with both the blunt ends and
backbone of dsRNA (i.e. F239, Q274, and I340) [258]. Therefore, altering the conformational
preferences of the second exposon could potentially disrupt the blunt end-binding mode and its
crucial role in Ebola’s ability to evade an immune response. However, the largest conforma-
tional change involved in the formation of this exposon is a displacement of the loop between
72
helices 3 and 4 (Fig. 4.2D). This rearrangement does not create a cryptic pocket that is large

















Figure 4.2: Exposons identify a large cryptic pocket and suggest potential allosteric coupling.
A. Structure of VP35’s IID highlighting residues in two exposons (blue and orange), the N-
terminus (N-term), and C-terminus (I340). B. Network representation of the coupling between
the solvent exposure of residues in the two exposons. The edge width between residues is
proportional to the mutual information between them. C. Structure highlighting the opening of
a cryptic pocket via the displacement of helix 7 that gives rise to the blue exposon. D. Structure
highlighting the conformational change that gives rise to the orange exposon overlaid on the
crystal structure (gray) to highlight that the rearrangements are subtler than in the blue exposon.
4.3.2 The cryptic pocket is allosterically coupled to the blunt end-binding
interface.
Even though the cryptic pocket does not coincide with the interface of VP35’s IID that binds
dsRNA blunt ends, it could still serve as a cryptic allosteric site that allosterically controls RNA
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binding. Indeed, the physical proximity of the two exposons and the coupling between them
both hint at the possibility for allosteric coupling. Furthermore, our exposons analysis could
easily underestimate this coupling given that it focuses on correlated transitions of residues
between solvent exposed and completely buried states, leaving it blind to more subtle confor-
mational fluctuations and the coupling of residues that are always buried (or always exposed).
To explore the potential for a broader allosteric network, we applied the correlation of all ro-
tameric and dynamical states (CARDS) algorithm [90]. CARDS classifies each dihedral in each
snapshot of a simulation as being in one of three rotameric states (gauche+, gauche-, or trans)
and one of two dynamical states (ordered or disordered). A dihedral is said to be disordered if it
is rapidly hopping between different structural states, and it is classified as ordered if it appears
to be locked into a single rotameric state for a prolonged time. The mutual information metric
is then used to quantify how strongly coupled the structural and dynamical states of each pair
of dihedrals are, enabling CARDS to capture the roles of both concerted structural changes
and conformational entropy in allosteric communication. Importantly, CARDS accounts for
the potential role of residues that are always buried or always exposed to solvent and subtle
conformational changes that do not alter the solvent exposure of residues.
CARDS reveals a broader allosteric network than that identified by our exposons analysis and
suggests strong coupling between the cryptic pocket and blunt end-binding interface (Fig. 4.3).
This network consists of five communities of strongly coupled residues, four of which coincide
with large portions of the two dsRNA-binding interfaces. One of these communities (orange) is
a hub in the network, having significant coupling to all the other communities. It encompasses
part of the orange exposon, particularly residues around the loop between helices 3 and 4. The
orange CARDS community and exposon both capture Q274, which engages in both dsRNA-
binding interfaces, and S272, which contacts the backbone [258]. However, the CARDS com-
munity includes many additional residues not captured by exposons analysis. Examples in-
clude I278, which engages in both dsRNA-binding interfaces, and D271, which is part of the
PPI between the two binding modes [258]. One of the orange community’s strongest allosteric
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connections is to the green community. This community encompasses the rest of the residues
in the orange exposon, including F239 and I340, which are part of both dsRNA-binding in-
terfaces [258]. The green community also captures additional residues, reaching deep into the
helical domain. The orange community is also strongly coupled to the blue community, which
includes much of helix 7 and nearby residues that move to give rise to the cryptic pocket that
was captured by the blue exposon. Notably, the orange and blue communities are both coupled
to a cyan cluster that was not hinted at by our exposons analysis because the residues involved
are always solvent exposed. It includes R322, which is part of the blunt end-binding inter-
face and the PPI between the two binding modes, and K282, which also contacts dsRNA blunt
ends [258]. In addition, this community includes K339, which is an important determinant
of the electrostatic favorability of dsRNA binding [258]. Together, these results suggest that
opening of the cryptic pocket could strongly impact residues involved in both dsRNA-binding
interfaces, as well as the PPI between the two binding modes.
To determine the relative importance of the structural and dynamical preferences of this com-
munity, we compared the magnitudes of the structural and dynamical components of CARDS.
This analysis revealed that concerted structural changes are the dominant mode of allosteric
communication in the IID, rather than conformational entropy and dynamical allostery (C.2).
Therefore, examining structures where the orange community undergoes large conformational
changes might reveal the perturbations these motions induce elsewhere in the protein.
To understand the potential impact of targeting the cryptic pocket on the blunt end-binding
mode, we performed a dimensionality reduction based on the orange community. Since the
orange community is a hub in the allosteric network, we reasoned that performing a dimension-
ality reduction based on the structural preferences of this community and examining represen-
tative structures would report on what is happening throughout the protein. To understand what
sort of conformational changes are present, we performed a dimensionality reduction on our
simulation dataset by applying principal component analysis (PCA) to the distances between


















Figure 4.3: eVP35 allosteric network revealed by the CARDS algorithm. A. Structure of
VP35’s IID with residues in the allosteric network shown in sticks and colored according to
which of five communities they belong to. Substitution of residues labeled in red with alanine
disrupts binding to dsRNA blunt ends and results in a dramatic reduction in immune suppres-
sion. B. Network representation of the coupling between communities of residues, colored as
in A. Node size is proportional to the strength of coupling between residues in the community,
and edge widths are proportional to the strength of coupling between the communities. C. Free
energy landscape of the orange exposon projected onto the first two principal components, PC1
and PC2, highlighting the centroid structures of the free energy minimum (gray circle) and
excited state (orange circle). D. Structures of the centroids (colored as in panel C) capture
opening of the cryptic pocket and rearrangements involving key residues for PPIs and PNIs.
first two principal components (PC1 and PC2) reveals one dominant free energy minimum and
a broad excited state (Fig. 4.3C).
Comparing representative structures for the orange community’s two dominant states suggests
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the cryptic pocket is indeed a cryptic allosteric site, targeting of which could allosterically dis-
rupt binding of VP35’s IID to dsRNA blunt ends. Most importantly, conformational changes of
the orange community are associated with opening of the cryptic pocket (Fig. 4.3D). Therefore,
targeting the cryptic pocket could modulate the entire allosteric network in addition to its po-
tential direct effect on the backbone-binding mode. Comparing the structures also reveals that
the end of helix 4 frays and the preceding loop, which sits at the PPI between the two dsRNA-
binding modes, is displaced. So, targeting the cryptic pocket could allosterically modulate this
PPI. Finally, we note a substantial reshuffling of residues F239, H231, and P273 and modest
displacements of R322 and K339. Previous work has demonstrated that F239A, R322A, and
K339A substitutions are each sufficient to disrupt dsRNA binding and IFN suppression [258].
CARDS analysis suggests targeting the cryptic pocket could allosterically alter the structures
of these residues and have a similar impact on dsRNA binding.
4.3.3 Thiol labeling experiments corroborate the predicted cryptic pocket.
One way to experimentally test our prediction of a cryptic pocket is to probe for solvent ex-
posure of residues that are buried in available crystal structures but become exposed to solvent
upon pocket opening. Cysteines are particularly appealing candidates for such experiments
because 1) they have a low abundance and 2) their thiol groups are highly reactive, so it is
straightforward to detect exposed cysteines by introducing labeling reagents that covalently
bind accessible thiols. Fortuitously, VP35’s IID has two cysteines (C307 and C326) that are
buried in available crystal structures but become exposed to solvent when the cryptic pocket
opens (Fig. 4.4A). There is also a cysteine (C275) that is on the surface of the apo crystal struc-
ture [257] and a fourth cysteine (C247) that is buried in the helical bundle. C275 is typically
solvent exposed in our simulations, as expected based on the crystallographic data. Examining
the solvent exposure of C247 revealed it is sometimes exposed to solvent via an opening of he-
lix 1 relative to the rest of the helical bundle (C.3), but FTMap did not identify any hotspots that
are likely to bind drug-like molecules in this region. Therefore, we expect to observe labeling
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of all four cysteines on a timescale that is faster than global unfolding of the protein.
To experimentally test our predicted pocket, we applied a thiol labeling technique that probes
the solvent exposure of cysteine residues [271]. For these experiments, 5,5’-Dithiobis-(2-
Nitrobenzoic Acid) (also known as DTNB or Ellman’s reagent, Fig. 4.4B) is added to a protein
sample. Upon reaction with the thiol group of an exposed cysteine, DTNB breaks into two
TNB molecules, one of which remains covalently bound to the cysteine while the other is re-
leased into solution. The accumulation of free TNB can be quantified based on the increased
absorbance at 412 nm. We have previously applied this technique to test predicted pockets in










Figure 4.4: Thiol labeling supports the existence of the predicted cryptic pocket. Structure
of VP35’s IID highlighting the locations of the four native cysteines (sticks). C307 and C326
are both buried and point into the proposed cryptic pocket. B) Structure of the DTNB labeling
reagent. C) Observed labeling rates (circles) at a range of DTNB concentrations. Fits to the
Linderstrøm-Lang model are shown in dashed colored lines and the expected labeling rate
from the unfolded state is shown as black dotted lines. The mean and standard deviation from
three replicates are shown but error bars are generally smaller than the symbols. Labeling
for C275 is not shown because it is surface exposed in both the available crystal structures
and our simulations, and it behaves as expected (labeling rate greater than 1 s−1 with a linear
dependence on [DTNB]).
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As expected from our computational model, the observed signal from our thiol labeling exper-
iments is consistent with opening of the cryptic pocket (Fig. 4.4C). Absorbance curves are best
fit by four exponentials, each with an approximately equivalent amplitude that is consistent
with expectations based on the extinction coefficient for DTNB (C.4). To assign these label-
ing rates to individual cysteines, we systematically mutated the cysteines to serines, performed
thiol labeling experiments, and assessed which rates disappeared and which remained (C.6).
For example, labeling of the C275S variant lacks the very fastest rate for wild-type, consis-
tent with the intuition that a residue that is surfaced exposed in the crystal structure (i.e. C275)
should label faster than residues that are generally buried. To test whether the observed labeling
could be due to an alternative process, such as global unfolding, we determined the population
of the unfolded state and unfolding rate of VP35’s IID under native conditions (C.7) and the in-
trinsic labeling rate for each cysteine (C.6). As shown in Fig. 4.4C, the observed labeling rates
are all considerably faster than the expected labeling rate from the unfolded state at a range of
DTNB concentrations. This result confirms that labeling of all four cysteines arises from fluc-
tuations within the native state, consistent with our computational predictions. Furthermore,
the exposure of C247 is far rarer than C307 or C326 (equilibrium constants for the exposure of
C247 and C307 are 5.4×10−4±8.1×10−6 and 8.5×10−2±2.8×10−3, respectively). Therefore,
a ligand would have to pay a greater energetic cost to stabilize the conformational change that
exposes C247 than to stabilize the open state of the cryptic allosteric site created by the motion
of helix 7.
4.3.4 Stabilizing the open cryptic pocket allosterically disrupts binding
to dsRNA blunt ends.
We reasoned that covalent attachment of TNB to C307 and C326 would provide a means to
capture the open pocket and assess the impact of stabilizing this state on dsRNA binding.
Addition of TNB to these cysteines is sterically incompatible with the closed conformation
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of VP35’s IID that has been observed crystallographically. TNB’s mass of 1̃98 Da is also
similar to many drug fragments used in screening campaigns, making it a reasonable surrogate
for the type of effect one might achieve with a fragment hit. Given that we already know
DTNB labels the IID’s cysteines, a TNB-labeled sample is easily obtainable by waiting until
the labeling reaction goes to completion. Finally, we have previously used this same strategy
to identify cryptic pockets that exert allosteric control over the activity of β-lactamase enzymes
[49,147]. To ensure that we primarily capture the effect of labeling on pocket opening, we used
a C247S/C275S variant of VP35’s IID that only has cysteines pointing into the cryptic pocket.
As with the wild-type protein, thiol labeling of the C247S/C275S variant is consistent with the
formation of the proposed cryptic pocket (Supplementary Fig. C.5).
To measure the effect of TNB labeling on the IID’s interaction with dsRNA, we developed a
fluorescence polarization (FP) assay for monitoring dsRNA binding. Paralleling our past work
on VP35-peptide interactions [272], we added varying concentrations of C247S/C275S IID to
a fixed concentration of 25-bp dsRNA with a fluorescein isothiocyanate (FITC) conjugation
at one end (C.7). Free FITC-dsRNA emits depolarized light upon excitation with polarized
light because of the molecule’s fast rotation. Binding of one or more VP35 molecules restricts
the motion of FITC-dsRNA, resulting in greater emission of polarized light, which is best
monitored by the change in anisotropy [273].
Monitoring the binding of unlabeled protein to 25-bp dsRNA with either blunt ends or 3’ over-
hangs demonstrates that our FP assay is sensitive to both dsRNA-binding modes and gives
affinities that are consistent with past work. Past work using a dot-blot assay to measure
binding reported an apparent dissociation constant (Kd) for blunt-ended dsRNA of 3.4±0.07
±M [259]. Furthermore, sterically hindering binding of the IID to dsRNA blunt ends by adding
2-nucleotide overhangs to the 3’ of the RNA reduces the apparent dsRNA-binding affinity by
10-fold [274]. This weaker interaction was attributed to the backbone-binding mode since it is
still available to VP35’s IID even when the presence of an overhang inhibits blunt end binding.
Similarly, our FP assay gives an apparent Kd of 3.6±0.34 µM for blunt-ended dsRNA (Fig.
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5A). Addition of 3’ overhangs results in a strong rightwards shift of the binding curve, consis-
tent with at least a 5-fold reduction in the apparent binding affinity (apparent Kd of 20.4±1.1
µM). However, an upper baseline could not be captured due to limitations in the protein’s sol-
ubility, so this apparent Kd is a lower bound. The data are also fit well assuming an apparent
Kd of 30.1±7.2 µM that was reported previously [274].
Figure 4.5: Stabilizing the open cryptic pocket in VP35’s IID disrupts dsRNA binding. A.
Binding of both TNB-labeled and unlabeled C247S/C275S variants of the IID to two different
dsRNA constructs. This protein variant only has cysteines in the cryptic pocket. The RNA
constructs both have a 25-bp double-stranded segment, and one has 2 nucleotide overhangs on
the 3’ ends. The anisotropy was measured via a fluorescence polarization assay and fit to a
single-site binding model (black lines). The mean and standard deviation from three replicates
are shown but error bars are generally smaller than the symbols. B. Circular dichroism (CD)
spectra of labeled and unlabeled protein demonstrate that labeling does not unfold the protein.
The opaque and semi-transparent lines represent the mean and standard deviation, respectively,
from three replicates.
Repeating our FP assay with TNB-labeled protein reveals that labeling allosterically reduces
the affinity for blunt-ended dsRNA by at least 5-fold (Fig. 4.5A). Solubility limitations again
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prevented us from observing complete binding curves for labeled protein, but the data are suf-
ficient to demonstrate that TNB-labeling has at least as strong an effect on binding as addition
of a 3’ overhang. As a control to ensure that labeling does not disrupt binding by simply un-
folding the protein, we measured the circular dichroism (CD) spectra of labeled and unlabeled
protein. The similarity between the CD spectra (Fig. 4.5B) demonstrates that the IID’s overall
fold is not grossly perturbed. The slight decrease in helicity at 220 nm can be attributed to the
covalent modification disrupting the stability of helix 5 potentially causing local unfolding of
this motif. Since the cryptic pocket does not coincide with the blunt end-binding interface, our
results suggests the impact on dsRNA binding is allosteric. Furthermore, past work demon-
strated that reducing the blunt end-binding affinity by as little as 3-fold is sufficient to allow a
host to mount an effective immune response [258], so targeting our cryptic pocket could be of
great therapeutic value.
4.4 Discussion.
We have identified a cryptic allosteric site in the IID of the Ebola VP35 protein that pro-
vides a new opportunity to target this essential viral component. Past work identified sev-
eral sites within the VP35 IID that are critical for immune evasion and viral replication [253,
256, 261, 262], but structural snapshots captured crystallographically lacked druggable pock-
ets [257, 258]. We used adaptive sampling simulations to access more of the ensemble of
conformations that VP35 adopts, uncovering an unanticipated cryptic pocket. While the pocket
directly coincides with the interface that binds the backbone of dsRNA, it was not clearly
of therapeutic relevance since binding dsRNA’s blunt ends is more important for Ebola’s im-
mune evasion mechanism [259]. However, our simulations also suggested the cryptic pocket
is allosterically coupled to the blunt end-binding interface and, therefore, could modulate this
biologically-important interaction. Subsequent experiments confirmed that fluctuations within
the folded state of the IID expose two buried cysteines that line the proposed cryptic pocket
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to solvent. Moreover, covalently modifying these cysteines to stabilize the open form of the
cryptic pocket allosterically disrupts binding to dsRNA blunt ends by at least 5-fold. Previous
work demonstrated that reducing the binding affinity by as little as 3-fold is sufficient to allow
a host to mount an effective immune response [258]. Therefore, it may be possible to attenuate
the impact of viral replication and restrict pathogenicity by designing small molecules to target
the cryptic allosteric site we report here.
More generally, our results speak to the power of simulations to provide simultaneous access
to both hidden conformations and dynamics with atomic resolution. Such information is ex-
tremely difficult to obtain from single structural snapshots or powerful techniques that report
on dynamics without directly yielding structures, such as NMR and hydrogen deuterium ex-
change. As a result, simulations are a powerful means to uncover unanticipated features of
proteins’ conformational ensembles, such as cryptic pockets and allostery, providing a foun-
dation for the design of further experiments. We anticipate such simulations will enable the
discovery of cryptic pockets and cryptic allosteric sites in other proteins, particularly those
that are currently considered undruggable. Furthermore, the detailed structural insight from
simulations will facilitate the design of small molecule drugs that target these sites.
4.5 Methods
4.5.1 Molecular dynamics simulations and analysis
Simulations were initiated from chain B of PDB 3L25 [258] and run with Gromacs [145] using
the amber03 force field [146] and TIP3P explicit solvent [143] at a temperature of 300 K and
1 bar pressure, as described previously [9]. We first applied our FAST-pockets algorithm [35]
to balance 1) preferentially simulating structures with large pocket volumes that may harbor
cryptic pockets with 2) broad exploration of conformational space. For FAST, we performed
10 rounds of simulations with 10 simulations/round and 80 ns/simulation. To acquire better
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statistics across the landscape, we performed an RMSD-based clustering using a hybrid k-
centers/k-medoids algorithm [230] implemented in Enspara [39] to divide the data into 1,000
clusters. Then we ran three simulations initiated from each cluster center on the Folding@home
distributed computing environment, resulting in an aggregate simulation time of 122 µs.
Exposons were identified using our previously described protocols,11 as implemented in En-
spara [39]. Briefly, the solvent accessible surface area (SASA) of each residue’s side-chain
was calculated using the Shrake-Rupley algorithm [275] implemented in MDTraj [148] us-
ing a drug-sized probe (2.8 Å sphere). Conformations were clustered based on the SASA of
each residue using a hybrid k-centers/k-medoids algorithm, using a 2.5 Å2 distance cutoff and
5 rounds of k-medoids updates. A Markov time of 6 ns was selected based on the implied
timescales test (C.8). The center of each cluster was taken as an exemplar of that conforma-
tional state, and residues were classified as exposed if their SASA exceeded 2.0 Å2 and buried
otherwise. The mutual information between the burial/exposure of each pair of residues was
then calculated based on the MSM (i.e. treating the centers as samples and weighting them by
the equilibrium probability of the state they represent). Finally, exposons were identified by
clustering the matrix of pairwise mutual information values using affinity propagation [276].
The CARDS algorithm [90] was applied to identify allosteric coupling using our established
protocols [48], as implemented in Enspara [90]. Briefly, each dihedral angle in each snapshot
of the simulations was assigned to one of three rotameric states (gauche+, gauche-, or trans)
and one of two dynamical states (ordered or disordered). The total coupling between each pair
of dihedrals X and Y was then calculated as
IH(XR, YR) = I(XR, YD) + I(XR, YD) + I(XD, YR) + I(XD, YD) (4.1)
where I is the mutual information metric, XR is the rotameric state of dihedral X , and XD is
the dynamical state of dihedral X . The term I(XR, YR) is the purely structural coupling, while
the sum of the other three terms is referred to as the disorder-mediated coupling. The dihedral
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level couplings were coarse-grained into residue-level coupling by summing the total coupling
between all the relevant dihedrals. Communities of coupled residues were identified by cluster-
ing the residue-level matrix of total couplings using affinity propagation [276]. The constructed
network was subsequently filtered to only retain significant edges [277].These algorithms are
available at github.com/bowman-lab.
4.5.2 Protein expression and purification
All variants of VP35’s IID were purified from the cytoplasm of E. coli BL21(DE3) Gold cells
(Agilent Technologies). Variants were generated using the site directed mutagenesis method
and confirmed by DNA sequencing. Transformed cells were grown at 37°C until OD 0.3 then
grown at 18°C until induction at OD 0.6 with 1 mM IPTG (Gold Biotechnology, Olivette, MO).
Cells were grown for 15 hours then centrifuged after which the pellet was resuspended in 20
mM Sodium Phosphate pH 8, 1 M sodium chloride, with 5.1 mM β-mercaptoethanol. Resus-
pended cells were subjected to sonication at 4°C followed by centrifugation. The supernatant
was then subjected to Ni-NTA affinity, TEV digestion, cation exchange (BioRad UNOsphere
Rapid S column), and size exclusion chromatography (BioRad Enrich SEC 70 column) into 10
mM Hepes pH 7, 150 mM NaCl, 1 mM MgCl2, 2 mM TCEP.
4.5.3 Thiol labeling
We monitored the change in absorbance over time of 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB,
Ellman’s reagent, Thermo Fisher Scientific). Various concentrations of DTNB were added to
protein and change in absorbance was measured in either an SX-20 Stopped Flow instrument
(Applied Photophysics, Leatherhead, UK), or an Agilent Cary60 UV-vis spectrophotometer at
412 nm until the reaction reached steady state (3̃00 s). Data were fit with a Linderstrøm-Lang
model to extract the thermodynamics and/or kinetics of pocket opening, as described in detail
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previously [49]. As a control, the equilibrium constant for folding and the unfolding rate were
measured (C.1) and used to predict the expected labeling rate from the unfolded state. The
equilibrium constant was inferred from a two-state fit to urea melts monitored by fluorescence
and unfolding rates were inferred from single exponential fits to unfolding curves monitored by
fluorescence after the addition of urea, as described previously [49,147,278]. Fluorescence data
were collected using a Photon Technology International Quanta- Master 800 rapid excitation
spectrofluorometer with Quantum Northwest Inc. TC-125 Peltier-controlled cuvette holder.
4.5.4 Fluorescence polarization binding assay
Binding affinities between variants of VP35’s IID and dsRNA were measured using fluores-
cence polarization in 10 mM Hepes pH 7, 150 mM NaCl, 1 mM MgCl2. A 25 base pair FITC-
dsRNA (Integrated DNA Technologies) substrate with and without a 2 nucleotide 3’ overhang
was included at 100 nM. The sample was equilibrated for one hour before data collection. Data
were collected on a BioTek Synergy2 Multi-Mode Reader as polarization and were converted
to anisotropy as described previously [273]. TNB-labeled samples were generated by allowing
DTNB and VP35’s IID to react for 3 minutes and then removing excess DTNB with a Zeba
spin desalting columns (Thermo Fisher Scientific). A single-site binding model was sufficient
to fit the data.
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The SARS-CoV-2 nucleocapsid protein is
dynamic, disordered, and phase separates
with RNA.
This chapter is adapted from the following publication:
Cubuk, J., Alston, J.J., Incicco, J.J., Singh, S., Stuchell-Brereton, M.D., Ward, M.D., Zimmer-
man, M.I., Vithani, N., Griffith, D., Wagoner, J.A., Bowman, G.R., Hall, K.B., Soranno, A.,
Holehouse, A.S., The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase
separates with RNA, Available on Biorxiv: https://doi.org/10.1101/2020.06.17.158121 [2]
In this work, my work in setting up, simulating, and generating seed conformations of the folded
domains (and populations) led to the data presented in figures 5.1, 5.2, and 5.4.
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5.1 Abstract
The SARS-CoV-2 nucleocapsid (N) protein is an abundant RNA binding protein critical for
viral genome packaging, yet the molecular details that underlie this process are poorly under-
stood. Here we combine single-molecule spectroscopy with all-atom simulations to uncover
the molecular details that contribute to N protein function. N protein contains three dynamic
disordered regions that house putative transiently-helical binding motifs. The two folded do-
mains interact minimally such that full-length N protein is a flexible and multivalent RNA bind-
ing protein. N protein also undergoes liquid-liquid phase separation when mixed with RNA,
and polymer theory predicts that the same multivalent interactions that drive phase separation
also engender RNA compaction. We offer a simple symmetry-breaking model that provides
a plausible route through which single-genome condensation preferentially occurs over phase
separation, suggesting that phase separation offers a convenient macroscopic readout of a key
nanoscopic interaction.
5.2 Introduction
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-
strand RNA virus that causes the disease COVID-19 (Coronavirus Disease-2019) [279]. While
coronaviruses typically cause relatively mild respiratory diseases, COVID-19 is on course to
kill half a million people in the first six months since its emergence in late 2019 [279–281].
Given the timeframe for vaccine development is on the order of months to years, alternative
therapeutic approaches are sought to ameliorate viral morbidity and mortality [282].
A challenge in identifying candidate drugs is our relatively sparse understanding of the molec-
ular details that underlie the function of SARS-CoV-2 proteins. As a result, there is a surge of
biochemical and biophysical exploration of these proteins, with the ultimate goal of identifying
proteins that are suitable targets for disruption, ideally with insight into the molecular details
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of how disruption could be achieved [283, 284].
While much attention has been focused on the Spike (S) protein, many other SARS-CoV-2
proteins play equally critical roles in viral physiology, yet we know relatively little about their
structural or biophysical properties [285–288]. Here we performed a high-resolution structural
and biophysical characterization of the SARS-CoV-2 nucleocapsid (N) protein, the protein re-
sponsible for genome packaging [289–291]. A large fraction of N protein is predicted to be
intrinsically disordered, which constitutes a major barrier to conventional structural character-
ization [290]. To overcome these limitations, we combined single-molecule spectroscopy with
all-atom simulations to build a residue-by-residue description of all three disordered regions
in the context of their folded domains The combination of single-molecule spectroscopy and
simulations to reconstruct structural ensembles has been applied extensively to uncover key
molecular details underlying disordered protein regions [292–297]. Our goal here is to provide
biophysical and structural insights into the physical basis of N protein function.
In exploring the molecular properties of N protein, we discovered it undergoes phase separation
with RNA, as was also reported recently [298–300]. Given N protein underlies viral packaging,
we reasoned phase separation may in fact be an unavoidable epiphenomenon that reflects phys-
ical properties necessary to drive compaction of long RNA molecules. To explore this principle
further, we developed a simple physical model, which suggested symmetry breaking through a
small number of high-affinity binding sites can organize anisotropic multivalent interactions to
drive single-polymer compaction, as opposed to multi-polymer phase separation. Irrespective
of its physiological role, our results suggest that phase separation provides a macroscopic read-
out (visible droplets) of a nanoscopic process (protein:RNA and protein:protein interaction).
In the context of SARS-CoV-2, those interactions are expected to be key for viral packaging,
such that assays which monitor phase separation of N protein with RNA may offer a convenient
route to identify compounds that will also attenuate viral assembly.
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5.3 Results
Coronavirus nucleocapsid proteins are multi-domain RNA binding proteins that play a critical
role in many aspects of the viral life cycle [291,301]. The SARS-CoV-2 N protein shares a num-
ber of sequence features with other nucleocapsid proteins from coronaviruses (Fig. D.1-D.5).
Work on N protein from a range of model coronaviruses has shown that N protein undergoes
both self-association, interaction with other proteins, and interaction with RNA, all in a highly
multivalent manner.
The SARS-CoV-2 N protein can be divided into five domains; a predicted intrinsically dis-
ordered N-terminal domain (NTD), an RNA binding domain (RBD), a predicted disordered
central linker (LINK), a dimerization domain, and a predicted disordered C-terminal domain
(CTD) (Fig. 5.1). While SARS-CoV-2 is a novel coronavirus, decades of work on model
coronaviruses (including SARS coronavirus) have revealed a number of features expected
to hold true in the SARS-CoV-2 N protein. Notably, all five domains are predicted to bind
RNA [303–309], and while the dimerization domain facilitates the formation of well-defined
stoichiometric dimers, RNA-independent higher-order oligomerization is also expected to oc-
cur [308, 310–312]. Importantly, protein-protein and protein-RNA interaction sites have been
mapped to all three disordered regions.
Despite recent structures of the RBD and dimerization domains from SARS-CoV-2, the solution-
state conformational behavior of the full-length protein remains elusive [313–315]. Under-
standing N protein function necessitates a mechanistic understanding of the flexible predicted
disordered regions and their interplay with the folded domains. A recent small-angle X-ray
study shows good agreement with previous work on SARS, suggesting the LINK is relatively
extended, but neither the structural basis for this extension nor the underlying dynamics are
known [303, 316].
Here, we address these questions by probing three three full-length constructs of the N protein
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Figure 5.1: Sequence and structural summary of N protein . A. Domain architecture of the
SARS-CoV-2 N protein. Dye positions used in this study are annotated across the top, dis-
order prediction calculated across the bottom. The specific positions were selected such that
fluorophores are sufficiently close to be in the dynamic range of FRET measurements. Label-
ing was achieved using cysteine mutations and thiol-maleimide chemistry. B. Structure of the
SARS-CoV-2 RNA binding domain (RBD) (PDB: 6yi3). Center and left: coloured based on
surface potential calculated with the Adaptive Poisson Boltzmann Method [302], revealing the
highly basic surface of the RBD. Right: ribbon structure with N- and C-termini highlighted.
C. Dimer structure of the SARS-CoV-2 dimerization domain (PDB: 6yun). Center and left:
coloured based on surface potential, revealing the highly basic surface. Right: ribbon structure
with N- and C-termini highlighted.
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with fluorescent labels (Alexa 488 and 594) flanking the NTD, the LINK, and the CTD (see
Fig. 5.1A). These constructs allow us to probe conformations and dynamics of the disordered
regions in the context of the full-length protein using single-molecule Förster Resonance En-
ergy Transfer (FRET) and Fluorescence Correlation Spectroscopy (FCS) (see SI for details).
In parallel to the experiments, we performed all-atom Monte Carlo simulations of each of the
three IDRs in isolation and in context with their adjacent folded domains.
5.3.1 The NTD is disordered, flexible, and transiently interacts with the
RBD.
We started our analysis by investigating the NTD conformations. Under native conditions,
single-molecule FRET measurements revealed the occurrence of a single population with a
mean transfer efficiency of 0.61± 0.03 (Fig. 5.2A and Fig. D.6). To assess whether this transfer
efficiency reports about a rigid distance (e.g. structure formation or persistent interaction with
the RBD) or is a dynamic average across multiple conformations, we first compare the lifetime
of the fluorophores with transfer efficiency. Under native conditions, the donor and acceptor
lifetimes for the NTD construct lie on the line that represents fast conformational dynamics
(Fig. D.8A). To properly quantify the timescale associated with these fast structural rearrange-
ments, we leveraged nanoseconds FCS. As expected for a dynamic population [317, 318], the
cross-correlation of acceptor-donor photons for the NTD is anticorrelated (Fig. 5.2B and D.11).
A global fit of the donor-donor, acceptor-acceptor, and acceptor-donor correlations yields a re-
configuration time τr = 170 ± 30 ns. This is longer than reconfiguration times observed for
other proteins with a similar persistence length and charge content [318–321], hinting at a large
contribution from internal friction due to rapid intramolecular contacts (formed either within
the NTD or with the RBD) or transient formation of short structural motifs [322].
As a next step, we assessed the stability of the folded RBD and its influence on the conforma-
tions of the NTD by studying the effect of a chemical denaturant on the protein. The titration
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with guanidinium chloride (GdmCl) reveals a decrease of transfer efficiencies when moving
from native buffer conditions to 1 M GdmCl, followed by a plateau of the transfer efficiencies
at concentrations between 1 M and 2 M and a subsequent further decrease at higher concentra-
tions (Fig. D.6 and D.8). This behavior can be understood assuming that the plateau between
1 M and 2 M GdmCl represents the average of transfer efficiencies between two populations in
equilibrium that have very close transfer efficiency and are not resolved because of shot noise.
Indeed, this interpretation is supported by a broadening in the transfer efficiency peak between
1 M and 2 M GdmCl, which is expected if two overlapping populations react differently to
denaturant. Besides the effect of the unfolding of the RBD, the dimensions of the NTD are
also modulated by change in the solvent quality when adding denaturant (Fig. 5.2C, D.6, D.8)
and this contribution to the expansion of the chain can be described using an empirical bind-
ing model [323–327]. A fit of the interdye root-mean-square distances to this model and the
extracted stability of RBD (midpoint: 1.25 ± 0.2 M; ∆G0 = (3 ± 0.6) RT) is presented in
Fig. 5.2C A comparative fit of the histograms with two populations yields an identical result in
terms of RBD stability and protein conformations (Fig. D.9).
These observations provide two important insights. Firstly, the RBD is completely folded under
native conditions (Fig. 5.2C). Secondly, the RBD contributes significantly to the conformations
of the measured NTD construct, mainly by reducing the accessible space of the disordered tail
and favoring expanded configurations, as shown by the shift in transfer efficiency when the
RBD is unfolded.
To better understand the sequence-dependent conformational behavior of the NTD we turned
to all-atom simulations of an NTD-RBD construct. We used a novel sequential sampling ap-
proach that integrates long timescale MD simulations performed using the Folding@home dis-
tributed computing platform with all-atom Monte Carlo simulation performed with the AB-
SINTH forcefield to generate an ensemble of almost 400,000 distinct conformations (see meth-
ods [37, 328]. We also performed simulations of the NTD in isolation.
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We observed excellent agreement between simulation and experiment for the equivalent inter-
residue distance (Fig. 5.2D). The peaks on the left side of the histogram reflect specific sim-
ulations where the NTD engages more extensively with the RBD through a fuzzy interaction,
leading to local kinetic traps [328]. We also identified several regions in the NTD where tran-
sient helices form, and using normalized distance maps found regions of transient attractive
and repulsive interaction between the NTD and the RBD. In particular, the basic beta-strand
extension from the RBD (Fig. 5.1B) repels the arginine-rich C-terminal region of the NTD,
while a phenylalanine residue (F17) in the NTD engages with a hydrophobic face on the RBD
(Fig. 5.2G). Finally, we noticed the arginine-rich C-terminal residues (residues 31 - 41) form
a transient alpha helix projecting three of the four arginines in the same direction (Fig. 5.2H).
These features provide molecular insight into previously reported functional observations (see
Discussion).
5.3.2 The linker is highly dynamic and there is minimal interaction be-
tween the RBD and the dimerization domain.
We next turned to the linker (LINK) construct to investigate how the disordered region modu-
lates the interaction and dynamics between the two folded domains. Under native conditions
(50 mM Tris buffer), single-molecule FRET reveals a narrow population with mean transfer
efficiency of 0.52 ± 0.03. Comparison of the fluorescence lifetime and transfer efficiency indi-
cates that, like the NTD, the transfer efficiency represents a dynamic conformational ensemble
sampled by the LINK (Fig. D.7B). ns-FCS confirms fast dynamics with a characteristic recon-
figuration time τr of 120± 20 ns (Fig. 5.3B and D.11). This reconfiguration time is compatible
with high internal friction effects, as observed for other unstructured proteins [318, 319], but
may also account for the drag of the surrounding domains. The root-mean-square interdye dis-
tance for the LINK r172−245 is equal to 57 ± 2 Å (lp= 5.8 ± 0.4 Å) when assuming a Gaussian
Chain distribution and 55 ± 2 Å (lp= 5.4 ± 0.4 Å) when using a SAW model (see appendix E).
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Figure 5.2: The N-terminal domain (NTD) is disordered with residual helical motifs. A. His-
togram of the transfer efficiency distribution measured across the labeling positions 1 and 68 in
the context of the full-length protein, under native conditions (50 mM Tris buffer). B. Donor-
acceptor cross-correlation measured by ns-FCS (see Appendix E). The observed anticorrelated
rise is the characteristic signature of FRET dynamics and the timescale associated is directly re-
lated to the reconfiguration time of the probed segment. C. Interdye distance as extracted from
single-molecule FRET experiments across different concentrations using a Gaussian chain dis-
tribution, examining residues 1-68 in the context of the full length protein. The full line repre-
sents a fit to the model in Eq. D.19, which accounts for denaturant binding (see Table D.1) and
unfolding of the folded RBD. The dashed line represents the estimate of folded RBD across
different denaturant concentrations based on Eq. D.20 D. All-atom simulations of the NTD
in the context of RBD reveal good agreement with smFRET-derived average distances. The
peaks on the left shoulder of the histogram are due to persistent NTD-RBD interactions in a
small subset of simulations. E. Transient helicity in the NTD in isolation or in the context of
the RBD. Perfect profile overlap suggests interaction between the NTD and the RBD does not
lead to a loss of helicity. F. Normalized distance maps (scaling maps) quantify heterogeneous
interaction between every pair of residues in terms of average distance normalized by distance
expected for the same system if the IDR had no attractive interactions (the “excluded volume”
limit [329]). Both repulsive (yellow) and attractive (blue) regions are observed for NTD-RBD
interactions. G. Projection of normalized distances onto the folded domain reveals repulsion is
through electrostatic interaction (positively charged NTD is repelled by the positive face of the
RBD, which is proposed to engage in RNA binding) while attractive interactions are between
positive, aromatic, and polar residues in the NTD and a slightly negative and hydrophobic sur-
face on the RBD (see Fig. 5.1B, center). H. The C-terminal half of transient helicity in H2
encodes an arginine-rich surface.
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Next, we addressed whether the LINK segment populates elements of persistent secondary
structure or forms stable interaction with the RBD or dimerization domains. Addition of the de-
naturant shows a continuous shift of the transfer efficiency toward lower values (Fig. D.6,D.8),
that corresponds to an almost linear expansion of the chain (see Fig. 5.3C). These observations
support a model in which LINK is unstructured and flexible and do not reveal a significant frac-
tion of folding or persistent interactions with or between folded domains. Overall, our single-
molecule observations report a relatively extended average inter-domain distance, suggesting
a low number of interactions between folded domains. To further explore this conclusion, we
turned again to Monte Carlo simulations.
As with the NTD, all-atom Monte Carlo simulations provide atomistic insight that can be com-
pared with our spectroscopic results. Given the size of the system an alternative sampling
strategy to the NTD-RBD construct was pursued here that did not include MD simulations of
the folded domains, but we instead ran simulations of a construct that included the RBD, LINK
and dimerization domain. In addition, we also performed simulations of the LINK in isolation.
We again found good agreement between simulations and experiment (Fig. 5.3D). The root
mean square inter-residue distance between simulated positions 172 and 245 is 59.1 Å, which
is within the experimental error of the single-molecule observations. Normalized distance map
shows a number of regions of repulsion, notably that the RBD repels the N-terminal part of
the LINK and the dimerization domain repels the C-terminal part of the LINK (Fig. 5.3E). We
tentatively suggest this may reflect sequence properties chosen to prevent aberrant interactions
between the LINK and the two folded domains. In the LINK-only simulations we identified
two regions that form transient helices at low populations (20-25%), although these are much
less prominent in the context of the full length protein (Fig. 5.3F). Those helices encompass
a serine-arginine (SR) rich region known to mediate both protein-protein and protein-RNA
interaction, and leads to the alignment of three arginine residues along one face of a helix.
The second helix (H4) is a leucine/alanine-rich hydrophobic helix which may contribute to
oligomerization, or act as a helical recognition motif for other protein interactions (notably as
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a nuclear export signal for Crm1, see Discussion).
Figure 5.3: The RNA binding domain (RBD) and dimerization domains do not significantly
interact and are connected by a disordered linker (LINK) A. Histogram of the transfer effi-
ciency distribution measured across the labeling positions 172 and 245 in the context of the
full-length protein, under native conditions (50 mM Tris buffer). B. Donor-acceptor cross-
correlation measured by ns-FCS (see SI). The observed anticorrelated rise is the characteristic
signature of FRET dynamics and the timescale associated is directly related to the reconfig-
uration time of the probed segment. C. Interdye distance as extracted from single-molecule
FRET experiments across different denaturant concentrations. The full line represents a fit to
the model in Eq. D.18, which accounts for denaturant binding. D Inter-residue distance distri-
butions calculated from simulations (histogram) show good agreement with distances inferred
from single-molecule FRET measurements (green bar). E. Scaling maps reveal repulsive inter-
actions between the N- and C-terminal regions of the LINK with the adjacent folded domains.
We also observe relatively extensive intra-LINK interactions around helix H4 (see Fig. 5.3F).
F. Two transient helices are observed in the linker. The N-terminal helix H3 overlaps with
part of the SR-region and orientates three arginine residues in the same direction, analogous to
behavior observed for H2 in the NTD. The C-terminal helix H4 overlaps with a Leu/Ala rich
motif which we believe is a conserved nuclear export signal (see Discussion).
5.3.3 The CTD engages in transient but non-negligible interactions with
the dimerization domain.
Finally, we turned to the CTD. Single-molecule FRET experiments again reveal a single popu-
lation with a mean transfer efficiency of 0.59± 0.03 (Fig. 5.4A) and the denaturant dependence
follows the expected trend for a disordered region, with a shift of the transfer efficiency toward
lower values (Fig. D.6,D.8), from 0.59 to 0.35. Interestingly, when studying the denaturant
dependence of the protein, we noticed that the width of the distribution increases while mov-
ing toward native conditions. This suggests that the protein may form transient contacts or
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adopt local structure. To investigate this aspect, we turned to the investigation of the dynam-
ics. Though the comparison of the fluorophore lifetimes against transfer efficiency (Fig. D.7c)
appears to support a dynamic nature underlying this population, nanosecond FCS reveals a flat
acceptor-donor cross-correlation on the ns timescale (Fig. 5.4B). However, inspection of the
donor-donor and acceptor-acceptor autocorrelations reveal a correlated decay with a character-
istic time of 240 ± 50 ns. This is different from that expected for a completely static system
such as polyprolines [330], where the donor-donor and acceptor-acceptor autocorrelation are
also flat. An increase in the autocorrelations can be observed for static quenching of the dyes
with aromatic residues.Interestingly, donor dye quenching can also contribute to a positive am-
plitude in the donor-acceptor correlation [331,332]. Therefore, a plausible interpretation of the
flat cross-correlation data is that we are observing two populations in equilibrium whose corre-
lations (one anticorrelated, reflecting conformational dynamics, and one correlated, reflecting
quenching due contact formation) compensate each other.
To further investigate the possible coexistence of these different species, we performed ns-FCS
at 0.2 M GdmCl, where the width of the FRET population starts decreasing and the mean
transfer efficiency is slightly shifted to larger values, under the assumption that the decreased
width of the population reflects reduced interactions. Indeed, the cross-correlation of ns-FCS
reveals a dynamic behavior with a reconfiguration time τr= 70 ± 15 ns (Fig. D.11). Based on
these observations, we suggest that a very similar disordered population to the one observed
at 0.2 M is also present under native conditions, but in equilibrium with a quenched species
that forms long-lived contacts. Under the assumption that the mean transfer efficiency still
originates (at least partially) from a dynamic distribution, the estimate of the inter-residue root-
mean-square distance is r363−419 = 51± 2 Å (lp= 6.1± 0.4 Å) for a Gaussian chain distribution
and r363−419 = 49 ± 2 Å (lp= 5.6 ± 0.4 Å) for the SAW model (see SI). However, some caution
should be used when interpreting these numbers since we know there is some contribution
from fluorophore quenching, which may in turn contribute to an underestimate of the effective
transfer efficiency [333].
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We again obtained good agreement between all-atom Monte Carlo simulations and experiment
(Fig. 5.4D). We identified two transient helices, one (H5) is minimally populated but the sec-
ond (H6) is more highly populated in the IDR-only simulation and still present at ∼20% in the
folded state simulations (Fig. 5.4E). The difference reflects the fact that several of the helix-
forming residues interact with the dimerization domain, leading to a competition between helix
formation and intramolecular interaction. Scaling maps reveal extensive intramolecular inter-
action by the residues that make up H6, both in terms of local intra-IDR interactions and inter-
action with the dimerization domain (Fig. 5.4F). Mapping normalized distances onto the folded
structure reveals that interactions occur primarily with the N-terminal portion of the dimeriza-
tion domain (Fig. 5.4G). As with the LINK and the NTD, a positively charged set of residues
immediately adjacent to the folded domain in the CTD drive repulsion between this region and
the dimerization domain. H6 is the most robust helix observed across all three IDRs, and is a
perfect amphipathic helix with a hydrophobic surface on one side and charged/polar residues
on the other (Fig. 5.4H). The cluster of hydrophobic residues in H6 engage in intramolecular
contacts and offer a likely physical explanation for the complex lifetime data.
5.3.4 N protein undergoes phase separation with RNA.
Over the last decade, biomolecular condensates formed through phase separation have emerged
as a new mode of cellular organization [334–337]. Given the high interaction valency and
the presence of molecular features similar to other proteins we had previously studied, we
anticipated that N protein would undergo phase separation with RNA [338–340].
In line with this expectation, we observed robust droplet formation with homopolymeric RNA
(Fig. 5.5A-B) under native buffer conditions (50 mM Tris) and at higher salt concentration (50
mM NaCl). Turbidity assays at different concentrations of protein and poly(rU) (200-250 nu-
cleotides) demonstrate the classical reentrant phase behavior expected for a system undergoing
heterotypic interaction (Fig. 5.5C-D). It is to be noted that turbidity experiments do not exhaus-
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Figure 5.4: The C-terminal domain (CTD) is disordered, engages in transient interaction with
the dimerization domain, and contains a putative helical binding motif. A. Histogram of the
transfer efficiency distribution measured across the labeling positions 363 and 419 in the con-
text of the full-length protein, under native conditions (50 mM Tris buffer). B. Donor-acceptor
cross-correlation measured by ns-FCS (see Appendix E). The flat correlation indicates a lack of
dynamics in the studied timescale or the coexistence of two populations in equilibrium whose
correlations (one correlated and the other anticorrelated) compensate each other. C. Interdye
distance as extracted from single-molecule FRET experiments across different denaturant con-
centrations. The full line represents a fit to the model in Eq. D.18, which accounts for denat-
urant binding. D. Inter-residue distance distributions calculated from simulations (histogram)
show good agreement with distances inferred from single-molecule FRET measurements (pur-
ple bar). E. Two transient helices (H5 and H6) are observed in the CTD. Both show a reduction
in population in the presence of the dimerization domain at least in part because the same sets of
residues engage in transient interactions with the dimerization domain. F. Normalized contacts
maps describe the average inter-residue distance between each pair of residues, normalized by
the distance expected if the CTD behaved as a self-avoiding random coil. H6 engages in ex-
tensive intra-CTD interactions and also interacts with the dimerization domain. We observe
repulsion between the dimerization domain and the N-terminal region of the CTD. G. The nor-
malized distances are projected onto the surface to map CTD-dimerization interaction. The
helical region drives intra-molecular interaction, predominantly with the N-terminal side of the
dimerization domain. H. Helix H6 is an amphipathic helix with a polar/charged surface (left)
and a hydrophobic surface (right).
tively cover all the conditions for phase separation and are only indicative of the low-boundary
concentration regime explored in the current experiments. In particular, turbidity experiments
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do not provide a measurement of tie-lines, though they are inherently a reflection of the free
energy and chemical potential of the solution mixture [341]. Interestingly, phase separation
occurs at relatively low concentrations, in the low µM range, which are compatible with phys-
iological concentration of the protein and nucleic acids. Though increasing salt concentration
results in an upshift of the phase boundaries, one has to consider that in a cellular environment
this effect might be counteracted by cellular crowding.
One peculiar characteristic of our measured phase-diagram is the narrow regime of conditions
in which we observe phase separation of nonspecific RNA at a fixed concentration of protein.
This leads us to hypothesize that the protein may have evolved to maintain a tight control of
concentrations at which phase separation can (or cannot) occur. Interestingly, when rescaling
the turbidity curves as a ratio between protein and RNA, we find all the curve maxima aligning
at a similar stoichiometry, approximately 20 nucleotides per protein in absence of added salt
and 30 nucleotides when adding 50 mM NaCl (Fig. D.12). These ratios are in line with the
charge neutralization criterion proposed by Banerjee et al., since the estimated net charge of the
protein at pH 7.4 is +24 [342]. Finally, given we observed phase separation with poly(rU), the
behavior we are observing is likely driven by relatively nonspecific protein:RNA interactions.
In agreement, work from the Gladfelter [298], Fawzi [299], Zweckstetter [300], and Yildiz
(unpublished) labs have also established this phenomenon across a range of solution conditions
and RNA types.
Having established phase separation through a number of assays, we wondered what -if any-
physiological relevance this may have for the normal biology of SARS-CoV-2.
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Figure 5.5: Nucleocapsid protein undergoes phase separation with RNA. A-B. Appearance
of solution turbidity upon mixing was monitored to determine the concentration regime in
which N protein and poly(rU) undergo phase separation. Representative turbidity titrations
with poly(rU) in 50 mM Tris, pH 7.5 (HCl) at room temperature, in absence of added salt (A)
and in presence of 50 mM NaCl (B), at the indicated concentrations of N protein. Points and
error bars represent the mean and standard deviation of 2-4 consecutive measurements from the
same sample. Solid lines are simulations of an empirical equation fitted individually to each
titration curve (see SI). An inset is provided for the titration at 3.1 µM N protein in 50 mM
NaCl to show the small yet detectable change in turbidity on a different scale. C-D. Projection
of phase boundaries for poly(rU) and N protein mixtures highlights a re-entrant behavior, as
expected for phase-separations induced by heterotypic interactions. Turbidity contour lines are
computed from a global fit of all titrations curves (see Appendix E)
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5.3.5 A simple polymer model shows symmetry-breaking can facilitate
multiple metastable single-polymer condensates instead of a single
multi-polymer condensate.
Why might phase separation of N protein with RNA be advantageous to SARS-CoV-2? One
possible model is that large, micron-sized cytoplasmic condensates of N protein with RNA
form through phase separation and play a role in genome packaging. These condensates may
act as molecular factories that help concentrate the components for pre-capsid assembly (where
we define a pre-capsid here simply as a species that contains a single copy of the genome
with multiple copies of the associated N protein), a model that has been proposed in other
viruses [343].
However, given that phase separation is unavoidable when high concentrations of multiva-
lent species are combined, we propose that an alternative interpretation of our data is that in
this context, phase separation is simply an inevitable epiphenomenon that reflects the inherent
multi-valency of the N protein for itself and for RNA. This poses questions about the origin of
specificity for viral genomic RNA (gRNA), and, of focus in our study, how phase separation
might relate to a single genome packaging through RNA compaction.
Given the expectation of a single genome per virion, we reasoned SARS-CoV-2 may have
evolved a mechanism to limit phase separation with gRNA (i.e. to avoid multi-genome conden-
sates), with a preference instead for single-genome packaging (single-genome condensates).
This mechanism may exist in competition with the intrinsic phase separation of the N protein
with other nonspecific RNAs (nsRNA).
One possible way to limit phase separation between two components (e.g. gRNA/nsRNA and
N protein) is to ensure the levels of these components are held at a sufficiently low total con-
centration such that the phase boundary is never crossed. While possible, suc,h a regulatory
mechanism is at the mercy of extrinsic factors that may substantially modulate the saturation
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concentration [?, 344–346]. Furthermore, not only must phase separation be prevented, but
gRNA compaction should also be promoted through the binding of N protein. In this sce-
nario, the affinity between gRNA and N protein plays a central role in determining the required
concentration for condensation of the macromolecule (gRNA) by the ligand (N protein).
Given a defined valence of the system components, phase boundaries are encoded by the
strength of interaction between the interacting domains in the components. Considering a long
polymer (e.g. gRNA) with proteins adsorbed onto that polymer as adhesive points (“stickers”),
the physics of associative polymers predicts that the same interactions that cause phase separa-
tion will also control the condensation of individual long polymers [338, 347–351]. With this
in mind, we hypothesized that phase separation is reporting on the physical interactions that
underlie genome compaction.
To explore this hypothesis, we developed a simple computational model where the interplay
between compaction and phase separation could be explored. Our setup consists of two types of
species: long multivalent polymers and short multivalent binders (Fig. 5.6A). All interactions
are isotropic and each bead is inherently multivalent as a result. In the simplest instantiation of
this model, favourable polymer:binder and binder:binder interactions are encoded, mimicking
the scenario in which a binder (e.g. a protein) can engage in nonspecific polymer (RNA)
interaction as well as binder-binder (protein-protein) interaction.
Simulations of binder and polymer undergo phase separation in a concentration-dependent
manner, as expected (Fig. 5.6B,C). Phase separation gives rise to a single large spherical
cluster with multiple polymers and binders (Fig. 5.6D, 5.6H). For a homopolymer, the bal-
ance of chain-compaction and phase separation is determined in part through chain length and
binder Kd. In our system the polymer is largely unbound in the one-phase regime (suggesting
the concentration of ligand in the one-phase space is below the Kd) but entirely coated in the
two-phase regime, consistent with highly-cooperative binding behavior. In the limit of long,
multivalent polymers with multivalent binders, the sharpness of the coil-to-globule transition is
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such that an effective two-state description of the chain emerges, in which the chain is either ex-
panded (non-phase separation-competent) OR compact (coated with binders, phase separation
competent).
In light of these observations, we wondered if a break in the symmetry between intra- and inter-
molecular interactions would be enough to promote single-polymer condensation in the same
concentration regime over which we had previously observed phase separation. Symmetry
breaking in our model is achieved through a single high-affinity binding site (Fig. 5.6A). We
choose this particular mode of symmetry-breaking to mimic the presence of a packaging signal
-a region of the genome that is essential for efficient viral packaging- an established feature
in many viruses (including coronaviruses) although we emphasize this is a general model, as
opposed to trying to directly model gRNA with a packaging signal [352–354].
We performed identical simulations to those in Fig. 5.6C-D using the same system with poly-
mers that now possess a single high affinity binding site (Fig. 5.6E). Under these conditions
we did not observe large phase separated droplets (Fig. 5.6F). Instead, each individual polymer
undergoes collapse to form a single-polymer condensate (Fig. 5.6E). Collapse is driven by the
recruitment of binders to the high-affinity site, where they “coat” the chain, forming a local
cluster of binders on the polymer. This cluster is then able to interact with the remaining re-
gions of the polymer through weak “nonspecific” interactions, the same interactions that drove
phase separation in Fig. 5.6B,C,D. Symmetry breaking is achieved because the local concen-
tration of binder around the site is high, such that intramolecular interactions are favoured over
intermolecular interaction. This high local concentration also drives compaction at low binder
concentrations. As a result, instead of a single multi-polymer condensate, we observe multiple
single-polymers condensates, where the absolute number matches the number of polymers in
the system (Fig. 5.6G).
Our results can also be cast in terms of two distinct concentration (phase) boundaries - one for
binder:high affinity site interaction (c1), and a second boundary for “nonspecific” binder:polymer
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interactions (c2) at a higher concentration. c2 reflects the boundary observed in Fig. 5.6C that
delineated the one and two-phase regimes. At global concentrations below c2, (but above c1)
the clustering of binders at a high affinity site raises the apparent local concentration of binders
above c2, from the perspective of other beads on the chain. In this way, a local high affinity
binding site can drive “local” phase separation of a single polymer.
The high affinity binding site polarizes the single-polymer condensate, such that they are or-
ganized, recalcitrant to fusion, and kinetically stable. A convenient physical analogy is that of
a micelle, which are non-stoichiometric stable assemblies. Even for micelles that are far from
their optimal size, fusion is slow because it requires substantial molecular reorganization and
the breaking of stable interactions [355, 356].
Finally, we ran simulations under conditions in which binder:polymer interactions were re-
duced, mimicking the scenario in which non-specific protein:RNA interactions are inhibited
(Fig. 5.6L). Under these conditions no phase separation occurs for polymers that lack a high-
affinity binding site, while for polymers with a high-affinity binding site no chain compaction
occurs (in contrast to when binder:polymer interactions are present, see Fig. 5.6J). This re-
sult illustrates how phase separation offers a convenient readout for molecular interactions that
might otherwise be challenging to measure.
We emphasize that our conclusions from simulations are subject to the parameters in our model.
We present these results to demonstrate an example of “how this single-genome packaging
could be achieved”, as opposed to the much stronger statement of proposing “this is how it
is” achieved. Recent elegant work by Ranganathan and Shakhnovich identified kinetically ar-
rested microclusters, where slow kinetics result from the saturation of stickers within those
clusters [357]. This is completely analogous to our results (albeit with homotypic interactions,
rather than heterotypic interactions), giving us confidence that the physical principles uncov-
ered are robust and, we tentatively suggest, quite general. Future simulations are required to
systematically explore the details of the relevant parameter space in our system. However,
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regardless of those parameters, our model does establish that if weak multivalent interactions
underlie the formation of large multi-polymer droplets, those same interactions cannot also
drive polymer compaction inside the droplet
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Figure 5.6: A simple polymer suggests symmetry breaking can promote single-polymer con-
densates over multi-polymer assemblies. A. Summary of our model setup, which involves long
‘polymers’ (61 beads) or short ‘binders’ (2 beads). Each bead is multivalent and can inter-
act with every adjacent lattice site. The interaction matrix to the right defines the pairwise
interaction energies associated with each of the bead times. B. Concentration dependent as-
sembly behavior for polymers lacking a high-affinity binding site. C. Phase diagram showing
the concentration-dependent phase regime - dashed line represents the binodal (phase bound-
ary) and is provided to guide the eye. D. Analysis in the same 2D space as C assessing the
number of droplets at a given concentration. When phase separation occurs a single droplet ap-
pears in almost all cases. E. TConcentration dependent assembly behavior for polymers with
a high-affinity binding site. F. No large droplets are formed in any of the systems, although
multiple polymer:binder complexes form. G. The number of clusters observed matches the
number of polymers in the system - i.e. each polymer forms an individual cluster. H. Sim-
ulation snapshots from equivalent simulations for polymers with (top) or without (bottom) a
single high-affinity binding site. I. Polymer dimensions in the dense and dilute phase (for the
parameters in our model) for polymers with no high-affinity binding site. Note that compaction
in the dense phase reflects finite-size effects, as addressed in panel K, and is an artefact of
the relatively small droplets formed in our systems (relative to the size of the polymer). The
droplets act as a bounding cage for the polymer, driving their compaction indirectly. J. Polymer
dimensions across the same concentration space for polymers with a single high-affinity bind-
ing site. Across all concentrations, each individual polymer is highly compact. K. Compaction
in the dense phase (panel I) is due to small droplets. When droplets are sufficiently large we
observe chain expansion, as expected from standard theoretical descriptions. L. Simulations
performed under conditions in which nonspecific interactions between binder and polymer are
reduced (interaction strength = 0 kT). Under these conditions phase separation is suppressed.
Equivalent simulations for polymers with a high-affinity site reveal these chains are no longer




The nucleocapsid (N) protein from SARS-CoV-2 is a multivalent RNA binding protein critical
for viral replication and genome packaging [289, 291]. To better understand how the various
folded and disordered domains interact with one another, we applied single-molecule spec-
troscopy and all-atom simulations to perform a detailed biophysical dissection of the protein,
uncovering several putative interaction motifs. Furthermore, based on both sequence analysis
and our single-molecule experiments, we anticipated that N protein would undergo phase sep-
aration with RNA. In agreement with this prediction, and in line with work from the Gladfelter
and Yildiz groups working independently from us, we find that N protein robustly undergoes
phase separation in vitro with model RNA under a range of different salt conditions. Using
simple polymer models, we propose that the same interactions that drive phase separation may
also drive genome packaging into a dynamic, single-genome condensate. The formation of
single-genome condensates (as opposed to multi-genome droplets) is influenced by the pres-
ence of one (or more) symmetry-breaking interaction sites, which we tentatively suggest could
reflect packaging signals in viral genomes.
5.4.1 All three IDRs are highly dynamic
Our single-molecule experiments and all-atom simulations are in good agreement with one an-
other, and reveal that all three IDRs are extended and highly dynamic. Simulations suggest
the NTD may interact transiently with the RBD, which offers an explanation for the slightly
slowed reconfiguration time measured by nanosecond FCS. The LINK shows rapid rearrange-
ment, demonstrating the RBD and dimerization domain are not interacting. Finally, we see
more pronounced interaction between the CTD and the dimerization domain, although these
interactions are still highly transient.
Single-molecule experiments and all-atom simulations were performed on monomeric versions
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of the protein, yet N protein has previously been shown to undergo dimerization and form
higher-order oligomers in the absence of RNA [310]. To assess the formation of oligomeric
species, we use a combination of nativePAGE, crosslinking and FCS experiments (see Fig.
D.13). These experiments also verified that under the conditions used for single-molecule
experiments the protein exists only as a monomer.
5.4.2 Simulations identify multiple transient helices
We identified a number of transient helical motifs which provide structural insight into pre-
viously characterized molecular interactions. Transient helices are ubiquitous in viral dis-
ordered regions and have been shown to underlie molecular interactions in a range of sys-
tems [343, 358–360].
Transient helix H2 (in the NTD) and H3 (in the LINK) flank the RBD and organize a set of
arginine residues to face the same direction (Fig. 5.2E). Both the NTD and LINK have been
shown to drive RNA binding, such that we propose these helical arginine-rich motifs (ARMs)
may engage in both both nonspecific binding and may also contribute to RNA specificity, as has
been proposed previously [303, 361, 362]. The serine-arginine SR-region (which includes H3)
has been previously identified as engaging in interaction with a structured acidic helix in Nsp3
in the model coronavirus MHV, consistent with an electrostatic helical interaction [363, 364].
Recent NMR data also shows excellent agreement with our results, identifying a transient helix
that shows 1:1 overlap with H3 [300].The SR-region is necessary for recruitment to replication-
transcription centers (RTCs) in MHV, and also undergoes phosphorylation, setting the stage for
a complex regulatory system awaiting exploration [365, 366].
Transient helix H4 (Fig. 5.3H), was previously predicted bioinformatically and identified as a
conserved feature across different coronaviruses [303]. Furthermore, the equivalent region was
identified in SARS coronavirus as a nuclear export signal (NES), such that we suspect this too
is a classical Crm1-binding leucine-rich NES [367].
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Transient helix H6 is an amphipathic helix with a highly hydrophobic face (Fig. 5.4H). Recent
hydrogen-deuterium exchange mass spectrometry also identified H6 [315]. Residues in this
region have previously been identified as mediating M-protein binding in other coronaviruses,
such that we propose H6 underlies that interaction [368–370]. Recent work has also identified
amphipathic transient helices in disordered proteins as interacting directly with membranes,
such that an additional (albeit entirely speculative) role could involve direct membrane interac-
tion, as has been observed in other viral phosphoproteins [371, 372].
5.4.3 The physiological relevance of nucleocapsid protein phase separa-
tion in SARS-CoV-2 physiology
Our work has revealed that SARS-CoV-2 N protein undergoes phase separation with RNA
when reconstituted in vitro. The solution environment and types of RNA used in our experi-
ments are very different from the cytoplasm and viral RNA. However, similar results have been
obtained in published and unpublished work by several other groups under a variety of condi-
tions, including via in cell experiments (Yildiz group, unpublished) [298–300]. Taken together,
these results demonstrate that N protein can undergo bona fide phase separation, and that N
protein condensates can form in cells. Nevertheless, the complexity introduced by multidimen-
sional linkage effects in vivo could substantially influence the phase behavior and composition
of condensates observed in the cell [346, 350, 373]. Of note, the regime we have identified in
which phase separation occurs (Fig. 5.5) is remarkably relatively narrow, a prerequisite for the
assembly of virion particles containing a single viral genome.
Does phase separation play a physiological role in SARS-CoV-2 biology? Phase separation
has been invoked or suggested in many different viral contexts to date [374–378]. In SARS-
CoV-2, one possible model suggests phase separation may drive recruitment of components
to viral replication sites, although how this dovetails with the fact that replication occurs in
double-membrane bound vesicles (DMVs) remains to be explored [300, 379]. An alternative
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(and non-mutually exclusive) model is one in which phase separation catalyzes nucleocapsid
polymerization, as has been proposed in elegant work on measles virus [343]. Here, the process
of phase separation is decoupled from genome packaging, where gRNA condensation occurs
through association with a helical nucleocapsid. If applied to SARS-CoV-2, such a model
would suggest that (1) initially N protein and RNA phase separate in the cytosol, (2) some
discrete pre-capsid state forms within condensates and, (3) upon maturation, the pre-capsid is
released from the condensate and undergoes subsequent virion assembly by interacting with
the membrane-bound M, E, and S structural proteins at the ER-Golgi intermediate compart-
ment (ERGIC). While this model is attractive it places a number of constraints on the physical
properties of this pre-capsid, not least that the ability to escape the “parent” condensate dic-
tates that the assembled pre-capsid must interact less strongly with the condensate components
than in the unassembled state. This requirement introduces some thermodynamic complexities:
how is a pre-capsid state driven to assemble if it is necessarily less stable than the unassembled
pre-capsid, and how is incomplete or abortive pre-capsid formation avoided if – as assembly
occurs – the pre-capsid becomes progressively less stable?
A phase separation and assembly model raises additional questions, such as the origins of
specificity for recruitment of viral proteins and viral RNA, the kinetics of pre-capsid-assembly
within a large condensate, and preferential packaging of gRNA over sub-genomic RNA. None
of these questions are unanswerable, nor do they invalidate this model, but they should be ad-
dressed if the physiological relevance of large cytoplasmic condensates is to be further explored
in the context of virion assembly.
Our preferred interpretation is that N protein has evolved to drive genome compaction for
packaging (Fig. 5.7). In this model, a single-genome condensate forms through N protein
gRNA interaction, driven by a small number of high-affinity sites. This (meta)-stable single-
genome condensate undergoes subsequent maturation, leading to virion assembly. In this
model, condensate-associated N proteins are in exchange with a bulk pool of soluble N protein,
such that the interactions that drive compaction are heterogeneous and dynamic. Our model
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provides a physical mechanism in good empirical agreement with data for N protein oligomer-
ization and assembly [380–382]. Furthermore, the resulting condensate is then in effect a
multivalent binder for M protein, which interacts with N directly, and may drive membrane
curvature and budding in a manner similar to that proposed by Bergeron-Sandoval and Mich-
nick (though with a different directionality of the force) and in line with recent observations
from cryo electron tomography (cryoET) [379, 383–385].
An open question pertains to specificity of packaging gRNA while excluding other RNAs. One
possibility is for two high-affinity N-protein binding sites to flank the 5’ and 3’ ends of the
genome, whereby only RNA molecules with both sites are competent for compaction A recent
map of N protein binding to gRNA has revealed high-affinity binding regions at the 5’ and 3’
ends of the gRNA, in good agreement with this qualitative prediction [298]. Alternatively only
gRNA condensates may possess the requisite valency to drive virion budding through interac-
tion with M at the cytoplasmic side of the ERGIC, offering a physical selection mechanism for
budding.
Genome compaction through dynamic multivalent interactions would be especially relevant
for coronaviruses, which have extremely large single-stranded RNA genomes. This is evo-
lutionarily appealing, in that as the genome grows larger, compaction becomes increasingly
efficient, as the effective valence of the genome is increased [348, 349]. The ability of mul-
tivalent disordered proteins to drive RNA compaction has been observed previously in vari-
ous contexts [292, 386]. Furthermore, genome compaction by RNA binding protein has been
proposed and observed in other viruses [382, 387, 388], and the SARS coronavirus N protein
has previously been shown to act as an RNA chaperone, an expected consequence of com-
paction to a dynamic single-RNA condensate that accommodates multiple N proteins with a
single RNA [292, 389]. Furthermore, previous work exploring the ultrastructure of phase sep-
arated condensates of G3BP1 and RNA through simulations and cryoET revealed a beads-on-
a-string type architecture, mirroring recent results for obtained from cryoET of SARS-CoV-2
virions [339, 379].
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N protein has been shown to interact directly with a number of proteins studied in the context
of biological phase separation which may influence assembly in vivo [283, 298, 338, 345, 390].
In particular, G3BP1-an essential stress-granule protein that undergoes phase separation-was
recently shown to co-localize with overexpressed N protein [300, 339, 345, 391]. G3BP1 in-
teraction may be part of the innate immune response, leading to stress-granule formation, or
alternatively N protein may attenuates the stress response by sequestering G3BP1, depleting the
cytosolic pool, and preventing stress granule formation, as has been shown for HIV-1 [378].
Our model is also in good empirical agreement with recent observations made for other viruses
[392]. Taken together, we speculate that viral packaging may -in general- involve an initial
genome compaction through multivalent protein:RNA and protein:protein interactions, fol-
lowed by a liquid-to-solid transition in cases where well-defined crystalline capsid structures
emerge. Liquid-to-solid transitions are well established in the context of neurodegeneration
with respect to disease progression [393–395]. Here we suggest nature is leveraging those
same principles as an evolved mechanism for monodisperse particle assembly.
Regardless of if phase separated condensates form inside cells, all available evidence suggests
phase separation is reporting on a physiologically important interaction that underlies genome
compaction (Fig. 5.6L). With this in mind, from a biotechnology standpoint, phase separation
may be a convenient readout for in vitro assays to interrogate protein:RNA interaction. Regard-
less of which model is correct, N protein:RNA interaction is key for viral replication. As such,
phase separation provides a macroscopic reporter on a nanoscopic phenomenon, in line with
previous work [338,348,396,397]. In this sense, we believe the therapeutic implications of un-
derstanding and modulating phase separation here (and elsewhere in biology) are conveniently
decoupled from the physiological relevance of actual, large phase separated “liquid droplets”,
but instead offer a window into the underlying physical interactions that lead to condensate
formation.
116
5.4.4 The physics of single polymer condensates
Depending on the molecular details, single-polymer condensates may be kinetically stable (but
thermodynamically unstable, as in our model simulations) or thermodynamically stable. Delin-
eation between these two scenarios will depend on the nature, strength, valency and anisotropy
of the interactions. It is worth noting that from the perspective of functional biology, kinetic
stability may be essentially indistinguishable from thermodynamic stability, depending on the
lifetime of a metastable species.
It is also important to emphasize that at higher concentrations of N protein and/or after a suf-
ficiently long time period we expect robust phase separation with viral RNA, regardless of
the presence of a symmetry-breaking site. Symmetry breaking is achieved when the appar-
ent local concentration of N protein (from the “perspective” of gRNA) is substantially higher
than the actual global concentration. As effective local and global concentrations approach
one another, the entropic cost of intra-molecular interaction is outweighed by the availabil-
ity of inter-molecular partners. On a practical note, if the readout in question is the pres-
ence/absence of liquid droplets, a high-affinity site may be observed as a shift in the saturation
concentration which, confusingly, could either suppress or enhance phase separation. Further, if
single-genome condensates are kinetically stable and driven through electrostatic interactions,
we would expect a complex temperature dependence, in which larger droplets are observed
at higher temperature (up to some threshold). Recent work is showing a strong temperature-
dependence of phase separation is consistent with these predictions [298].
Finally, we note no reason to assume single-RNA condensates should be exclusively the purview
of viruses. RNAs in eukaryotic cells may also be processed in these types of assemblies, as op-
posed to in large multi-RNA RNPs. The role of RNA:RNA interactions both here and in other
systems is also of particular interest and not an aspect explored in our current work, but we
anticipate may play a key role in the relevant biology.
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Figure 5.7: Summary and proposed model for N protein behavior. A. Summary of results
from single-molecule spectroscopy experiments and all-atom simulations. All three predicted
IDRs are disordered, highly flexible, and house a number of putative helical binding regions
which overlap with subregions identified previously to drive N protein function. B. Overview of
general symmetry breaking model. For homopolymers, local collapse leads to single-polymer
condensates with a small barrier to fusion, rapidly assembling into large multi-polymer con-
densates. When one (or a small number of) high-affinity sites are present, local clustering of
binders at a lower concentration organize the polymer such that single-polymer condensates
are kinetically stable. C. Proposed model for SARS-CoV-2 genome packaging. (1) Simplified
model of SARS-CoV-2 genome with a pair of packaging region at the 5’ and 3’ end of the
genome (2) N protein preferentially binds to packaging signal regions in the genome, leading
to a local cluster of N protein at the packaging signal RNA. (3) The high local concentration of
N protein drives condensation of distal regions of the genome, forming a stable single-genome
condensate. (4) Single-genome condensates may undergo subsequent maturation through a
liquid-to-solid (crystallization) transition to form an ordered crystalline capsid, or solidify into
an amorphous ribonuclear particle (RNP), or some combination of the two. While in some
viruses an ordered capsid clearly forms, we favour a model in which the SARS-CoV-2 capsid
is an amorphous RNP. Compact single-genome condensates ultimately interact with E, S and
M proteins at the membrane, whose concerted action leads to envelope formation around the
viral RNA and final virion packaging.
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5.5 Methods
5.5.1 All atom simulations
All-atom Monte Carlo simulations were performed with the ABSINTH implicit solvent model
and CAMPARI simulation engine (http://campari.sourceforge.net/) [398,399] with the solution
ion parameters of Mao et al. [400]. Simulations were performed using movesets and Hamil-
tonian parameters as reported previously [338, 401]. All simulations were performed in suf-
ficiently large box sizes to prevent finite size effects (where box size varies from system to
system). For simulations with IDRs in isolation all degrees of freedom available in CAMPARI
are sampled. For simulations with folded domains with IDRs, the backbone dihedral angles in
folded domains are not sampled, such that folded domains remain structurally fixed (although
sidechains are fully sampled). The IDR has backbone and sidechain degrees of freedom sam-
pled.
All-atom molecular dynamics simulations were performed using GROMACS, using the FAST
algorithm in conjunction with the Folding@home platform [35,37,222]. Post-simulation anal-
ysis was performed with Enspara [39]. For additional simulation details see the supplementary
information.
5.5.2 Coarse-grained Polymer Simulations
Coarse-grained Monte Carlo simulations were performed using the PIMMS simulation engine
[402]. All simulations were performed in a 70 x 70 x 70 lattice-site box. The results averaged
over the final 20% of the simulation to give average values at equivalent states. The “polymer”
is represented as a 61-residue polymer with either a central high-affinity binding site or not.
The binder is a 2-bead species. Every simulation was run for 20 x 109 Monte Carlo steps, with
four independent replicas. Bead interaction strengths were defined as shown in Fig. 5.6A. For
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additional simulation details see the supplementary information.
5.5.3 Protein Expression, purification, and labeling.
SARS-CoV-2 Nucleocapsid protein (NCBI Reference Sequence: YP 009724397.2) including
an N term extension containing His9-HRV 3C protease site was cloned into the BamHI EcoRI
sites in the MCS of pGEX-6P-1 vector (GE Healthcare). Site-directed mutagenesis was per-
formed on the His9-SARS-CoV-2 Nucleocapsid pGEX vector to create M1C R68C, Y172C
T245C, and F363C A419C variant N protein constructs and sequences were verified using
Sanger sequencing. All variants were expressed recombinantly in BL21 Codon-plus pRIL cells
(Agilent) or Gold BL21(DE3) cells (Agilent) and purified using a FF HisTrap column. The
GST-His9-N tag was then cleaved using HRV 3C protease and further purified to remove the
cleaved tag. Finally, purified N protein variants were analyzed using SDS-PAGE and verified
by electrospray ionization mass spectrometry (LC-MS). Activity of the protein was assessed
by testing whether the protein is able to bind and condense nucleic acids (see phase-separation
experiments) as well as to form dimers (see oligomerization in SI).
All Nucleocapsid variants were labeled with Alexa Fluor 488 maleimide and Alexa Fluor 594
maleimide (Molecular Probes) under denaturing conditions following a two-step sequential
labeling procedure (see SI).
5.5.4 Single-molecule fluorescence spectroscopy.
Single-molecule fluorescence measurements were performed with a Picoquant MT200 instru-
ment (Picoquant, Germany). FRET experiments were performed by exciting the donor dye
with a laser power of 100 µW (measured at the back aperture of the objective). For pulsed
interleaved excitation of donor and acceptor, the power used for exciting the acceptor dye was
adjusted to match the acceptor emission intensity to that of the donor (between 50 and 70 mW).
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Single-molecule FRET efficiency histograms were acquired from samples with protein concen-
trations between 50 pM and 100 pM and the population with stoichiometry corresponding to
1:1 donor:acceptor labeling was selected. Trigger times for excitation pulses (repetition rate 20
MHz) and photon detection events were stored with 16 ps resolution. For FRET-FCS, samples
of double-labeled protein with a concentration of 100 pM were excited by either the diode laser
or the supercontinuum laser at the powers indicated above.
All samples were prepared in 50 mM Tris pH 7.32, 143 mM β-mercaptoethanol (for photo-
protection), 0.001% Tween 20 (for limiting surface adhesion) and GdmCl at the reported con-
centrations. All measurements were performed in uncoated polymer coverslip cuvettes (Ibidi,
Wisconsin, USA), which significantly decrease the fraction of protein adhering to the surface
(compared to normal glass cuvettes) under native conditions. For comparison, experiments
have been performed also in glass cuvette coated with PEG, which provided analogous results
to the polymeric cuvette. Each sample was measured for at least 30 min at room temperature
(295 ± 0.5 K) (see appendix E).
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Chapter 6
Citizen Scientists Create an Exascale
Computer to Combat COVID-19
This chapter is adapted from the following publication:
Zimmerman, M.I., Porter, J.R., Ward, M.D., Singh, S., Vithani, N., Meller, A., Mallimadugula,
U.L., Kuhn, C.E., Borowski, J.H., Wiewiora, R.P., Hurley, M.F.D., Coffland, J.E., Voelz, V.A.,
Chodera, J.D., Bowman, G.R., Available on BiorXiv at https://doi.org/10.1101/2020.06.27.175430
[403]
My work in setting up almost all SARS-CoV-2 system for simulation and managing the Fold-
ing@home network led figures 6.1 and 6.4 and the data described in table 6.1
6.1 Abstract
The SARS-CoV-2/COVID-19 pandemic continues to threaten global health and socioeconomic
stability. Experiments have revealed snapshots of many of the viral components but remain
blind to moving parts of these molecular machines. To capture these essential processes, over
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a million citizen scientists have banded together through the Folding@home distributed com-
puting project to create the world’s first Exascale computer and simulate protein dynamics. An
unprecedented 0.1 seconds of simulation of the viral proteome reveal how the spike complex
uses conformational masking to evade an immune response, conformational changes impli-
cated in the function of other viral proteins, and ‘cryptic’ pockets that are absent in experimen-
tal snapshots. These structures and mechanistic insights present new targets for the design of
therapeutics.
6.2 Introduction
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that
poses an imminent threat to global human health and socioeconomic stability [404, 405]. With
estimates of the basic reproduction number at 3-4 and a case fatality rate for coronavirus dis-
ease 2019 (COVID-19) ranging from 0.1-12% (high temporal variation), SARS-CoV-2/COVID-
19 has the potential to spread quickly and endanger the global population [405–409]. As of June
23rd, 2020, there have been over 9.1 million confirmed cases and over 472,000 fatalities, glob-
ally. Quarantines and social distancing are effective at slowing the rate of infection; however,
they cause significant social and economic disruption. Taken together, it is crucial that we find
immediate therapeutic interventions.
A structural understanding of the SARS-CoV-2 proteins could accelerate the discovery of new
therapeutics by enabling the use of rational design [410]. Towards this end, the structural
biology community has made heroic efforts to rapidly build models of SARS-CoV-2 proteins
and the complexes they form. However, it is well established that a protein’s function is dictated
by the full range of conformations it can access; many of which remain hidden to experimental
methods. Mapping these conformations for proteins in SARS-CoV-2 will provide a clearer
picture of how they accomplish their functions, such as infecting cells, evading the immune
system, and replicating. Such maps may also present new therapeutic opportunities, such as
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‘cryptic’ pockets that are absent in experimental snapshots but provide novel targets for drug
discovery.
Molecular dynamics simulations have the ability to capture the full ensemble of structures a
protein adopts but require significant computational resources. Such simulations capture an
all-atom representation of the range of motions a protein undergoes. Modern datasets often
consist of a few µs of simulation for a single protein, with a few noteworthy examples reaching
ms timescales. However, many important processes occur on slower timescales. Moreover,
simulating every protein that is relevant to SARS-CoV-2 for biologically relevant timescales
would require compute resources on an unprecedented scale.
To overcome this challenge, more than a million citizen scientists from around the world have
donated their computer resources to simulate SARS-CoV-2 proteins. This massive collabora-
tion was enabled by the Folding@home distributed computing platform, which has crossed the
Exascale computing barrier and is now the world’s largest supercomputer. Using this resource,
we constructed quantitative maps of the structural ensembles of over two dozen proteins and
complexes that pertain to SARS-CoV-2. Together, we have run an unprecedented 0.1 s of
simulation. Our data uncover the mechanisms of conformational changes that are essential
for SARS-CoV-2’s replication cycle and reveal a multitude of new therapeutic opportunities.
The data are supported by a variety of experimental observations and have been made publicly
available (https://covid.molssi.org/) in accordance with open science principles to accelerate
the discovery of new therapeutics.
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6.3 Results and discussion
6.3.1 To the Exascale and beyond!
Folding@home is a community of citizen scientists, researchers, and tech organizations that
apply their collective computational and intellectual resources to understand the role of pro-
teins’ dynamics in their function and dysfunction, and to aid in the design of new proteins and
therapeutics. The project was founded in the year 2000 with the intent of understanding how
proteins fold. At the time, simulating the folding of even small proteins could easily take thou-
sands of years on a single computer. To overcome this challenge, the scientific team created a
way to break these intractable problems into small pieces that could be performed completely
independently of one another. They then created the Folding@home project to enable anyone
with a computer and an internet connection to volunteer to run these small chunks of simula-
tion, called work units.
Over the years, Folding@home has generalized to address many aspects of protein dynamics,
and the algorithms have developed significantly. The project has provided insight into diverse
topics, ranging from signaling mechanisms [48, 411, 412] to the connection between pheno-
type and genotype [9, 10, 59]. Translational applications have included new means to combat
antimicrobial resistance, Ebola virus, and SFTS virus [49, 54, 413, 414].
In response to the COVID-19 pandemic, Folding@home quickly pivoted to focus on SARS-
CoV-2 and the host factors it interacts with. Many people found the opportunity to take action
at a time when they were otherwise feeling helpless alluring. In less than three months, the
project grew from 30,000 active devices to over a million devices around the globe (Fig. 6.1A
and 6.1B).
Estimating the aggregate compute power of Folding@home is non-trivial due to factors like
hardware heterogeneity, measures to maintain volunteers’ anonymity, and the fact that vol-
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Figure 6.1: Summary of Folding@home’s computational power. A. The growth and usage of
Folding@home in response to COVID-19. Users are colored blue and COVID-19 cases are
orange. B. Location of folding at home users. Each yellow dot represents a unique IP address
contributing to Folding@home. C. The processing speed of Folding@home and the next 10
fastest supercomputers, in exaFLOPS.
unteers can turn their machines on and off at-will. Furthermore, volunteers’ machines only
communicate with the Folding@home servers at the beginning and end of a work unit, each
of which can take anywhere from tens of minutes to a few days depending on the volunteer’s
hardware and the protein to simulate. Therefore, we chose to estimate the performance by
counting the number of GPUs and CPUs that participated in Folding@home during a three-day
window and making a conservative assumption about the computational performance of each
device (see Methods for details).
Given the above, we estimate the peak performance of Folding@home hit 1.01 exaFLOPS.
This performance was achieved at a point when 280,000 GPUs and 4.8 million CPU cores
were performing simulations. For reference, that performance is 5-fold greater than the peak
performance of the world’s fastest traditional supercomputer, called Summit (Fig. 6.1C). It
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is also more than the top 100 supercomputers combined. Prior to Folding@home, the first
exascale supercomputer was not scheduled to come online until the end of 2021.
6.3.2 Unmasking the spike complex
The spike complex (S) is a prominent vaccine target that is known to undergo substantial con-
formational changes as part of its function [415–417]. Structurally, S is composed of three
interlocking proteins, with each chain having a cleavage site separating an S1 and S2 fragment.
S resides on the virion surface, where it waits to engage with an angiotensin-converting enzyme
2 (ACE2) receptor on a host cell to trigger infection [418, 419]. The fact that S is exposed on
the virion surface makes it an appealing vaccine target. However, it has a number of effective
defense strategies. First, S is decorated extensively with glycans that aid in immune evasion by
shielding potential antigens [420]. S also uses a conformational masking strategy, wherein it
predominantly adopts a closed conformation that buries the receptor-binding domains (RBDs)
to evade immune surveillance mechanisms. To engage with ACE2, S undergoes rare transitions
to an open state that exposes the conserved binding interface of the RBDs. Characterization
of the full range of this motion is important for understanding pathogenesis and could provide
insights into novel therapeutic options.
To capture S opening, we employed our goal-oriented adaptive sampling algorithm, FAST,
in conjunction with Folding@home. The FAST method iterates between running a batch of
simulations, building an MSM, ranking the MSM states based on how likely starting a new
simulation from that state is to yield useful data, and starting a new batch of simulations from
the top ranked states [35, 421]. The ranking function is designed to balance between favoring
structures with a desired geometric feature (in this case opening of S) and broad exploration
of conformational space. By balancing exploration-exploitation tradeoffs, FAST often cap-
tures conformational changes with orders of magnitude less simulation time than alternative
methods. Broadly distributed structures from our FAST simulations were then used as starting
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points for extensive Folding@home simulations, totaling 1 ms of data, enabling us to obtain a
statistically sound final model.
Our SARS-CoV-2 S protein simulations capture opening of S and substantial conformational
heterogeneity in the open state (Fig. 6.3). Capturing opening of S is an impressive technical
feat given that previous large-scale simulations were unable to observe this essential event for
the initiation of infection. Intriguingly, we find that opening occurs only for a single RBD at
a time, akin to that observed in cryoEM structures [422]. Additionally, we find that the scale
of this opening can be substantially larger than has been observed in experimental snapshots
(Fig. 6.3). The dramatic opening we observe is consistent with the observation that antibodies
can bind to regions of the RBD that are deeply buried and seemingly inaccessible in existing
experimental snapshots [423].
To understand the potential role of conformational masking in determining the lethality and
infectivity of different coronaviruses, we also simulated the opening of S proteins from two
related viruses: SARS-CoV-1 and HCoV-NL63. These viruses were selected because they also
bind the ACE2 receptor but are associated with varying mortality rates. SARS-CoV-1 caused
an outbreak in 2003 with a high case fatality rate but has not become a pandemic [424]. NL63
was discovered the following year and continues to spread around the globe, although it is
significantly less lethal than either SARS virus [425]. We hypothesized that these phenotypic
differences may be explained by changes to the S conformational ensemble. Specifically, we
propose mutations or other perturbations can increase the S-ACE2 affinity by increasing the
probability that S adopts an open conformation or by increasing the affinity between an exposed
RBD and ACE2.
As expected, the three S complexes have very different propensities to adopt an open state
and bind ACE2. Structures from each ensemble were classified as competent to bind ACE2
if superimposing an ACE2-RBD structure on S did not result in any steric clashes between
ACE2 and the rest of the S complex. We find that SARS-CoV-1 has the highest population
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Figure 6.2: Structural characterization of conformational masking in different spike com-
plexes. A. A representative structure of SARS-CoV-2 spike protein in an open conformation, as
pulled from our molecular dynamic simulations. ACE2 (gray) is superimposed onto the struc-
ture to highlight binding compatibility. The three chains of Spike are illustrated with a cartoon
and transparent surface representation (orange, teal, and purple), and glycans are shown as
sticks (green). B. The probability that each sequence adopts an ACE2 binding competent pose.
HCoV-NL63, SARS-CoV-1, and SARS-CoV-2 are shown as light-blue, orange, and black, re-
spectively. C. The probability that the center of mass of an RBD deviates from its position in
the closed state for HCoV-NL63, SARS-CoV-1, and SARS-CoV-2.
of conformations that can bind to ACE2 without steric clashes, followed by SARS-CoV-2,
while opening of NL63 is sufficiently rare that we did not observe ACE2-binding competent
conformations in our simulations (Fig. 6.2B). Interestingly, S proteins that are more likely to
adopt structures that are competent to bind ACE2 are also more likely to adopt highly open
structures (Fig. 6.2C).
We also observe a number of interesting correlations between conformational masking, lethal-
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ity, and infectivity of different coronaviruses. First, more deadly coronaviruses have S proteins
with less conformational masking. Second, there is an inverse correlation between S opening
and the affinity of an isolated RBD for ACE2 (RBD-ACE2 affinities of 35 nM, 44 nM, and
185 nM for HCoV-NL63, SARS-CoV-2, and SARS-CoV-1, respectively) [426, 427].
These observations suggest a tradeoff wherein greater conformational masking enables immune
evasion but requires a higher affinity between an exposed RBD and ACE2 to successfully infect
a host cell. We propose that the NL63 S complex is probably best at evading immune detection
but is not as infectious as the SARS viruses because strong conformational masking reduces the
overall affinity for ACE2. In contrast, the SARS-CoV-1 S complex adopts open conformations
more readily but is also more readily detected by immune surveillance mechanisms. Finally,
SARS-CoV-2 balances conformational masking and the RBD-ACE2 affinity in a manner that
allows it to evade an immune response while maintaining its ability to infect a host cell. Based
on this model, we predict that mutations that increase the probability that the SARS-CoV-2 S
complex adopts open conformations may be more lethal but spread less readily.
Our atomically detailed model of S can enable rapid structure-based vaccine antigen design
through identification of regions minimally protected by conformational masking or the gly-
can shield [428]. To identify these potential epitopes, we calculated the probability that each
residue in S could be exposed to therapeutics (e.g. not shielded by a glycan or buried by con-
formational masking), as shown in Fig. 6.3A. Visualizing these values on the protein reveals a
few patches of protein surface that are exposed through the glycan shielding (Fig. 6.3B). How-
ever, another important factor when targeting an antigen is picking a region with a conserved
sequence to yield broader and longer lasting efficacy. Not surprisingly, many of the exposed re-
gions do not have a strongly conserved sequence. Promisingly, though, we do find a conserved
area with a larger degree of solvent exposure (Fig. 6.3C). Another possibility for antigen de-
sign is to exploit the opening motion. A number of conserved residues of the RBD show an
increase in exposure by 3̃0% in ACE2 binding competent structures (Fig. 6.3C). Consistent
with immunoassays, this region was recently found to be a cluster for neutralizing antibody
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binding [423, 424].
6.3.3 Cryptic pockets and functional dynamics
Every protein in SARS-CoV-2 is a potential drug target. So, to understand their role in disease
and help progress the design of antivirals, we unleashed the full power of Folding@home to
simulate dozens of systems related to pathogenesis. While we are interested in all aspects of
a proteins’ functional dynamics, expanding on the number of antiviral targets is of immedi-
ate value. Towards this end, we seeded Folding@home simulations from our FAST-pockets
adaptive sampling to aid in the discovery of cryptic pockets. We briefly discuss two illustrative
examples, out of 36 datasets.
Nonstructural protein number 5 (NSP5, also named the main protease, Mpro, or 3CLpro) is
critical for the lifecycle of coronaviruses and is a major target for the design of antivirals [429].
It is highly conserved between coronaviruses, owing to its necessary function of processing
polyproteins. NSP5 is only active as a dimer, however it exists in a monomer-dimer equilibrium
with estimates of its dissociation constant in the low µM range [430]. Small molecules targeting
this protein to inhibit enzymatic activity, either by altering its active site or favoring the inactive
monomer state, would be promising broad-spectrum antiviral candidates [431].
Our simulations reveal two novel cryptic pockets on NSP5 that expand our current therapeutic
options. These are shown in figure 6.4A, which projects states from our MSM onto the solvent
exposure of residues that make up the pockets. The first cryptic pocket is an expansion of
NSP5’s catalytic site. We find that the loop bridging domains II and III is highly dynamic and
can fully disengage the protein. This motion may be necessary for catalysis and is similar to
motions we have observed previously for the enzyme β-lactamase [49]. Owing to its location,
a small molecule bound in this pocket is likely to prevent catalysis by obstructing polypeptide
association with catalytic residues. The second pocket is a large opening between domains I/II
and domain III. Located at the dimerization interface, this pocket offers the possibility to find
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small molecule or peptide stabilizers that favor the inactive monomer state.
In addition to cryptic pockets, our data captures many potentially functionally relevant motions
within the SARS-CoV-2 proteome. We illustrate this with the SARS-CoV-2 nucleoprotein. The
nucleoprotein is a multifunctional protein responsible for major lifecycle events such as viral
packaging, transcription, and physically linking RNA to the envelope [289, 301]. As such, we
expect the protein to accomplish these goals through a highly dynamic and rich conformational
ensemble, akin to context-dependent regulatory modules observed in Ebola virus nucleopro-
tein [2, 3]. Investigating the RNA-binding domain, we observe both cryptic pockets and an
incredibly dynamic beta-hairpin, which hosts the RNA binding site, referred to as a “positive
finger” (Fig. 6.4C-D). Our observed conformational heterogeneity of the positive finger is con-
sistent with a structural ensemble determined using solution-state nuclear magnetic resonance
spectroscopy [432]. Our simulations also capture numerous states of the putative RNA binding
pose, where the positive finger curls up to form a cradle for RNA. These states can provide
a structural basis for the design of small molecules that would compete with RNA binding,
preventing viral assembly. Additionally, knowledge of these probabilities can provide further
insight into the mechanisms and regulation of genome compaction/release.
The data we present in this paper represents the single largest collection of all-atom simulations.
Table 6.1 is a comprehensive list of the systems we have simulated. Systems span various
oligomerization states, include important complexes, and include representation from multiple
coronaviruses. We also include human proteins that are targets for supportive therapies and
preventative treatments. To accelerate the discovery of new therapeutics and promote open
science, we are posting all of our data online (https://covid.molssi.org/).
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Table 6.1: A list of protein systems we have simulated on Folding@home. Systems are or-
ganized by viral strain and include name, oligomerization state, starting structure, number of
residues, number of atoms in the system, aggregate simulation time, and the number of cryptic
pockets we have identified.
*Missing residues were modeled using Swiss model [1].
**Structural model was generated from a homologous sequence using Swiss model [1].
***Missing residues were modeled using CHARMM-GUI [2, 3]
System name Oligomerization Initial struc-
ture (homol-
ogy)
Residues Atoms in system Aggregate simulation time (us) Cryptic pock-
ets discovered
SARS-CoV-2
NSP3 (Macrodomain ÒXÓ) Monomer 6W02 167 23907 10,531 TBD
NSP3 (Papain-like protease 2, PL2pro) Monomer 3E9S** 306 97285 621 TBD
NSP5 (main protease, 3CLpro) Monomer 6Y2E 306 64791 6,050 TBD
NSP5 (main protease, 3CLpro) Dimer 6Y2E 612 77331 2,189 TBD
NSP7 Monomer 5F22** 79 20094 7,622 TBD
NSP8 Monomer 2AHM** 191 156282 1,259 TBD
NSP9 Dimer 6W4B* 226 49885 7,503 TBD
NSP10 Monomer 6W4H* 131 29560 3,050 TBD
NSP12 (polymerase) Monomer 6NUR** 891 186622 1,114 TBD
NSP13 (helicase) Monomer 6JYT** 596 129368 939 TBD
NSP14 Monomer 5C8S** 527 216380 359 TBD
NSP15 Monomer 6VWW 347 67345 3,618 TBD
NSP15 Hexamer 6VWW 2082 230339 1,461 TBD
NSP16 Monomer 6W4H* 298 45672 2,684 TBD
Nucleoprotein (RBD) Monomer 6VYO 173 29125 8,742 TBD
Nucleoprotein Dimerization Domain Monomer 6YUN* 118 34905 2,420 TBD
Nucleoprotein Dimerization Domain Dimer 6YUN* 236 72733 1,251 TBD
Spike Trimer 6VXX*** 3363 442881 949 TBD
NSP7 / NSP8 / NSP12 Trimer complex 6NUR** 1184 215694 291 TBD
NSP10 / NSP14 Dimer complex 5C8S** 688 226672 469 TBD
NSP10 / NSP16 Dimer complex 6W4H* 429 63752 2,415 TBD
SARS-CoV-1
NSP3 (Macrodomain ÒXÓ) Monomer 2FAV 172 33117 507 TBD
NSP9 Dimer 1QZ8* 226 49599 6,736 TBD
NSP15 Monomer 2H85 345 67345 2,663 TBD
NSP15 Hexamer 2H85 2070 230339 829 TBD
Nucleoprotein RBD Monomer 2OFZ 174 29125 4,124 TBD
Nucleoprotein Dimerization Domain Monomer 2GIB 370 34905 874 TBD
Nucleoprotein Dimerization Domain Dimer 2GIB 740 72733 427 TBD
Spike Trimer 5X58*** 3261 375851 784 TBD
NSP10 / NSP16 Dimer complex 6W4H** 425 69589 175 TBD
Human
IL6 Monomer 1ALU 166 26855 1,263 TBD
IL6-R Monomer 1N26 299 149764 132 TBD
ACE2 Monomer 6LZG 596 75787 244 TBD
MERS
NSP13 Monomer 5WWP 596 121134 288 TBD
NSP10 / NSP16 Dimer Complex 6W4H** 424 69127 174 TBD
HCoV-NL63
Spike Trimer 5SZS*** 3606 453348 618 TBD
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Figure 6.3: Effects of glycan shielding and conformational masking on the accessibility of
different parts of the spike to potential therapeutics. A. The probability that a residue is exposed
to potential therapeutics, as determined from our structural ensemble. B. Exposure probabilities
colored on the surface of the spike protein. Exposed patches are circled orange. Red residues
have a higher probability of being exposed, whereas blue residues have a lower probability of
being exposed. C. Sequence conservation score colored onto the Spike protein. A conserved
patch on the protein is circled in orange. Red residues have higher conservation, whereas blue
residues have lower conservation. D. The difference in the probability that each residue is
exposed between the ACE2-binding competent conformations and the entire ensemble. Red
residues have a higher probability of being exposed upon opening, whereas blue residues have
a lower probability of being exposed.
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Figure 6.4: Examples of cryptic pockets and functionally-relevant dynamics. A-B) Conforma-
tional ensemble of the main protease (NSP5) projected onto the solvent accessible surface areas
(SASAs) of residues surrounding either the active-site or a cryptic pocket. Cluster centers are
represented as black circles with representative structures depicted with cartoon. The starting
structure for simulations (6Y2E) is shown as a red dot. Domains I and II are colored cyan and
domain III is colored gray. The loop of domain III, that covers the active-site residues and is
seen to be highly dynamic, is colored tan. C-D) Conformational ensemble of Nucleoprotein
projected onto the distance and angle between the positive finger and a nearby loop. Angles
were calculated between vectors that point along each red segment in panel D and distances
were calculated between their centers of mass. Cluster centers are represented as black circles
and representative structures are depicted with cartoon. The starting structure for simulations
(6VYO) is shown as a red dot.
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6.4 Discussion
In this work, we have utilized the largest computer in the world to tackle a global threat. The
pandemic caused by SARS-CoV-2 has necessitated a call-to-arms; a call that over a million
citizen-scientists have answered, generating more than 0.1 seconds of simulation data. The
unprecedented scale of these simulations has helped to characterize crucial stages of infection.
We find that spike proteins have a strong trade-off between making ACE2 binding interfaces ac-
cessible to infiltrate cells and conformationally masking epitopes to subvert immune responses.
SARS-CoV-2 represents a more optimal tradeoff than related coronaviruses, which may explain
its success in spreading globally. Our simulations also provide an atomically detailed roadmap
for targeting proteins for vaccines and antivirals. Furthermore, we are working on making a
comprehensive repository of cryptic pockets hosted online to accelerate the development of
novel therapeutics.
Beyond SARS-CoV-2, we expect this work to aid in a better understanding of the roles of pro-
teins in the coronaviridae family. Coronaviruses have been around for millennia, yet many of
their proteins are still poorly understood. Because climate change has made zoonotic trans-
mission events more commonplace, it is imperative that we continue to perform basic research
on these viruses to better protect us from future pandemics. For each protein system in Table
6.1, an extraordinary amount of sampling has led to the generation of a quantitative map of its
conformational landscape. There is still much to learn about coronavirus function and these
conformational ensembles contain a wealth of information to pull from.
While we have aggressively targeted research on SARS-CoV-2, Folding@home is a general
platform for running molecular dynamics simulations at scale. Before the COVID-19 pan-
demic, Folding@home was already generating datasets that were orders of magnitude greater
than from conventional means. With our explosive growth, our compute power has increased
around 100-fold. Our work here highlights the incredible utility this compute power has to
rapidly understand health, disease, and aid in drug design. Both in terms of scale and approach,
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we are in a new frontier of using molecular dynamics simulations to understand biophysics; the
complex task of simulating an organism’s entire proteome could become commonplace. With
the continued support of the citizen scientists that have made this work possible, we have the
opportunity to make a profound impact on other global health crises such as cancer, neurode-
generative diseases, and antibiotic resistance.
6.5 Methods
6.5.1 System preparations
All simulations were prepared using Gromacs 2020 [222]. Initial structures were placed in a
dodecahedron box that extends 1.0 nm beyond the protein in any dimension. Systems were
then solvated and energy minimized with a steepest descents algorithm until the maximum
force fell below 100 kJ/mol/nm using a step size of 0.01 nm and a cutoff distance of 1.2 nm for
the neighbor list, Coulomb interactions, and van der Waals interactions. The AMBER03 force
field was used for all systems except spike protein with glycans, which used CHARMM36
[146, 433]. All simulations were simulated with explicit TIP3P solvent [143].
Systems were then equilibrated for 1.0 ns, where all bonds were constrained with the LINCS
algorithm and virtual sites were used to allow a 4 fs time step [226, 228]. Cutoffs of 1.1 nm
were used for the neighbor list with 0.9 for Coulomb and van der Waals interactions. The Verlet
cutoff scheme was used for the neighbor list. The stochastic velocity rescaling (v-rescale)
thermostat was used to hold the temperature at 300 K [224].
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6.5.2 Adaptive sampling simulations
The FAST algorithm was employed for each protein in Table 6.1 to enhance conformational
sampling and quickly explore dominant motions. The procedure for FAST simulations is as
follows: 1) run initial simulations, 2) build MSM, 3) rank states based on FAST ranking, 4)
restart simulations from the top ranked states, 5) repeat steps 2-4 until ranking is optimized.
For each system, MSMs were generated after each round of sampling using a k-centers clus-
tering algorithm based on the RMSD between select atoms. Clustering continued until the
maximum distance of a frame to a cluster center fell within a predefined cutoff. In addition
to the FAST ranking, a similarity penalty was added to promote conformational diversity in
starting structures, as has been described previously [278].
FAST-distance simulations of all Spike proteins were run at 310 K on the Microsoft Azure
cloud computing platform. The FAST-distance ranking favored states with greater RBD open-
ings using a set of distances between atoms. Each round of sampling was performed with 22
independent simulations that were 40 ns in length (0.88 µs aggregate sampling per round),
where the number of rounds totaled 13 (11.44 µs), 22 (19.36 µs), and 17 (14.96 µs), for SARS-
CoV-1, SARS-CoV-2, and HCoV-NL63, respectively.
For all other proteins, FAST-pocket simulations were run at 300 K for 6 rounds, with 10 sim-
ulations per round, where each simulation was 40 ns in length (2.4 µs aggregate simulation).
The FAST-pocket ranking function favored restarting simulations from states with large pocket
openings. Pocket volumes were calculated using the LIGSITE algorithm [434].
6.5.3 Folding@home simulations
For each adaptive sampling run, a conformationally diverse set of structures was selected to
be run on Folding@home. Structures came from the final k-centers clustering of adaptive
sampling, as is described above. Simulations were deployed using a simulation core based on
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either GROMACS 5.0.4 or OpenMM 7.4.1 [34, 222].
6.5.4 Markov state models
A Markov state model is a network representation of a free energy landscape and is a key
tool for making sense of molecular dynamics simulations [38]. All MSMs were built using
our python package, enspara [39]. Each system was clustered with the combined FAST and
Folding@home datasets. In the case of spike proteins, states were defined geometrically based
on the RMSD between backbone Cα coordinates. States were generated as the top 3000 centers
from a k-centers clustering algorithm. All other proteins were clustered based on the euclidean
distance between the solvent accessible surface area of residues, as is described previously
[49]. Systems generated either 2500, 5000, 7500, or 10000 cluster centers from a k-centers
clustering algorithm. Select systems were refined with 1-10 k-medoid sweeps. Transition
probability matrices were produced by counting transitions between states, adding a prior count
of 1/nstates, and row-normalizing, as is described previously [42]. Equilibrium populations
were calculated as the eigenvector of the transition probability matrix with an eigenvalue of
one.
6.5.5 Spike/ACE2 binding competency
To determine Spike protein binding competency to ACE2 the following structures of the RBD
bound to ACE2 were used: 3D0G, 6M0J, and 3KBH, for SARS-CoV-1, SARS-CoV-2, and
HCoV-NL63, respectively. The RBD of the bound complex was superimposed onto each RBD
for structures in our MSM. Steric clashes were then determined between backbone atoms on
the ACE2 molecule and the rest of the spike protein. If any of the structures had a superposition
that resulted in no clashes, it was deemed binding competent.
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6.5.6 Cryptic pockets and solvent accessible surface area
For ease of detecting cryptic pockets and other functional motions, we employed our exposon
analysis method [49]. This method correlates the solvent exposure between residues to find
concerted motions that tend to represent cryptic pocket openings. Solvent accessible surface
area calculations were computed using the Shrake-Rupley algorithm as implemented in the
python package MDTraj [148]. For all proteins and complexes, a solvent probe radius of 0.28
nm was used, which has been shown to produce a reasonable clustering and exposon map [49].
Spike protein solvent accessible surface areas for SARS-CoV-2 were computed with glycan
chains modeled onto each cluster center. Multiple glycan rotamers were sampled for each
state and accessible surface areas for each residue were weighted based on MSM equilibrium
populations.
6.5.7 Sequence conservation
Sequence conservation of spike proteins was calculated using the Uniprot database [435]. Se-
quences between 30% - 90% were pulled and aligned with the Muscle algorithm [436]. The
entropy at each position was calculated to quantify variability of amino acids. Conservation
was defined as one minus the entropy [237].
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CTX-M β-lactamases are widespread in Gram-negative bacterial pathogens and provide re-
sistance to the cephalosporin cefotaxime but not to the related antibiotic ceftazidime. Never-
theless, variants have emerged that confer resistance to ceftazidime. Two natural mutations,
causing P167S and D240G substitutions in the CTX-M enzyme, result in 10-fold increased
hydrolysis of ceftazidime. Although the combination of these mutations would be predicted to
increase ceftazidime hydrolysis further, the P167S/D240G combination has not been observed
in a naturally occurring CTX-M variant. Here, using recombinantly expressed enzymes, min-
imum inhibitory concentration measurements, steady-state enzyme kinetics, and X-ray crys-
tallography, we show that the P167S/D240G double mutant enzyme exhibits decreased cef-
tazidime hydrolysis, lower thermostability, and decreased protein expression levels compared
with each of the single mutants, indicating negative epistasis. X-ray structures of mutant en-
zymes with covalently trapped ceftazidime suggested that a change of an active-site Ω-loop to
an open conformation accommodates ceftazidime leading to enhanced catalysis. 10-µs molec-
ular dynamics simulations further correlated -loop opening with catalytic activity. We observed
that the WT and P167S/D240G variant with acylated ceftazidime both favor a closed conforma-
tion not conducive for catalysis. In contrast, the single substitutions dramatically increased the
probability of open conformations. We conclude that the antagonism is due to restricting the
conformation of the -loop. These results reveal the importance of conformational heterogeneity
of active-site loops in controlling catalytic activity and directing evolutionary trajectories.
7.2 Introduction
Enzymes have evolved to catalyze reactions critical to the functioning of the cell [438]. Evo-
lution of enzyme function proceeds through the accumulation of amino acid substitutions that
shape stability, solubility, and catalytic activity, among other properties. How substitutions
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interact when combined plays a key role in the trajectory of mutations that accumulate dur-
ing evolution [439, 440]. For example, amino acid substitutions can act additively on catalysis
whereupon each substitution increases activity, and upon combination, the increase in activity
in the double mutant is the product of the fold changes of the individual mutations [441]. Al-
ternatively, combinations of substitutions are often nonadditive where the double mutant has a
greater activity or less activity than expected based on the activity of the single mutants. Such
nonadditive effects are termed epistasis and can strongly influence the mutational pathways that
are possible in the evolution of enzyme function [442].
Enzymes act by binding substrates and stabilizing transition states of reactions [438]. Toward
this end, conformational changes are often important, and flexible loops in the active site are
a common feature involved in enzyme function [443–445]. Moreover, conformational dynam-
ics have been proposed to play an important role in protein evolvability [446, 447]. By this
view, conformational fluctuations can result in an enzyme adopting multiple structures, some
of which have properties that allow interactions with alternate ligands. These conformations
may be rare in the ensemble of WT structures, but mutations may shift the distribution toward
alternate conformations that become dominant in an evolved enzyme, thereby allowing for al-
tered substrate specificity or new enzyme functions to emerge on an enzyme scaffold [447,448].
Here, we address the role of epistasis and conformational diversity of active-site loops in the
evolution of variants of the CTX-M β-lactamase with a broadened substrate specificity for β-
lactam antibiotics. β-Lactams are the most frequently prescribed class of antibiotic worldwide,
making up 65% of all use [449]. However, bacterial resistance to these drugs is a growing
problem, and the most common mechanism of resistance is enzyme-mediated hydrolysis of the
β-lactam ring [450]. This hydrolysis is catalyzed by various β-lactamases, which are divided
into classes A–D based on primary amino acid sequence homology [450, 451].
Class A β-lactamases, such as CTX-M, are widespread in Gram-negative bacteria and share
a similar mechanism of catalysis but can differ widely in substrate profile [452, 453]. These
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enzymes are serine hydrolases that hydrolyze the amide bond in the β-lactam ring via sequential
acylation and deacylation steps. The conserved catalytic Ser70 residue is activated by Lys73
and Glu166 for attack on the carbonyl carbon to form an acyl-enzyme intermediate. A catalytic
water molecule is then activated by Glu166 for attack on the carbonyl of the covalent complex
to deacylate the enzyme and release the product (Fig. 7.1) [453–455]. The reaction scheme and
mechanism of serine β-lactamases is shown in Fig. 7.1.
Figure 7.1: β-Lactamase mechanism. A, reaction scheme for β−lactamase where E represents
β−lactamase, ES represents the enzyme-substrate complex, EAc represents the acyl-enzyme
complex, and P represents product. k1 and k-1 are the rate constants for association and dis-
sociation of the enzyme substrate complex, and k2 and k3 are the rate constants for acylation
and deacylation, respectively. B, schematic illustration of β−lactamase mechanism. The cat-
alytic Ser70 hydroxyl group is activated for nucleophilic attack on the carbonyl oxygen of the
amide bond of the β−lactam by an active-site residue serving as a general base. This residue
is viewed as either Lys73 or Glu166 acting through a water molecule. This leads to formation
of the acyl enzyme intermediate, which is subsequently deacylated by a water that is activated
by Glu166 acting as a base and resulting in free enzyme and the hydrolyzed product.
CTX-M β-lactamases are a family of class A extended-spectrum β-lactamases that are so
named because they efficiently hydrolyze the oxyimino-cephalosporin cefotaxime [456] (Fig.
7.2). To date, more than 140 variants of the CTX-M enzymes have been identified [457].
CTX-M-14 β-lactamase has become a model system for studies of the structure and function
of CTX-M enzymes [458–461].
CTX-M enzymes efficiently hydrolyze cefotaxime but not another commonly used oxyimino-
cephalosporin, ceftazidime (Fig. 7.2A). Natural variants containing either the P167S or D240G
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Figure 7.2: Structures of antibiotics and CTX-M-14 β-lactamase. A, cephalothin. R1 and
R2 denote the groups that differ between cephalosporins. B, cefotaxime. C, ceftazidime. D,
structure of CTX-M-14 β-lactamase (PDB code 1YLT). The Ω-loop is colored green. The
catalytic Ser70 is colored orange. Pro167 and Asp240 are colored gray. Note that Pro167 is
located on the Ω-loop.
substitutions have emerged, however, that more efficiently hydrolyze ceftazidime [457, 462–
464]. These two substitutions, when present, individually increase kcat/Km for ceftazidime
hydrolysis by 10-fold, resulting in increased ceftazidime resistance for bacteria containing the
mutants [458,461]. Multiple natural variants in the CTX-M family possess one of these substi-
tutions [457].
Pro167 resides in the Ω-loop that forms the bottom of the active site in class A β-lactamases
including CTX-M enzymes [458,465] (Fig. 7.2D). It is adjacent to Glu166, which is conserved
and serves as a general base to activate a water molecule for deacylation of β-lactam substrates
[465]. The peptide bond preceding Pro167 is in a cis conformation in CTX-M enzymes, which
strongly influences the conformation of the Ω-loop and the positioning of the Asn170 residue
that hydrogen bonds to Glu166 and the deacylation water. We previously used the CTX-M-14
enzyme as a model system to examine the structural changes caused by the P167S substitution
[461]. These studies revealed a large conformational change of the Ω-loop that results in a
larger active-site cavity to accommodate ceftazidime. This conformational change required
both the P167S substitution and the presence of acylated ceftazidime [461] In addition, the
structures showed that the conformational change is associated with a shift in the peptide bond
preceding residue 167 from cis to trans and that the P167S substitution was required for this
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shift. Thus, the P167S substitution appears to cause increased ceftazidime hydrolysis through
promoting a conformational change to relieve steric restraints on catalysis.
Chen et al. [458] previously determined the X-ray structure of the D240G mutant enzyme, and
anisotropic B-factor analysis revealed increased flexibility of the B3 β-strand that forms one
side of the CTX-M active site. The increased flexibility of the B3 β-stand was proposed to
allow access for the bulky side chain of ceftazidime.
Despite the increase in ceftazidime hydrolysis and bacterial resistance resulting from each of
the substitutions, there has yet to be a CTX-M enzyme identified in clinical isolates that har-
bors both the P167S and D240G mutations. Based on simple additivity, the combination of
substitutions that each increase hydrolysis by 10-fold would be expected to increased hydroly-
sis 100-fold relative to the WT enzyme [441]. However, a P167S/D240G double mutant created
by site-directed mutagenesis in a CTX-M-3 enzyme background exhibited a loss of ceftazidime
resistance, indicating an antagonist effect and negative epistasis [466]. The mechanism of this
antagonism, however, was not examined.
Here, we show that the P167S/D240G double mutant displays decreased ceftazidime hydrolysis
compared with either of the single mutants, indicating antagonism. Further, X-ray structures of
single and double mutants as apoenzymes and acylated with ceftazidime show alternate open
and closed conformations of the Ω-loop that are associated with high and low activity. Fi-
nally, molecular dynamics simulations of the WT, P167S, D240G, and P167S/D240G enzymes
acylated with ceftazidime indicate that the single substitutions dramatically increase the prob-
ability of open conformations of the Ω-loop, whereas the WT and P167S/D240G variant both
favor a well-defined closed conformation not favorable for catalysis. Taken together, the results
suggest that the P167S/D240G double mutant has not been observed in resistant clinical iso-
lates because the combination results in decreased catalysis, decreased stability, and therefore
decreased fitness in the presence of ceftazidime for bacteria containing this enzyme.
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pTP123 12 0.0625 0.19
CTX-M-14 wt >256 1.5 0.75
P167S >256 0.375 12
D240G >256 1 1.5
P167S/D240G >256 0.19 0.75
7.3 Results
7.3.1 Ceftazidime resistance levels of P167S/D240G double mutant are
reduced compared with single mutants.
The P167S and D240G substitutions have been observed in multiple CTX-M β-lactamase vari-
ants and are associated with 10-fold increased ceftazidime hydrolysis [458,460]. Further, intro-
duction of the P167S and D240G substitutions into the CTX-M-3 β-lactamase results in lower
ceftazidime resistance than either of the single mutants [466]. We extended these findings to
the CTX-M-14 model system by determining minimum inhibitory concentrations (MICs)7.1
for ceftazidime, cefotaxime, and cephalothin for Escherichia coli harboring WT and the mu-
tants (Table 7.1). The results show that the P167S and D240G individual substitutions both
result in increased resistance to ceftazidime, whereas the P167S/D240G double mutant exhibits
a loss of ceftazidime resistance compared with either the P167S or D240G single mutants (Ta-
ble 7.1) [460, 466]. These data confirm the apparent incompatibility of the P167S and D240G
substitutions as first suggested by Novais et al. [466] and extends the findings to the CTX-M-14
enzyme background.
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Table 7.2: Enzyme kinetic parameters of CTX-M-14 β-lactamase and mutant enzymes
Enzyme Parameter Cephalothin Cefotaxime Ceftazidime
CTX-M-14 kcat (s−1) 1400 ± 38 161 ± 9 NDa
Km (µM) 83 ± 6 60 ± 7 >500
kcat/Km (µM−1s−1) 17.0 ± 0.7 2.71 ± 0.16 0.0011 ± 0.00007
P167Sb kcat (s−1) 681 ± 36.8 297 ± 29.7 ND
Km (µM) 32 ± 0.8 37 ± 6.3 >500
kcat/Km (µM−1s−1) 21.1 ± 1.3 8.0 ± 1.6 0.011 ± 0.0002
D240Gb kcat (s−1) 471 ± 10.9 321 ± 46.2 ND
Km (µM) 47.1 ± 41.7 52 ± 8.6 >500
kcat/Km (µM−1s−1) 10.0 ± 2.5 6.2 ± 1.4 0.013 ± 0.0007
P167S/D240G kcat (s−1) 165 ± 11 139 ± 3 ND
Km (µM) 15 ± 3 42 ± 0.5 >500
kcat/Km (µM−1s−1) 10.8 ± 1.4 3.27 ± 0.1 0.0060 ± 0.00004
7.3.2 Antibiotic hydrolysis by the P167S/D240G double mutant is reduced
compared with single mutants.
Although the P167S and D240G substitutions increase the catalytic efficiency (kcat/Km) for
ceftazidime hydrolysis by ∼10-fold, the activity of the P167S/D240G double mutant enzyme
has not been examined [460, 462, 463, 467]. Therefore, both WT and the double mutant CTX-
M-14 enzymes were purified, and their kinetic parameters were determined for hydrolysis of
the oxyimino-cephalosporins cefotaxime and ceftazidime, as well as cephalothin (Table 7.2).
Ceftazidime hydrolysis by the WT, P167S, and D240G enzymes exhibits high Km values (¿500
µM), which precluded determination of kcat values [460]. Nevertheless, kcat/Km values for
the P167S and D240G enzymes were 10-fold higher than that observed for WT CTX-M-14.
If the P167S and D240G substitutions act additively, kcat/Km for ceftazidime by the double
mutant should be a further 10-fold higher than that observed for the single mutants [441].
However, kcat/Km for ceftazidime hydrolysis by the double mutant was ∼2-fold lower than
that observed for the P167S and D240G single mutants (Table 7.2). Therefore, the P167S and
D240G substitutions are antagonistic with respect to ceftazidime hydrolysis. This suggests that
the presence of one substitution alters the environment of the other to perturb its contribution
to catalysis [441].
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The P167S and D240G substitutions were previously observed to modestly increase kcat/Km
for cefotaxime hydrolysis (∼2-fold) compared with the WT enzyme [460]. The P167S/D240G
double mutant exhibited a kcat/Km value similar to WT and 2-fold lower than the single mutants
indicating possible antagonism, as found for ceftazidime hydrolysis (Table 7.2).
The second-generation cephalosporin cephalothin is an excellent substrate for the WT CTX-
M-14 enzyme (Table 7.2) [460]. The P167S and D240G substitutions reduce both kcat and
Km values for cephalothin hydrolysis (Table 7.2). The P167S/D240G double mutant exhib-
ited a further reduction in kcat and Km compared with the single mutants. Interestingly, the
P167S and D240G substitutions act additively in the double mutant for cephalothin hydrol-
ysis. Therefore, the additivity relationship between the P167S and D240G substitutions is
substrate-dependent, with simple additivity observed for cephalothin and antagonism observed
for ceftazidime hydrolysis, suggesting that the effects are mediated through interaction with the
substrates.
7.3.3 P167S/D240G double mutant exhibits reduced stability compared
with single mutants
Amino acid substitutions can affect catalysis, as shown above, but also can impact protein
stability. It was previously shown that the P167S and D240G single mutants destabilize CTX-
M-14 [460]. We extended this finding to the P167S/D240G enzyme using CD spectroscopy to
monitor α-helix ellipticity with increasing temperature (Fig. 7.3). Previous studies showed that
the WT CTX-M-14 exhibited a melting temperature (Tm) of 54.6 °C, and the single mutants
D240G and P167S decreased the Tm by 0.4 and 2.8 °C, respectively [460]. The P167S/D240G
enzyme exhibited a Tm of 50.5 °C, indicating that the double mutant is less stable than WT and
the single mutants (Fig. 7.3).
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Figure 7.3: Thermal stability of WT and mutant β-lactamases, as measured by CD. Mean
ellipsivity is normalized and fit to a Boltzmann sigmoidal function. Tm, as determined by the
Boltzmann equation, is also plotted, as is ∆Tm, which is the change from the WT Tm. The
Tm indicates that each single mutant is less stable than the WT CTX-M-14 enzyme, and this
instability has an additive effect in the double mutant, P167S/D240G CTX-M-14. The data for
CTX-M-14, D240G, and P167S are from Patel et al. [460].
7.3.4 Steady-state levels of the P167S/D240G enzyme in E. coli are re-
duced compared with single mutants.
The level of antibiotic resistance conferred to bacteria by a β-lactamase depends on the rate
of hydrolysis, as well as the steady-state levels of enzyme expression [468]. A correlation has
been shown between β-lactamase stability and expression levels in E. coli caused by increased
proteolysis and aggregation of unstable proteins [468–470]. Because the P167S and D240G
substitutions decrease enzyme stability and the double mutant decreases stability further, we
hypothesized that the double mutant would display lower expression levels. Immunoblot anal-
ysis of whole cell lysates using α-CTX-M-14 β-lactamase polyclonal antibody showed that
the P167S mutant did not significantly decrease expression levels relative to WT, consistent
with previous studies (Fig. 7.4) [460]. The D240G mutant, which shows only a 0.4 °C de-
crease in stability relative to WT, displayed lower expression levels. Thus, although D240G
has higher thermal stability than P167S, it displays lower expression levels, indicating that
thermal stability does not fully correlate with expression levels. However, the P167S/D240G
enzyme exhibited lower expression levels than either WT or the P167S and D240G single mu-
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tants, consistent with the lower thermal stability of this mutant. Taken together, these findings
provide a rationale for why the P167S/D240G double mutant has not been observed in resistant
clinical isolates in that it is compromised for catalysis, stability, and expression levels compared
with the P167S and D240G single mutants.
Figure 7.4: Steady-state protein levels of WT CTX-M-14 and mutant β-lactamases. Western
blotting analysis with an anti-CTX-M-14 polyclonal antibody shows protein expression levels
of WT CTX-M-14 and the P167S, D240G, and P167S/D240G mutants in the periplasm of
recombinant E. coli cells. Analysis with a polyclonal antibody to the periplasmic protein MBP
was used as a loading control. The hybridization signal was visualized by chemiluminescence
and quantified by densitometry. The signal for CTX-M-14 β-lactamase was normalized to
that for MBP in the same sample. The protein levels of mutant CTX-M-14 β-lactamase are
expressed relative to that of WT CTX-M-14 β-lactamase in the bar graph. The quantification
data in the bar graph are the averages of two independent experiments, and one representative
immunoblot result is shown above the bar graph.
7.3.5 X-ray structures of P167S/D240G apo, E166A/D240G/CAZ, and
E166A/P167S/D240G/CAZ acyl-enzyme complexes reveal alternate
conformations of the Ω-loop.
We previously determined the X-ray structure of the P167S enzyme, which had a very similar
overall structure as WT [461]. The Ω-loop, which forms the bottom of the active site, was in
a folded, closed conformation with the peptide bond preceding Ser167 in a cis configuration
(Fig. 7.5, A–C). The structure of the D240G enzyme was previously determined, and it also
155
is highly similar to the WT structure [458] (Fig. 7.5D). We next determined the structure
of the P167S/D240G enzyme, which exhibits lower ceftazidime hydrolysis than either of the
single mutants. The structure includes a boronic acid from the crystallization buffer in complex
with Ser70 and is very similar to the WT, P167S, and D240G structures, with the Ser167
peptide bond in the cis configuration and the Ω-loop in a folded, closed conformation (Fig.
7.5, E–H, and Table E.1). A difference was noted, however, in the B-factors in the active-site
103–106 loop, suggesting increased disorder. B-factors reflect the degree to which electron
density is scattered and therefore indicate how ordered an atom is in the structure [471]. The
B-factors for residues in the 103–106 loop and the 164–179 Ω-loop were normalized to the
overall B-factor of each structure to facilitate comparison across structures (Fig. 7.6). The
normalized B-factors for the P167S/D240G structure for residues Val103 and Asn104 were
higher than in the WT, P167S, and D240G structures. These findings suggest increased disorder
for residues 103–104 in the P167S/D240G structure. We have previously shown that Asn104 is
important for cefotaxime and ceftazidime hydrolysis, and therefore increased disorder of this
residue in the P167S/D240G enzyme could result in the observed lower activity for ceftazidime
hydrolysis [472].
We next determined the structures of the mutant enzymes in complex with ceftazidime to eval-
uate whether the presence of substrate influences active-site structure (Table E.1). The E166A
mutation blocks deacylation and allows for crystallization of the acyl-enzyme complex [465].
The previously determined structure of the acyl-enzyme complex of the CTX-M-14 pseudo
WT E166A enzyme with ceftazidime (E166A/CAZ) shows the Pro167 peptide bond in the
cis configuration and the Ω-loop in the folded, closed conformation (Fig. 7.7A) [461]. Con-
tacts between ceftazidime and the enzyme include hydrogen bonds between the side chains of
Asn132 and Asn104 with the carbonyl oxygen of the acylamide of the ceftazidime R-2 group,
as well as hydrogen bonds between the hydroxyls of Thr235 and Ser237 with the C4 carboxy-
late of the dihydrothiazine ring (Figs. 7.2C and 7.7A). The imino group of ceftazidime is
pointed to solvent and does not interact with the enzyme. The previously determined structure
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Figure 7.5: Structures of the active-site region of WT CTX-M14 β-lactamase (PDB code
1YLT), as well as P167S (PDB code 5TWD), D240G (PDB code 1YLP), and P167S/D240G
mutant enzymes in the apo form. A, ribbon diagram showing structural alignment of the CTX-
M-14 WT (salmon), P167S (gray), D240G (blue), and P167S/D240G (cyan) enzymes. The
active-site region shown in B–H is boxed. B–E, active-site regions of CTX-M-14 WT (B),
P167S (C), D240G (D), and P167S/D240G (E). Note that the P167S/D240G structure has a
boronic acid in complex with Ser70, which is not shown for clarity. F, structural alignment of
active-site region of P167S apo enzyme (gray) with the P167S/D240G double mutant (cyan).
G, structural alignment of D240G apo enzyme (blue) with P167S/D240G (cyan). H, structural
alignment of CTX-M-14 WT apo enzyme with P167S/D240G (cyan). In all panels, oxygen is
shown in red, and nitrogen is in blue.
of E166A/P167S/CAZ (Fig. 7B) shows the Ser167 peptide bond in the trans configuration and
the Ω-loop in an unraveled, open conformation, which widens the floor of the active site by ∼5
Å to accommodate ceftazidime [461]. This leads to a change in conformation of ceftazidime in
the acyl-enzyme with the aminothiazole ring assuming a buried position (Fig. 7.7B) [461]. In
addition, there are hydrogen bonds between the C4 carboxylate of the dihydrothiazine ring and
the side chains of Thr235 and Ser237, as well as between the side chains of Asn132 and Asn104
with the carbonyl oxygen of the acylamide group (Fig. 7.7B). Further, there is a hydrogen
bond between Asn104 and the carboxyl group of the imino side chain of ceftazidime. These
interactions are consistent with tighter binding of ceftazidime and enhanced catalysis [461].
In addition, the normalized B-factors of Val103 and Asn104 are not increased relative to WT
CTX-M-14, suggesting that the Asn104 residue is well-ordered for interaction with ceftazidime
157
(Fig. 7.6A). Residues 168–170, however, show elevated B-factors, suggesting that the Ω-loop
has increased flexibility, consistent with its unfolded structure (Fig. 7.6B).
Figure 7.6: Normalized B-factors for the 103–106 loop and the 164–179 Ω-loop in the CTX-M
enzyme structures. The B-factors were normalized by dividing the B-factor for a given residue
by the average B-factor for the entire structure. Thus, a normalized B-factor of 1 means the
B-factor at that residue is the same as the average B-factor of the structure. A, normalized
B-factors for the 103–106 loop. B, normalized B-factors for the 164–179 Ω-loop. Black circle,
E166A/CAZ; blue square, E166A/P167S/CAZ; black triangle, E166A/D240G/CAZ; inverted
red triangle, E166A/P167S/D240G/CAZ-1; green diamond, E166A/P167S/D240G/CAZ-2;
open circle, P167S/D240G apo; open square, P167S apo; open triangle, D240G apo; inverted
open triangle, E166A/P167S/D240G apo; open diamond, CTX-M-14 WT.
The D240G substitution is also associated with increased ceftazidime hydrolysis [462, 464].
We therefore determined the structure of the E166A/D240G enzyme in complex with cef-
tazidime for comparison with the E166A and E166A/P167S acyl-enzyme structures. It was
found that the peptide bond preceding Pro167 is in the cis configuration, and the Ω-loop is in
the folded, closed conformation similar to the D240G apo enzyme structure and the E166A
structure with ceftazidime (Fig. 7.7C). In contrast to the E166A/CAZ structure, however, the
E166A/D240G/CAZ structure has the side chain of Ser237 rotated away from the C4 carboxy-
late and instead forms hydrogen bonds to the carboxylate of the imino side chain, which may
facilitate substrate binding and catalysis (Figs. 7.2C and 7.7C).
The P167S/D240G enzyme displays lower catalytic activity toward ceftazidime than either sin-
gle mutant (Table 7.2). To better understand the basis of this antagonism, we determined the
structure of the E166A/P167S/D240G enzyme in complex with ceftazidime. Two structures
from different space groups were obtained, and interestingly, they show different conforma-
tions of ceftazidime and the Ω-loop. In the first structure, the peptide bond preceding Ser167
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Figure 7.7: Structures of the active-site region of CTX-M-14 mutant β-lactamase acyl-
enzyme complexes with ceftazidime. A, structure of the E166A mutant (tan) with cef-
tazidime (dark gray) trapped in the acyl-enzyme form (PDB code 5U53). Oxygen is shown
in red, and nitrogen is in blue. Hydrogen bonds are indicated by thin black lines. Active-
site residues are labeled. B, structure of the E166A/P167S/CAZ acyl-enzyme (light blue)
(PDB code 5TW6). C, structure of the E166A/D240G/CAZ acyl-enzyme (light green).
D, structure of the E166A/P167S/D240G/CAZ-1 acyl-enzyme (pink). E, structure of the
E166A/P167S/D240G/CAZ-2 acyl-enzyme (white). F, structural alignment of the E166A/CAZ
(tan) and E166A/D240G/CAZ (green) acyl-enzyme complexes. The ceftazidime from the
E166A/CAZ structure is shown in dark gray, and that from E166A/D240G/CAZ is shown in
white. The Ω-loop region remains folded in the closed form and the ceftazidime occupies a
similar position with the aminothiazole ring surface exposed in these structures.
is in the trans configuration, which is in contrast to the cis bond found in the P167S/D240G
apo structure (Fig. 7.5, D and E). However, the Ω-loop in the E166A/P167S/D240G/CAZ-1
structure remains in the folded, closed conformation with ceftazidime located in a similar po-
sition as that in the E166A/D240G/CAZ structure (Fig. 7.7D). There are differences, however,
between these structures. First, the carboxylate group of the imino side chain of ceftazidime
in the E166A/P167S/D240G/CAZ-1 structure does not contact the enzyme, in contrast to the
E166A/D240G/CAZ structure (Fig. 7.7, C and D). More importantly, the positioning of the
active-site 103–106 loop is altered, and the side chain of Asn104 is shifted out of the ac-
tive site in the E166A/P167S/D240G/CAZ-1 structure (Fig. 7.7D). In addition, the normal-
159
ized B-factors for residues Val103 and Asn104 are elevated compared with the E166A/CAZ,
E166A/P167S/CAZ, and E166A/D240G/CAZ structures, suggesting that Val103 and Asn104
are disordered (Fig. 7.6A). We have previously shown that the hydrogen bond between Asn104
and the acyl-amide of cefotaxime and ceftazidime is important, and a N104A mutant exhibits
10-fold lower kcat/Km for both substrates [472]. These observations suggest that the conforma-
tion of the enzyme and ceftazidime observed in the E166A/P167S/D240G/CAZ-1 structure is
not consistent with hydrolysis.
It is noteworthy that the E166A/P167S/D240G/CAZ-1 structure described above was obtained
by soaking a crystal with ceftazidime. Another crystal was also soaked, and the structure
was determined with the same space group, but ceftazidime was not present in the active site.
Interestingly, this apo structure is very similar to the structure with bound ceftazidime. The
peptide bond preceding Ser167 is in the trans configuration and the Ω-loop is in the folded,
closed conformation (Fig. 7.8, C and D). In addition, the 103–106 loop is in a similar position
as in the ceftazidime-bound structure with the side chain of Asn104 pointed out of the active site
and with elevated B-factors for Val103 and Asn104 (Fig. 7.6A). Thus, this conformation of the
enzyme, and particularly the 103–106 loop, occurs in the absence of ceftazidime, in contrast to
the different conformations of the E166A/P167S apo and E166A/P167S/CAZ structures where
the presence of ceftazidime is apparently required to produce the conformational change.
The second E166A/P167S/D240G/CAZ structure is superimposable with that of the E166A/P167S/CAZ
structure where the peptide bond preceding Ser167 is in the trans configuration, and the Ω-
loop is in an unfolded, open conformation to accommodate ceftazidime (Fig. 7.7E). Because
the P167S enzyme exhibits enhanced ceftazidime hydrolysis, these findings suggest that the
conformation of the enzyme in the E166A/P167S/D240G/CAZ-2 structure is competent to hy-
drolyze ceftazidime.
The two structures of E166A/P167S/D240G/CAZ with distinct conformations of the enzyme
and ceftazidime suggests there are at least two conformational substates of the P167S/D240G
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Figure 7.8: Structures of the active-site region of CTX-M-14 mutant β-lactamase acyl-
enzyme complexes with ceftazidime. A, structure of the E166A mutant (tan) with cef-
tazidime (dark gray) trapped in the acyl-enzyme form (PDB code 5U53). Oxygen is shown
in red, and nitrogen is in blue. Hydrogen bonds are indicated by thin black lines. Active-
site residues are labeled. B, structure of the E166A/P167S/CAZ acyl-enzyme (light blue)
(PDB code 5TW6). C, structure of the E166A/D240G/CAZ acyl-enzyme (light green).
D, structure of the E166A/P167S/D240G/CAZ-1 acyl-enzyme (pink). E, structure of the
E166A/P167S/D240G/CAZ-2 acyl-enzyme (white). F, structural alignment of the E166A/CAZ
(tan) and E166A/D240G/CAZ (green) acyl-enzyme complexes. The ceftazidime from the
E166A/CAZ structure is shown in dark gray, and that from E166A/D240G/CAZ is shown in
white. The Ω-loop region remains folded in the closed form and the ceftazidime occupies a
similar position with the aminothiazole ring surface exposed in these structures.
enzyme in the presence of ceftazidime. We suggest that the form with the closed Ω-loop and
altered 103–106 loop with Asn104 pointed out of the active site does not efficiently hydrolyze
161
ceftazidime, whereas the form with the open Ω-loop is catalytically competent.
7.3.6 Molecular dynamics simulations reveal that conformational hetero-
geneity of the Ω-loop is greater in the single mutants than in the WT
or double mutant.
To directly probe the conformational heterogeneity of the Ω-loop and acyl-enzyme complex,
we conducted molecular dynamics simulations of the acylated forms of WT, D240G, P167S,
and P167S/D240G. In addition to providing atomically detailed models of the distribution
of structures that CTX-M adopts, the fact that no chemical reactions occur in these simula-
tions allowed us to include Glu166 and interrogate its interactions with ceftazidime and CTX-
M. Simulations of WT were initiated from a crystal structure of the acyl-enzyme complex
(PDB code 5U53) [461], and simulations of P167S were initiated based on a previous model
of the E166A/P167S/CAZ structure (PDB code 5TW6) [461]. Simulations of D240G were
initiated from the E166A/D240G/CAZ crystal structure presented in this work. The closed-
conformation crystal structure of E166A/P167S/D240G/CAZ-1 was the initial starting struc-
ture for simulations of P167S/D240G/CAZ. In all structures, Ala166 was mutated back to a
glutamic acid, and a total of 2.5 µs of simulation was run for each variant.
The distribution of Ω-loop conformations observed in our simulations suggests a correlation be-
tween Ω-loop opening and ceftazidime hydrolysis activity. The WT and P167S/D240G variant
with acylated ceftazidime both favor a well-defined closed conformation (Fig. 7.9). How-
ever, we note that the P167S/D240G variant with acylated ceftazidime sparsely samples open
conformations of the Ω-loop, some of which are very similar to the crystallographic structure
capturing the open state (Fig. 7.7, D and E, and Fig. E.3). A previous combination of simula-
tions and experiments have also demonstrated that the WT has a sparsely populated state with
an open Ω-loop [49]. In contrast, the P167S and D240G substitutions dramatically increase the
probability of a diversity of open conformations. The conformational heterogeneity of P167S is
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consistent with the open structure and elevated B-factors observed in the E166A/P167S/CAZ
crystal structure (Figs. 7.6 and 7.7B). Although D240G also displays substantial conforma-
tional heterogeneity, it has a deeper minima for the closed state than P167S, potentially ex-
plaining why only the closed state of D240G has been observed crystallographically so far
(Fig. 7.7C).
These simulations suggest that the closed conformation inhibits catalysis by favoring a confor-
mation of Glu166 that is incompatible with a deacylation reaction, whereas the open confor-
mation of the Ω-loop allows Glu166 to adopt a wider range of conformations, at least some
of which are compatible with the requirements for deacylation. Previous work has established
that Glu166 coordinates a water that plays a role in the deacylation reaction [473] and that mu-
tation of Glu166 traps the acyl intermediate by inhibiting deacylation [465]. Examining closed
structures preferentially adopted by WT and P167S/D240G reveals that the carboxyl group of
Glu166 tends to hydrogen bond with Asn170, trapping Glu166 under the Ω-loop and prevent-
ing it from coordinating the water required for deacylation (Figs. 7.9, B and C, and 7.10). In
the open conformations preferentially sampled by the D240G and P167S variants, the hydro-
gen bond between Asn170 and Glu166 is disrupted. This open conformation is stabilized by
a rearrangement of the hydrogen-bonding network in the active site where Asn132 hydrogen
bonds with Glu166 (Figs. 7.9C and 7.10).
The opening and closing of the Ω-loop is also associated with a rearrangement of ceftazidime
in the acyl-enzyme complex (Fig. 7.10 and Fig. E.1). One major feature observed in both
crystal structures and simulations is that the aminothiazole ring of ceftazidime is buried under
the Ω-loop when it is open (Figs. 7.7, B and E, and 7.10). Consistent with the crystal structures
of the single-mutant variants, this rearrangement of ceftazidime in the acyl-enzyme complex
is facilitated by new interactions with Asn104 and the β3 loop. In the D240G and P167S
constructs, Ser237 and Asn104 form interactions with ceftazidime (Fig. 7.10 and Figs. E.1 and
E.2). We also note an additional interaction between the imino group of ceftazidime and Ser237
that is present in the more open, active variants but not the more closed, inactive variants (Fig.
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E.2). These interactions with ceftazidime are rare in the WT and P167S/D240G simulations
(Figs. E.1 and E.2). Furthermore, Asn104 appears to point outward toward the solvent in the
closed configuration (Fig. 7.10), similar to what is seen in the crystal structure of the closed
configuration of the P167S/D240G/CAZ variant (Fig. 7.7D).
Overall, our simulations suggest that the CTX-M acyl-enzyme complex is in equilibrium be-
tween inactive and active conformations and that the P167S and D240G variants have a higher
probability of adopting active conformations (Fig. 7.10). In the inactive conformation the Ω-
loop is closed, burying the Asn170–Glu166 hydrogen bond under the aminothiazole ring (Fig.
7.10). Opening of the Ω-loop and rearrangement of ceftazidime via burial of the aminothiazole
ring and coordination between the imino group and Asn104 and the β3 loop likely transitions
CTX-M into a catalytically competent state. These rearrangements of the Ω-loop and cef-
tazidime allow Glu166 to coordinate a water molecule that can access the ester bond of the
ceftazidime–acyl-enzyme complex, facilitating the deacylation reaction. Taken together, the
crystallography and molecular dynamics results indicate that the P167S and D240G substi-
tutions promote an open conformation of the Ω-loop that creates access for ceftazidime and
allows Glu166 to sample conformations consistent with deacylation, whereas the WT and
P167S/D240G mutant exhibit a closed Ω-loop conformation that constrains access for cef-
tazidime and prevents Glu166 from efficiently coordinating water for deacylation.
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Figure 7.9: The conformational heterogeneity of the Ω-loop is greater in the single mutants
than in the WT or double mutant. A, joint distributions of two Cα–Cα distances that capture
the conformational heterogeneity of the Ω-Loop: (i) Asn104 to position 167 on one side of
the Ω-loop and (ii) Thr171 to position 240 on the other side. Distributions are shown for WT
(top left panel), D240G (top right panel), P167S (bottom left panel), and P167S/D240G (bottom
right panel). Each point represents a snapshot from the molecular dynamics simulations colored
according to its probability based on a 2D histogram. B, cumulative distribution of distances
between the Cγ atom of Glu166 and the Nδ atom of Asn170 for WT (black), D240G (blue),
P167S (red), and P167S/D240G (purple), capturing the loss of interaction between Glu166 and
Asn170 in the open state. C, distribution of distances between the sidechain Nδ atom of Asn132
and the Cγ of Glu166 for WT (black), D240G (blue), P167S (red), and P167S/D240G (purple),
capturing the newly formed interaction between Glu166 and Asn132 in the open state.
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Figure 7.10: Conformational changes between inactive and active forms of the acyl-enzyme.
Representative structures of the CTX-M acyl-enzyme complex with ceftazidime (labeled CAZ,
green) highlighting inactive (blue, left panels) and active (orange, right panels) conformations.
Conformations of the Ω-loop (top panels) and residues contacting ceftazidime (bottom panels)




The CTX-M β-lactamases emerged in the late 1980s and are characterized by their ability
to efficiently hydrolyze cephalosporins, particularly the oxyimino-cephalosporin cefotaxime
[456,457]. For example, the catalytic efficiency for cefotaxime hydrolysis by CTX-M enzymes
is 1500-fold higher than that exhibited by the common TEM-1 β-lactamase [453]. Neverthe-
less, the related oxyimino-cephalosporin ceftazidime is poorly hydrolyzed by CTX-M enzymes
with kcat/Km values 1000-fold lower than those observed for cefotaxime [453]. Natural vari-
ants of the TEM-1 enzyme have evolved through mutations that provide increased rates of cef-
tazidime catalysis. Similarly, the P167S and D240G substitutions have been found in multiple
variants of CTX-M enzymes that exhibit increased ceftazidime hydrolysis [457,462–464,474].
Each of these substitutions results in a 10-fold increased kcat/Km value for ceftazidime hydroly-
sis [458,460]. However, variants containing both substitutions have not been observed, despite
the prediction that such variants would exhibit increased hydrolysis. Here we have shown that
the failure of the double mutant to emerge in natural isolates is due to epistasis resulting from
decreased stability and lower bacterial expression levels of the P167S/D240G enzyme, as well
as antagonism between the substitutions with respect to catalysis.
The combination of amino acid substitutions that each increase catalytic activity can display
simple additivity or cooperativity when introduced together into an enzyme [441]. For additive
interactions, the fold change of the double mutant is expected to be the product of the fold
changes of the single mutants. Such additive combinations indicate that the substitutions have
independent effects on catalysis [441]. However, not all substitutions act additively. The CTX-
M P167S and D240G substitutions are antagonizing in the double mutant (Table 7.2). This
negative cooperativity suggests that the substitutions interact, either directly or indirectly, and
that the interaction has a negative effect on ceftazidime catalysis [441]. In the case of the
P167S and D240G substitutions, the interaction is not via direct contact, because the α-carbons
are located 10.7 Å apart.
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X-ray crystallography and molecular dynamics simulations of the P167S, D240G, and P167S/D240G
mutants provide a rationale for the increased ceftazidime hydrolysis by the single mutants and
the negative cooperativity observed for the double mutant. The acyl-enzyme complex of the
E166A/P167S/CAZ X-ray structure shows a trans configuration peptide bond preceding residue
167 and an unfolded Ω-loop in an open conformation with the aminothiazole ring of the an-
tibiotic in a buried position. This interaction increases van der Waals contacts and hydrogen
bonds between the enzyme and ceftazidime and is consistent with enhanced catalytic efficiency
toward ceftazidime. In contrast, the E166A/D240G/CAZ structure revealed a closed conforma-
tion. Two structures were obtained for the E166A/P167S/D240G ceftazidime acyl-enzyme, one
of which is superimposable with the open Ω-loop structure of E166A/P167S/CAZ and, based
on this similarity, is proposed to hydrolyze ceftazidime. The second structure, however, dis-
plays a closed Ω-loop and an altered conformation of the 103–106 loop such that the critical
Asn104 residue is turned out of the active site and does not interact with ceftazidime, suggest-
ing reduced ceftazidime catalysis.
Although the E166A/P167S/CAZ and E166A/D240G/CAZ structures suggest that the substi-
tutions act by different mechanisms, 2.5-µs molecular dynamics simulations of each variant
indicate that both the P167S and D240G substitutions promote an open conformation of the Ω-
loop to accommodate ceftazidime and that the WT and P167S/D240G enzymes exhibit reduced
ceftazidime hydrolysis because open conformations of the Ω-loop are less probable.
The TEM-1 β-lactamase is ∼35% identical in amino acid sequence to CTX-M enzymes and
efficiently hydrolyzes penicillins and many cephalosporins, but oxyimino-cephalosporins are
poor substrates [453]. Nevertheless, natural variants of TEM-1 have evolved that exhibit in-
creased catalytic efficiency for cefotaxime and ceftazidime hydrolysis [475, 476]. These vari-
ants, termed extended-spectrum β-lactamases (ESBLs), contain 1–5 amino acid substitutions,
and multiply substituted enzymes are common. Many of the substitutions found in these vari-
ants act additively when combined [453]. Some combinations of mutations, however, are not
additive. A well-studied example is the combination of the R164S and G238S substitutions.
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The Gly238 residue is on the β3 strand (analogous to Gly238 in CTX-M-14), and Arg164
is at the base of the Ω-loop. Each of these substitutions results in increased enzyme activ-
ity toward cefotaxime and ceftazidime, yet the double mutant has reduced activity [477, 478].
Dellus-Gur et al. [477] determined the structure of the TEM-1 G238S and R164S enzymes. The
G238S-containing enzyme exhibited two dominant conformations of the G238 loop, whereas
the R164S substitution induced an ensemble of conformations of the Ω-loop. The structure of
the R164S/G238S double mutant, however, exhibited a wider ensemble of conformations of
the Ω-loop than the single mutants [477]. Based on these results, it was hypothesized that the
entropic cost of the substrate selecting suitable conformations among many alternatives results
in the low activity for cefotaxime hydrolysis by the double mutant, accounting for the negative
epistasis observed for the combination [477].
In the case of the negative epistasis observed with the P167S and D240G combination in CTX-
M β-lactamase, multiple conformations of the enzyme also appear to play a role. Based on
our molecular dynamics simulation results, the P167S and D240G substitutions are analogous
to the R164S substitution in TEM-1, where the substitutions induce an ensemble of confor-
mations, some of which are predicted to be capable of hydrolyzing ceftazidime. The CTX-M
P167S and D240G substitutions antagonize each other in the double mutant, similar to the
TEM-1 R164S and G238S substitutions. The mechanism of antagonism, however, is different,
with the CTX-M P167S/D240G double mutant showing a reduced probability of sampling mul-
tiple conformations of the Ω-loop, whereas the TEM-1 R164S/G238S double mutant Ω-loop
samples an excess of conformations [477]. Nevertheless, both cases demonstrate the impor-
tance of conformational heterogeneity of active-site loops in controlling catalytic activity and
evolutionary trajectories.
Several studies have provided evidence that the conformation of the Ω-loop is an important
determinant of substrate specificity of class A β-lactamases, particularly with regard to the hy-
drolysis of oxyimino-cephalosporins. As described above, the TEM ESBL mutation R164S is
thought to broaden the specificity of the enzyme by increasing the conformational heterogene-
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ity of the Ω-loop [477]. In addition, the structure of an apo enzyme form of a triple mutant
of the TEM enzyme containing the substitutions W165Y/E166Y/P167G that hydrolyzes cef-
tazidime shows the Ω-loop in an unfolded, open conformation similar to that observed for
the CTX-M E166A/P167S/CAZ and E166A/P167S/D240G/CAZ-2 structures [479]. Further,
computational studies predict that TEM ESBL substitutions that broaden the specificity of the
enzyme to include cefotaxime stabilize conformations of the Ω-loop that facilitate substrate
binding [9].
The results also suggest an important role for the active-site 103–106 loop in cefotaxime and
ceftazidime hydrolysis. We recently showed that an N106S mutation in the 103–106 loop that
is found in CTX-M enzymes from clinical isolates lowers cefotaxime and ceftazidime hydrol-
ysis because of a change in conformation of the loop [472]. Asn106 is at the base of the loop
and not in the active site. However, the N106S substitution changes the hydrogen-bonding
network connectivity in the loop such that the side chain of Asn104 rotates out of the active
site, thereby eliminating a hydrogen bond with substrate. Further experiments showed that an
N104A mutant exhibits 10-fold reduced catalytic efficiency for oxyimino cephalosporin hy-
drolysis, suggesting that the hydrogen bond is important for catalysis. Thus, the conformation
of the 103–106 loop is a determinant of substrate specificity [472]. In this study, it was found
that the P167S/D240G enzyme, which exhibits reduced ceftazidime hydrolysis, has increased
B-factors for the 103–106 loop, suggesting disorder in Asn104 that is consistent with reduced
activity. In addition, in the structure of the E166A/P167S/D240 apo enzyme the B-factors of
the 103–106 loop are increased, and in one of the structures of E166A/P167S/D240G in com-
plex with ceftazidime, the side chain of Asn104 is rotated out of the active site, again consistent
with decreased ceftazidime hydrolysis. Thus, although the P167S and D240G substitutions are
not in the 103–106 loop, the antagonism between the substitutions is at least partially reflected
in changes in the conformation of the loop.
Thermal stability studies of the WT, P167S, D240G, and P167S/D240G enzymes show that
the single mutants are less stable than WT, whereas the double mutant is less stable than either
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single mutant. There is some correlation between stability and protein expression levels in
that the P167S/D240G mutant is the least stable and is also expressed at the lowest levels
among the mutants. However, also note the P167S mutant is less stable than D240G but is
expressed at higher levels, suggesting there are exceptions to the stability/protein expression
level correlation. Some recent studies have shown that lower enzyme stability correlates with
increased flexibility and increased cephalosporin hydrolysis in β-lactamases [480, 481]. Here,
we do not observe a correlation between stability and flexibility in that the P167S and D240G
mutants readily sample multiple conformations and yet are more stable than P167S/D240G,
which samples fewer conformations. Further, we do not observe a correlation between stability
and catalytic activity toward ceftazidime because P167S/D240G has low stability but also low
activity.
Taken together, the results presented here suggest that active-site loops play an important role
in the substrate specificity and evolutionary capacity of β-lactamases. Class A β-lactamases
such as TEM and CTX-M can evolve altered substrate specificity by mutations that change
the conformation of active-site loops. An active site with flexible loops loosely associated
with a highly ordered, stable scaffold structure has been described as fold polarity, and there
is evidence that such an organization facilitates the evolution of new functions because of a
tolerance to changes in the loops without drastically destabilizing the enzyme [443]. Such
an organization is clearly advantageous for antibiotic resistance enzymes such as CTX-M β-
lactamases that are under selective pressure for altered substrate specificity.
7.5 Methods
7.5.1 Bacterial strains and plasmids.
The CTX-M-14-pTP123 plasmid was used for site-directed mutagenesis, MIC determinations,
and immunoblotting. This plasmid was constructed by inserting the blaCTX-M-14 gene into
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the previously described pTP123 plasmid. CTX-M-14-pTP123 has a chloramphenicol (CMP)
resistance marker and β−-lactamase expression is controlled by the isopropyl−β−-D-galactopyranoside
(IPTG)–inducible Ptrc promoter [482]. Under conditions without IPTG, protein expression is
maintained at a basal level; these were the conditions under which MIC determination and
immunoblotting were performed. The E. coli strain XL1-Blue (recA1 endA1 gyrA96 thi-1
hsdR17 supE44 relA1 lac [F9 proAB lacIqZM15 Tn10 (Tetr)]) (Stratagene, Inc., La Jolla,
CA) was used as the host for the construction of the P167S/D240G CTX-M-14 mutant via
site-directed mutagenesis, as well as MIC determination. The E. coli strain RB791 (W3110
lacIqL8) was used as the host for the determination of protein expression levels of WT CTX-M-
14 β-lactamase and its mutants [483]. For protein purification, WT CTX-M-14 and the mutants
were expressed in the pET28a plasmid using the protocol outlined by Patel et al. [460]. CTX-
M-14 and mutants in the pET28a plasmid were expressed in BL21(DE3) [fhuA2 (lon) ompT
gal (λ DE3) (dcm) ∆hsdS λ DE3 = λsBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21
∆nin5] [484].
7.5.2 Site-directed mutagenesis.
The CTX-M-14 P167S/D240G mutant was constructed using the D240G mutant in pTP123 as
template for QuikChange mutagenesis using 1 unit of Phusion DNA polymerase (New England
Biolabs, Ipswich, MA) and 0.4 µM P167S primer (5’-CTGGATCGCACTGAAAGCACGCTGAATACCGCC-
3’) [460]. Primers were obtained from Integrated DNA Technologies (Coralville, IA). Thermo-
cycler products were digested with DpnI (New England Biolabs) and transformed into electro-
competent E. coli XL1-Blue cells and selected on LB agar supplemented with 12.5 µg/ml chlo-
ramphenicol. The DNA sequence of the resulting mutant was confirmed by DNA sequencing
(Genewiz, Plainfield, NJ). The E166A/P167S/D240G mutant was constructed by QuikChange
mutagenesis with a primer encoding the E166A/P167S mutations (5’-GATCGCACTGCTCCTACGCTGAAT-
3’) using CTX-M-14 P167S/D240G pTP123 as template and confirmed using DNA sequenc-
ing.
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7.5.3 Minimum inhibitory concentration determinations.
MICs for cephalothin were determined by Etest strip (BioMérieux, Marcy-l’Étoile, France).
This was performed by growing a single colony of E. coli XL1-Blue harboring the pTP123
plasmid with either WT, mutant CTX-M-14, or empty vector overnight in LB supplemented
with 12.5 µg/ml CMP in a shaking incubator at 37 °C. The overnight culture was diluted 102
and spread onto LB agar containing CMP, an Etest strip was placed on the agar, and the MIC
was determined based on the zone of inhibition.
MIC determinations for cefotaxime were performed by broth dilution. Again, a single colony
of E. coli XL1-Blue harboring pTP123 with WT or mutant CTX-M-14 or empty vector was
grown overnight in LB with CMP in a shaking incubator at 37 °C. The cultures were diluted
104, and 100 µl of culture was used to inoculate 2 ml of LB supplemented with increasing
concentrations of cefotaxime in 14-ml test tubes. Concentrations of cefotaxime (in µg/ml)
used for WT and D240G were 0, 1, 1.5, 2, and 3. The concentrations used for the P167S and
P167S/D240G mutants were 0, 0.1875, 0.25, 0.375, and 0.5, and for pTP123 empty vector
control, the concentrations were 0, 0.03, 0.045, and 0.06. The cultures were incubated with
shaking for 18 h at 37 °C. The concentration at which no visible growth was observed was
reported as the MIC.
MIC determinations for ceftazidime were performed by broth dilution, with a single colony
of E. coli XL1-Blue harboring pTP123 with WT or mutant CTX-M-14 or empty vector being
grown overnight in LB with CMP, as above. Saturated cultures were diluted 104, and 25 µl was
used to inoculate 500 µl of LB supplemented with increasing concentrations of ceftazidime
in a deep-well 96-well plate. Concentrations of ceftazidime (in µg/ml) used for WT, D240G,
P167S/D240G, and pTP123 empty vector were 0, 0.12, 0.19, 0.25, 0.38, 0.5, 0.75, 1, 1.5, 2,
3, and 4; for P167S, the concentrations were 0, 0.38, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8, and 12. The
96-well plate was covered with a sterile, breathable seal (Excel Scientific, Victorville, CA)
and incubated shaking at 37 °C for 18 h. The concentration at which no growth was observed
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(A600 < 0.1) was recorded as the MIC.
7.5.4 Immunoblotting.
To determine the effects of the P167S/D240G mutation on steady-state protein expression, sin-
gle colonies of E. coli RB791 harboring pTP123 or the recombinant pTP123 encoding WT
or mutant CTX-M-14 β-lactamase were incubated overnight with shaking in 2× YT medium
supplemented with 12.5 µg/ml CMP at 37 °C. A total of 10 ml of 2× YT medium with CMP
was inoculated with 100 µl of overnight culture and incubated at 37 °C while shaking until
the A600 reached between 0.9. The cells were pelleted, and the periplasmic proteins were
extracted by osmotic shock as described previously [472]. The proteins were fractionated by
SDS-PAGE and transferred onto a nitrocellulose membrane (GE Healthcare). The membrane
was probed with a rabbit serum raised against CTX-M-14 protein and a rabbit serum raised
against maltose-binding protein (MBP) (a gift from Dr. Anna Konovalova, University of Texas
Health Science Center at Houston), which functions as a loading control. Then the membrane
was probed with a donkey anti-rabbit secondary antibody conjugated with horseradish peroxi-
dase (GE Healthcare). After development of the immunoblot with the SuperSignal West Pico
chemiluminescent substrate (Thermo Fisher Scientific), the hybridization signals of CTX-M-
14 β-lactamase and MBP were quantified by densitometry using ImageJ software (National
Institutes of Health). The signal for WT and mutant CTX-M-14 β-lactamase was normalized
to that for MBP.
7.5.5 Protein purification.
WT CTX-M-14 β-lactamase and the P167S/D240G mutant were expressed from a pET28a
vector in E. coli BL21(DE3) cells. Proteins expressed in this plasmid have an N-terminal His
tag with a TEV protease cleavage site. E. coli BL21(DE3) cells harboring the CTX-M-14 plas-
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mid were used to inoculate LB supplemented with 25 µg/ml kanamycin and incubated at 37
°C in a shaking incubator until the A600 reached ∼0.9, at which time IPTG was added to yield
a final concentration of 0.2 mM to induce protein expression. The culture was then grown for
20 h at 23 °C in a shaking incubator. The culture was centrifuged at 8000 rpm at 4 °C, and the
pellet was stored overnight at -80 °C. The pellet was then thawed on ice and resuspended in
30 ml of lysis buffer (20 mM HEPES, pH 7.4, 300 mM NaCl, 20 mM imidazole). The cells
were lysed using a French Press at 1250 p.s.i. and a probe sonicator, followed by centrifugation
for 50 min at 10,000 rpm and filtration of the supernatant with a 0.45-µm filter (EMD Milli-
pore, Billerica, MA). Filtered lysate was then bound to a HisTrap FF column (GE Healthcare)
equilibrated with the lysis buffer. The CTX-M-14 enzyme was eluted using 20–500 mM imida-
zole gradient in the lysis buffer. Pure fractions containing His-CTX-M-14 protein were pooled,
concentrated, and buffer-exchanged to the lysis buffer using 10-kDa molecular mass cutoff
centrifugal filters (EMD Millipore). 0.25 mg of TEV protease was added to the His-tagged
enzyme and incubated overnight at 4 °C. TEV protease and uncleaved His-CTX-M-14 protein
were removed by incubation with nickel–Sepharose Hi-Performance beads (GE Healthcare).
CTX-M-14 proteins were further purified by gel-filtration chromatography with Superdex 75
Increase column using (20 mM HEPES, pH 7.4, 150 mM NaCl) as running buffer. The fractions
corresponding to monomer of CTX-M-14 WT or P167S/D240G mutant protein were pooled
and concentrated with 10-kDa molecular mass cutoff centrifugal filters. The purity of purified
proteins was >95% determined by SDS-PAGE. Their concentrations were determined by mea-
suring the absorbance at 280 nm with DU800 spectrophotometer (BecKman Coulter) and using
an extinction coefficient of 23, 950 M−1 cm−1.
7.5.6 Determination of thermal stabilities.
Thermal stabilities of the WT and mutant enzymes were determined as previously described
[460]. In short, the fraction of folded protein was measured with a spectropolarimeter at 222
nm, while the temperature was increased from 30 to 70 °C at a rate of 0.01 °C/s. The melting
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temperature (Tm), the temperature midpoint of protein unfolding, was determined by fitting the
data to a single Boltzmann two-state model using GraphPad Prism 6 (San Diego, CA) [469].
7.5.7 Steady-state enzyme kinetic parameters.
Michaelis–Menten steady-state kinetic parameters were measured as previously described [460,
485]. The kinetic parameters for CTX-M-14 P167S and D240G are from Patel et al. [460]. An-
tibiotic hydrolysis was measured at 30 °C in 50 mM phosphate buffer (pH 7.0) containing
1 µg/ml BSA. BSA was added to stabilize β-lactamase when it is diluted to low concentra-
tion for kinetic assays. Cephalothin, cefotaxime, and ceftazidime hydrolysis were measured
at 262, 264, and 260 nm, respectively [460]. Km and kcat were determined by fitting the ini-
tial velocities of increasing substrate concentrations to the Michaelis–Menten equation using
GraphPad Prism 6. For ceftazidime, which has a Km > 500 µM, kcat/Km was estimated using
the equation, v = kcat/Km[E][S], where [S] Km. All measurements were performed at least
in duplicate. kcat and Km values from each run were averaged, and the standard deviations
reported are the sums of the percent standard deviations of kcat and Km [460].
7.5.8 Protein crystallization and structure determination.
Crystallization conditions were screened based on previously solved crystal structures for CTX-
M-14. Purified P167S/D240G enzyme in 50 mM phosphate buffer, pH 7.0, was concentrated
to 40 mg/ml, and protein was mixed with mother liquor 1:1 in a 200-nl drop and grown by
hanging-drop vapor diffusion. Diffraction-quality crystals were obtained in 0.1 M MIB buffer
(malonic acid, imidazole, and boric acid buffer), pH 4.0, 25% (w/v) PEG 1500, and were
harvested and cryoprotected in 25% glycerol: 75% mother liquor. The crystals were plunged
in liquid nitrogen and sent to Beamline 5.0.2 at the Advanced Light Source (Berkeley, CA) for
data collection. Because the first data set appeared to show high twinning, a second data set
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was collected on the same crystal. This data set was processed at 1.5 Å in the space group
P41212 using HKL200 and the Phaser program from the CCP4 suite was used for molecular
replacement. CTX-M-14 (PDB code 1YLT) was used as a phasing model [458]. Refinement
was performed using REFMAC5 and phenix.refine, as part of the Phenix program suite [486].
The model was built manually using COOT [487].
E166A/P167S/D240G was crystallized by concentrating the protein in 50 mM phosphate buffer,
pH 7.0, to 40 mg/ml and mixing with mother liquor 1:1 in a 200-nl drop and grown by hanging-
drop vapor diffusion. Crystals from the condition containing 0.1 M PCB buffer, pH 6, 25%
(w/v) PEG 1500 were soaked for 24 h in 25 mM ceftazidime, 20% glycerol:80% mother liquor.
Structure determination indicated an acyl-enzyme complex with ceftazidime. Crystals grown in
the condition containing 0.2 M CaCl, 0.1 M sodium acetate, pH 5, 20% (w/v) PEG 6000 were
also soaked for 24 h in 25 mM ceftazidime, 20% glycerol:80% mother liquor but were not in
complex with ceftazidime, resulting in the apoenzyme. The data were collected on Beamline
ALS 501 and was processed as described above. The E166A/P167S/D240G enzyme was also
crystallized by concentrating the protein in 50 mM phosphate buffer, pH 7.0, to 36 mg/ml,
mixing with mother liquor 1:1 in a 200-nl drop, and grown by hanging-drop vapor diffusion.
Crystals obtained in the condition 0.1 M MMT (1:2:2 ratio of DL-malic acid:MES:Tris base),
pH 6.0, 25% (w/v) PEG 1500 were soaked for 24 h in 25 mM ceftazidime, 25% glycerol:75%
mother liquor. The data were collected on Beamline ALS 821. Structure determination revealed
an acyl-enzyme complex with ceftazidime with the Ω-loop in an open conformation.
E166A/D240G was crystallized by concentrating the protein in 50 mM phosphate buffer, pH
7.0, to 36 mg/ml and mixing with mother liquor 1:1 in a 200-nl drop and grown by hanging-
drop vapor diffusion. Crystals grown in 0.1 M Tris-HCl, pH 8.5, 25% (w/v) PEG 3000 were
soaked for 24 h in 25 mM ceftazidime, 25% glycerol:75% mother liquor. The data were col-
lected on Beamline ALS 822. However, structure determination revealed this to be the apo
enzyme. Crystals grown in the condition 0.2 M NaCl, 0.1 M Tris, pH 8.0, 20% (w/v) PEG 6000
were soaked for 24 h in 15 mM ceftazidime, 25% glycerol:75% mother liquor, the data were
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collected on Beamline ALS 822, and structure determination revealed an acyl-enzyme com-
plex with ceftazidime. The data set was processed as described above for the P167S/D240G
enzyme. X-ray crystallography statistics are listed in Table E.1.
7.5.9 Molecular dynamics simulations.
As described previously [9], simulations were run at 300 K with the GROMACS software
package [9,145,222,488] using the Amber03 force field [146] and TIP3P explicit solvent [143].
Mutations were introduced in PyMOL [144], and parameters for the acyl group were generated
with the generalized amber force field [489–491]. A total of 2.5 µ s of simulation were run for
each variant.
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7.8 Additional information.
The atomic coordinates and structure factors (codes 6V5E, 6V6G, 6V6P, 6V7T, 6V8V, and
6V83) have been deposited in the Protein Data Bank (http://wwpdb.org/).
Table 7.3: The abbreviations used are:
Abbreviation Expanded name
MIC Minimum inhibitory concentration
PDB Protein data bank









This thesis demonstrates how to measure allosteric communication in proteins from long-
timescale MD simulations, and illustrates how insight from allosteric networks can explain
fundamental protein behaviors and open up new therapeutic opportunities. This work also
highlights the utility of protein conformational ensembles and the tremendous scientific value
encoded within protein energy landscapes. The data presented provides further support to the
hypothesis that a protein’s thermal fluctuations contain all of its functionally relevant states.
In Chapter 2, the CARDS methodology is described as a means to integrate concerted struc-
tural and disorder-mediated correlations into a holistic view of allosteric communication. Ap-
plications of CARDS to the Catabolite Activator Protein (CAP), shown experimentally to un-
dergo allosteric coupling via conformational entropy, are described. Specifically, we showed
that examining the coupling of every residue to a known cAMP binding site naturally high-
lights regions of the protein that are known to be impacted by cAMP binding. Decomposing
correlations into disorder-mediated and purely structural components demonstrates an impor-
tant role for disorder-mediated coupling in the absence of concerted structural changes. Our
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global communication metric also provides a means to identify important functional sites with-
out foreknowledge of their existence and locations. I expect CARDS to be of great utility for
understanding allostery in systems where it is already known to occur, as well as for predicting
allostery in systems where it has yet to be observed.
In Chapter 3, we describe the complete process of G protein activation and GDP release,
specifically focusing on Gαq, which has the slowest dissociation rate. These results reveal a
previously unobserved intermediate that defines the rate-limiting step for GDP release and, ulti-
mately, G protein activation. The model synthesizes a wealth of experimental data and previous
analyses, and builds upon decades of literature to create a single, unified model. We highlight
roles in the allosteric network for regions of known importance and identify new regions of
value in the allosteric network coupling the receptor- and nucleotide-binding sites. The con-
sistency of our model with a wide variety of structural and biochemical data suggests that it is
a promising foundation for future efforts to understand the determinants of GPCR-Gα interac-
tion specificity, how mutations cause aberrant signaling and disease, and how small molecule
inhibitors modulate Gα activation. The model also adds weight to the growing appreciation
for the fact that a protein’s spontaneous fluctuations encode considerable information about its
functional dynamics. I hope this approach and combination of analyses will prove valuable for
understanding other slow conformational changes and unbinding processes.
Described in Chapter 4 is a cryptic allosteric site in the IID of the Ebola VP35 protein that
provides a new therapeutic opportunity against this essential viral protein. We used adap-
tive sampling simulations to access more of the ensemble of conformations that VP35 adopts,
uncovering an unanticipated cryptic pocket. Application of CARDS to these simulations sug-
gested that the cryptic pocket is allosterically coupled to the blunt end-binding interface and,
therefore, could modulate biologically-important interactions. Subsequent experiments high-
lighted that fluctuations within the folded state of the IID expose two buried cysteines that line
the proposed cryptic pocket to solvent. Moreover, covalently modifying these cysteines to sta-
bilize the open form of the cryptic pocket allosterically disrupts binding to dsRNA blunt ends
182
by at least 5-fold. Therefore, it may be possible to attenuate the impact of viral replication and
restrict pathogenicity by designing small molecules to target the cryptic allosteric site we report
here. More generally, these results speak to the power of simulations to provide simultaneous
access to both hidden conformations and dynamics with atomic resolution. Thus I hope this
demonstrate the potential of simulations as a means to uncover unanticipated features of pro-
teins’ conformational ensembles, such as cryptic pockets and allostery, providing a foundation
for the design of further experiments. We anticipate such simulations will enable the discov-
ery of cryptic pockets and cryptic allosteric sites in other proteins, particularly those that are
currently considered undruggable.
Chapter 5 and 6 highlight the power of Folding@home to tackle a myriad of biological prob-
lems, both fundamental and with potential relevance to therapeutic design. Work in Chapter 5
revealed that SARS-CoV-2 N protein undergoes phase separation with RNA when reconstituted
in vitro. In this work we propose a model where a single-genome condensate forms through N
protein gRNA interaction, driven by a small number of high-affinity sites. This (meta)-stable
single-genome condensate undergoes subsequent maturation, leading to virion assembly. In
this model, condensate-associated N proteins are in exchange with a bulk pool of soluble N
protein, such that the interactions that drive compaction are heterogeneous and dynamic. The
model provides a physical mechanism in good empirical agreement with data for N protein
oligomerization and assembly.
In Chapter 6 we describe how the excascale power of Folding@home allows us to hunt for
druggable opportunities throughout the entire SARS-CoV-2 proteome. The pandemic caused
by SARS-CoV-2 necessitated a call-to-arms; a call that over a million citizen-scientists an-
swered to generate 0.1 seconds of simulation data. We find that spike proteins have a strong
trade-off between making ACE2 binding interfaces accessible to infiltrate cells and conforma-
tionally masking epitopes to subvert immune responses. These simulations also provide an
atomically detailed roadmap for targeting proteins for vaccines and antivirals. We describe
a number of cryptic pockets that we identify throughout the proteome of SARS-CoV-2, with
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more to be described as they are discovered. For each protein system in Table 6.1, an extraordi-
nary amount of sampling has led to the generation of a quantitative map of its conformational
landscape.
Finally, in Chapter 7 we demonstrate how molecular simulations, when integrated with ex-
periments, can be used to study the biophysical impact of mutations, such as those that grant
Ceftazidime Resistance to the CTX-M β-lactamase (P167S and D240G). However, these muta-
tions actually undergo negative epistasis with one another. Here we show that while P167S and
D240G individually grant CTX-M ceftazidime resistance, the double mutant P167S/D240G
displays a wild-type behavior. The results presented here suggest that conformational hetero-
geneity, particularly in active-site loops, plays an important role in the substrate specificity and
evolutionary capacity of β-lactamases. The P167S and D240G mutants readily sample multi-
ple conformations and yet are more stable than P167S/D240G, which samples fewer confor-
mations. Crystallography and molecular dynamics results show that the CTX-M acyl-enzyme
complex exists in equilibrium between inactive and active conformations and that the P167S
and D240G variants have a higher probability of adopting active conformations. Taken to-
gether, our data suggests that the P167S and D240G substitutions promote an open confor-
mation of the Ω-loop that creates access for ceftazidime and allows Glu166 to sample con-
formations consistent with deacylation, whereas the WT and P167S/D240G mutant exhibit a
closed Ω-loop conformation that constrains access for ceftazidime and prevents Glu166 from
efficiently coordinating water for deacylation.
8.2 Future directions
Altogether, this thesis highlights the importance of understanding allostery in biological sys-
tems. Both in scale and approach, we are entering a new phase of using molecular dynamics
simulations to understand biophysics; the complex task of simulating an organism’s entire pro-
teome could become more commonplace. It is worth speculating what the future holds for
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studies of protein dynamics, allosteric communication, and the role of conformational entropy
in biological function and disease.
Methodologically, CARDS is already able to measure allosteric communication in a holistic
manner, but there are many new methodological enhancements through which we can obtain
an increased understanding of allosteric communication. As previously discussed, using a
rotameric library might improve upon identifying significant allosteric communication beyond
noise, and using a different a multi-exponential distribution to compute probabilities of ordered
and disordered regimes might improve detection of dynamical states.
Beyond previously discussed avenues of improvements, construction of our allosteric network
in chapter 3 is aided by the knowledge that the GPCR-binding site sends a signal to the GDP-
binding site [168–170]. While ample evidence exists to indicate that coupling occurs in both
directions, CARDS does not explicitly describe directionality in pairwise communication. This
kind of directional information has immense value in less well-studied systems. Hence, there
is value in identifying an alternative metric to mutual information that specifically measures a
directional transfer of information. Additionally, CARDS extracts data directly from simulation
datasets, rather than an MSM. As such, CARDS is inherently limited by the sampling bias
that may exist in a dataset, measuring stronger correlations between residues in states that
are closer to a trajectory’s starting configuration. While computing structural-correlations is
already possible using MSMs, it is difficult to assign dynamical states to MSMs. Therefore it
is valuable to develop frameworks to extract kinetic signatures of disorder from MSMs that can
be used to assign dynamical states. Then correlated motions will be able to be extracted from
MSMs trivially.
Along with developments with CARDS, there are a number of questions surrounding allostery
in G protein signalling that remain unexplored. While we highlight the potential utility of our
allosteric network in chapter 3, it is worth noting that an allosteric inhibitor of Gαq already
exists, YM-254890 (YM) [203]. This depsipeptide binds at the hinge between the two domains
185
and prevents G protein activation by trapping the protein in a GDP bound state, preventing
GDP dissociation. However, the mechanism of inhibition, efficacious even in cells [492], re-
mains unclear. Structural models suggest that the domain-opening motion of G proteins is
inhibited by YM, but simulation of large peptide-protein complexes, particularly at the scale of
heterotrimeric G proteins, remains a challenge. Learning the allosteric mechanism of G protein
inhibition by YM might inform chemical strategies to design a simplified peptide analog, as
well as inform design principles for the general design of highly-selective G protein inhibitors.
Building off the allosteric networks described in chapters 3 and 4, it is worth exploring if
protein homologs have conserved allosteric networks. For example, many G protein isoforms
have similar structures [171], but different behaviors ranging from their effector targets to their
GDP dissociation kinetics. Given previous success studying different isoforms of a protein
family [10], it may be that the differences in conformational landscapes encode similarities and
differences in allosteric networks. Assuming a “core” allosteric network exists across all G
protein isoforms, the differences between them may be all the more interesting as they might
provide a basis for regions that govern isoform-specific behaviors.
Going beyond primarily-simulation studies, it is exciting to enter an era where microsecond-
to-millisecond dynamics can be explored and integrated with experiments. While simulations
already provide predictive models for experimental measurements (see chapter 3, 4, 5 and 7),
there are opportunities to further integrate with experiments that directly measure conforma-
tional dynamics, such as single-molecule studies or Nuclear Magnetic Resonance (NMR) spec-
troscopy. NMR is able to observe major and minor conformational states and obtain thermody-
namic and kinetic information at residue-level resolution. It provides a powerful methodology
to identify and characterize excited states in a protein’s conformational landscape. However,
one limitation of NMR is that it remains difficult to characterize these excited states or to iden-
tify the motions that may drive the equilibrium motions (called “exchange processes”) observed
in NMR spectra. MD provides a powerful complement to these limitations, with the potential
to characterize the motions underlying conformational equilibria and the participating residues.
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NMR and MD together may be a powerful means by which protein conformational landscapes
can be more completely characterized. As we enter an era of exascale computing, it is exciting





Supplementary Material on the CARDS
method
The work in this Appendix is published in: Singh, S., and Bowman, G.R., Quantifying al-
losteric communication via both concerted structural changes and conformational disorder
with CARDS. Journal of Chemical Theory and Computation. 13:1507-1517, 2017. PMID:
28282132. [493]
A.1 Supplementary Methods
A.1.1 Molecular dynamics simulations
All simulations were carried out on GROMACS (version 5.1.1) [145, 222] using periodic
boundary conditions in a dodecahedron with explicit water solvent. Simulations were car-
ried out at 300K using the AMBER03 [146] force field with the TIP3P water model [143].
The starting conformations of wild-type apo and cAMP-bound CAP were generated by placing
crystallographic structures (PDB ID: 4N9H and 1CGP respectively) [129, 130] into separate
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dodecahedron boxes that extended 1.0 nm from the protein surface in any direction. Starting
conformations fore the S62F variant were generated using the PyMol [144] mutagenesis tool.
Each system was then minimized independently with the steepest-descent algorithm until the
maximum force fell below 1000 kJ/mol/min using a step size of 0.01nm and a cutoff distance of
1.2nm for the neighbor list, Coulomb interactions, and van der Waals interactions. For equili-
bration runs, all bonds were constrained with the LINCS algorithm [226] and virtual sites [228]
were used to allow for a 4fs time step. As before, cut-offs of 1.0 nm were used for the neighbor
list, Coulomb interactions, and van der Waals interactions. The Verlet cutoff scheme was used
for the neighbor list, and Particle Mesh Ewald [494] was employed for the electrostatics (with
a grid spacing of 0.12nm, PME order 4, and tolerance 1e-5). The stochastic velocity rescaling
(v-scale) thermostat [224] was used to hold the temperature at 300K, and the Berendsen baro-
stat [495] was used to bring the system to 1 bar pressure. For the production runs, the position
restraint was removed and the Parrinello-Rahman barostat [227] was employed. Conformations
were stored every 10 ps. For each system, three 500ns runs were conducted totaling to 1.5µs
of aggregate simulation time per system.
Dihedral angles were extracted using the MDTraj Library [148] (v. 1.7). Mappings were all
drawn in PyMol (version 1.7) [144], and all figures were constructed in Inkscape (v. 0.48).
A.1.2 Sensitivity analysis
We varied all the cutoff values employed in the CARDS algorithm to ensure the robustness of
our results. Specifically, we varied the core width from 60° to 90°, the likelihood ratio cutoff
from 1.5 to 5.0, and the neighbor distance cutoff from 2-6Å. Fig. A.1 demonstrates that the
communication to the CBD does not change dramatically as these parameters are varied.
A.2 Supplementary Figures
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Figure A.1: Pearson Correlation Coefficients (PearsonR) between the CARDS results presented
in the main text and those with varying A. the core width, B. the likelihood ratio cutoff, and C.
the neighbor distance cutoff.
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Figure A.2: The distribution of ordered and disordered times for a single dihedral across a
single simulation trajectory. The solid lines represent the histogram of times extracted from
the trajectory, while the dashed lines represent fits based on the average ordered (〈τord〉) and
disordered times (〈τdis〉).
Figure A.3: Two-dimensional histogram of the average ordered and disordered times (〈τord〉
and 〈τdis〉) for all dihedrals in CAP.
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Figure A.4: Residues with separable dihedrals into disordered regimes using a stricter threshold
(〈τord〉 ≥ 5×〈τdis〉) A. Residues with at least one backbone dihedral that is capable of disorder-
mediated communication (orange). B. Residues with at least one side-chain dihedral that is
capable of disorder-mediated communication (green).
Figure A.5: The top 5% of residues (orange sticks) with disorder-mediated communication to
the cAMP-binding pocket (blue sticks). Note that having disorder-mediated communication to
the CBD does not preclude the possibility of also having structural communication.
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Figure A.6: The top 2% of backbone-side-chain hubs (sticks).
Figure A.7: Change in global communication upon the S62F mutation. The color scale on the
right shows the proportional change in global communication relative to the scale in Figure 2.7
of the main text.
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Appendix B
Supplementary figures highlighting the
mechanism of GDP release
The work in this Appendix is published in: SSun, X.∗ and Singh, S.∗, Blumer, K.J., and Bowman,
G.R., Simulation of spontaneous G protein activation reveals a new intermediate driving GDP
unbinding. eLife, 7, October 2018, https://doi.org/10.7554/eLife.38465.001 [48]
B.1 Supplementary Figures
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Figure B.1: Free-energy surface from metadynamics simulations of GDP release for the full
Gαq (blue) and truncated form (green, without the last five C-terminal residues). Both sets
of simulations were run for the same amount of time with identical collective variables. The
rate-limiting step as identified from the highest flux pathway is marked with a dashed line.
The free-energy difference between the GDP-bound states of the two systems is marked with a
bracket.
Table B.1: Measurements comparing tilting and translation of H5 across PDB structures and
MD simulation.









Gαq-GDP 3AH8 13.5 10.6 Tyr325 to Leu349 Thr334 to Phe341
Gαq after rate
limiting step from MD N/A 15.1 11.1 Tyr325 to Leu349 Thr334 to Phe341
Gαi-GDP 1GP2 10.3 10.2 Tyr320 to Ile343 Thr329 to Phe336
Gαi-µOR 6DDF 14.6 13.0 Tyr320 to Ile343 Thr329 to Phe336
Gαi-A1AR 6D9H 13.8 10.1 Tyr321 to Ile344 Thr330 to Phe327
Gαi-Rhodopsin 6CMO 15.8 10.7 Tyr320 to Ile343 Thr329 to Phe336
Gαo-5HT1B 6G79 13.1 14.2 Tyr310 to Ile333 Thr319 to Phe326
Gαs-B2AR 3SN6 12.8 14.6 Tyr360 to Ile383 Thr369 to Phe376
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Figure B.2: Overlay of representative structures of Gαq when bound to GDP (blue) or across
the rate-limiting step (orange).
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Figure B.3: Changes in the structure (left) and disorder (right) of specific regions across the
rate-limiting step. (A) Residues that contact the phosphates of GDP, including the salt bridge
between Glu49G.s1h1.4 and Arg183G.hfs2.2, (B) the s6h5 loop, (C) the π−π stacking interaction
between Phe194G.S2.6 and His63G.H1.12, and (D) switch 2.
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Figure B.4: Distribution of distances between the side-chains of K275G.s5hg.1 and D155H.hdhe.5
for the GDP-bound state (blue), across the rate-limiting step (orange), and upon GDP dissoci-
ation (black).
Figure B.5: Implied timescales for the Markov state model. (A) Top 10 implied timescales for
the 5040 states of Gα. (B) Top 10 implied timescales for the final 221965 states.
Figure B.6: Probability distribution of the distance between Leu349G.H5.16 on H5 and
Phe194G.S2.6 on S2 to monitor the tilting motion of H5 upon GDP release when bound to GDP
(blue), across the rate-limiting step (orange), and upon GDP dissociation (black). In the GDP
bound state (blue), such a distance is peaked at 15 Å. Across the rate-limiting step (orange),
tilting motion of H5 upon GDP release occurs with a peak in distance at 12.5 Å.
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Figure B.7: H5 vertical motion is sampled across GDP release simulations. At each point, the
combined population (represented by the color scale) of that state is shown using both GDP-
bound and intermediate stages of the GDP release pathway. H5 vertical motion was measured
by computing the distance between Thr334G.H5.1 on the s6h5 loop and Phe341G.H5.8 on H5.
GDP release distance was measured as the distance from GDP β-phosphate to the center of
mass between residues Lys52G.H1.1, Ser53G.H1.2, and Thr54G.H1.3 on H1.
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Figure B.8: Allosteric network connecting hNs1 contacts to the P-loop and switch 1 via S4.
CARDS data showing communication per residue to a target site (dashed box) is plotted (left)
and mapped onto the structure of Gαq (right) for (A) hNs1, (B) S1 (C) S4 (D) the P-loop and
(E) Switch 1. Arrows indicate important regions with significant communication to the target
site.
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Figure B.9: Global communication of each residue in the Ras-like domain mapped onto the
structure of Gαq, colored based on the scale (right). The helical domain (gray) is shown for
orientation.
Figure B.10: Probability distributions of the twist angle between S1 and S3. The dihedral angle
is computed by taking the dihedral angle between the CA atoms of Leu45G.S1.7, Leu40G.S1.2,
Val199G.S3.1, and Asp205G.S3.7, so that the angle measured represents S1/S3 twisting at the




Supplementary Material to ”Discovery of
a cryptic allosteric site in Ebola’s
’undruggable’ VP35 protein”
This chapter is adapted from the following publication:
Cruz, M.A.∗ and Frederick, T.E.∗, Singh, S., Vithani, N., Zimmerman, M.I., Porter, J.R., Moeder,
K.E., Amarasinghe, G.K., and Bowman, G.R., Discovery of a cryptic allosteric site in Ebola’s




Figure C.1: FTMap results for the main cryptic pocket highlighting an example protein struc-
ture (gray) and hotspots where a variety of small organic probes (multicolored sticks) form
energetically favorable interactions. The probe molecules are intended to capture different
drug-like interactions (such as hydrogen bonding and Van der Waals contacts) and include ac-
etamide, acetonitrile, acetone, acetaldehyde, methylamine, benzaldehyde, benzene, isobutanol,
cyclohexane, N,N-dimethylformamide, dimethyl ether, ethanol, ethane, phenol, isopropanol,
or urea.
Figure C.2: Purely structural correlations (Istruct) dominate the allosteric network identi-
fied by CARDS as they are typically greater than the disorder-mediated couplings (Idisorder,
which includes correlations between the structure of one residue and the disorder of a second,
as well as correlations between the disorder of two residues).
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Figure C.3: Motion of helix 1 (green vs gray structures) sometimes exposes C247 (sticks) to
solvent. However, the resulting pocket is small and FTMAP does not identify any hotspots in
this region that are likely to bind drug-like molecules. Therefore, we focus our attention on the
cryptic pocket created by the displacement of helix 7.
Figure C.4: A representative time trace from a thiol labeling experiment (black) performed at
100 µM DTNB and a quadruple exponential fit (red). The data are background subtracted (e.g.
the average absorbance from three runs with DTNB but no protein were subtracted) to account
for spontaneous hydrolysis of DTNB.
Figure C.5: Thiol labeling of a C247S/C275S variant that only has cysteines in the main cryptic
pocket (C307, left and C326, right). Observed labeling rates (blue circles) are shown at a range
of DTNB concentrations. Fits to the Linderstrøm-Lang model are shown in dashed colored
lines and the expected labeling rate from the unfolded state is shown as black dotted lines.
The mean and standard deviation from three replicates are shown but error bars are generally
smaller than the symbols.
Figure C.6: Observed labeling rates at 100 µM DTNB for a set of variants with different
cysteines mutated to serines to uncover which rate in the wild-type fit corresponds to which
cysteine residue. Error is standard deviation from three replicates. Dash represents rates not
measured due to the absence of that cysteine residue.
205
Table C.1: Characterization of the folding/unfolding of VP35’s IID used to test whether the
observed thiol labeling is due to fluctuations within the native state or global unfolding of the
protein. K is the equilibrium constant between the folded and unfolded state determined from
denaturation data, kunfold is the unfolding rate of the respective variants measured by intrinsic
tryptophan fluorescence.
Variant K Kunfold(s−1)
Wild-type 6.57×10−5 ± 4.0×10−5 0.0175
C247S/C275S 4.01×10−4 ± 0.8×10−4 0.0083
Table C.2: Intrinsic labeling rates (kint) for each cysteine residue. Intrinsic labeling rates were
measured using either urea unfolded variants containing only the specified cysteine, or peptides
containing the specified cysteine and its surrounding residues.
Residue kintµM−1s−1
C247 0.0566 ± 0.0007
C275 0.00254 ± 0.001
C307 0.0290 ± 0.002
C326 0.395 ± 0.02
Figure C.7: RNA sequences used in fluorescence polarization binding assays. The sense and
antisense strands were annealed in a 1:1 molar ratio
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Figure C.8: Implied timescales test for the VP35 IID MSM suggests the kinetics are stable
from 3-6ns. Analysis in the main text uses a Markov time of 6 ns. Key results were consistent




Supplementary Material on the
SARS-CoV-2 nucleocapsid protein
This chapter is adapted from the following publication:
Cubuk, J., Alston, J.J., Incicco, J.J., Singh, S., Stuchell-Brereton, M.D., Ward, M.D., Zimmer-
man, M.I., Vithani, N., Griffith, D., Wagoner, J.A., Bowman, G.R., Hall, K.B., Soranno, A.,
The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA,
Available on Biorxiv: https://doi.org/10.1101/2020.06.17.158121 [2]
D.1 Supplementary Methods
D.1.1 Sequence analysis
Disorder prediction was performed using IUPred, with additional analysis and sequence parsing
done with localCIDER and protfasta, respectively [496–498]
Amino acid sequence of the N protein used in simulations. Highlighted regions delineate folded
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All simulations were performed at 330 K and at 15 mM NaCl, as have been used previously
in a variety of systems [338, 401, 496, 499, 499]. Simulation analysis was performed with
MDTraj and camparitraj (http://ctraj.com/) [?, 148]. For IDR only simulations all degrees of
freedom were fully sampled (backbone and sidechain dihedral angles and rigid-body positions)
as is standard in CAMPARI Monte Carlo simulations [398]. For simulations of IDRs in the
context of folded domains, the backbone dihedral angles of the folded domains were held fixed
while all sidechains were fully sampled, as were backbone dihedral angles for the disordered
regions, as applied previously [500]. The folded state starting structures were obtained from
PDB structures (listed below).
For IDR-only simulations 30-40 independent simulations were run generating final ensembles
of 40-60 K conformations. For simulations of IDRs in the context of folded domains, the
number of independent simulations and the length of the simulation varied. For the NTD-
RBD simulations 400 independent simulations were run, with 2 independent simulations per
starting seed from MD simulations (see methods below) leading to a final ensemble of ∼400
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K conformations (24 M steps per simulation). For the RBD-LINK-dimerization construct,
ten independent simulations were run for a final ensemble of 32 K conformers (66 M steps
per simulation). For the dimerization-CTD construct 40 independent simulations were run
providing a final ensemble of 40 K conformations (66 M steps per simulation). For a complete
description of simulation details see Table D.4.
For the NTD-RB construct, we used a sequential sampling approach in which long timescale
MD simulations of the RBD in isolation performed on the Folding@home distributed comput-
ing platform were first used to generate hundreds of starting conformations [37, 403]. Those
RBD conformations were then used as starting structures for independent all-atom Monte Carlo
simulations. Monte Carlo simulations were performed with the ABSINTH forcefield in which
the RBD backbone dihedral angles are held fixed but the NTD is fully sampled, as are RBD
sidechains. The RBD starting structure used was extracted from the 6VYO PDB crystal struc-
ture, which is equivalent to the 6YI3 NMR structure.
For RBD-Link-dimerization domain simulations, we opted to use a single starting seed struc-
ture for the folded domains based on the NMR and crystal-structure conformations for the
RBD and dimerization domains, respectively. To generate the monomeric starting structure of
the dimerization domain, we first built a homology model of the SARS-CoV-2 dimerization
dimer from the NMR structure of the SARS dimerization structure (PDB: 2jw8) using SWISS-
MODEL [1,306]. We chose this strategy because at the time, no dimerization structure existed,
a situation that has since resolved itself [314]. Nevertheless, the SARS and SARS-CoV-2
dimerization domains are essentially identical, such that this is a minor detail.
For dimerization domain-CTD simulations, a single starting structure for the dimerization do-
main was again used, selected after MD simulations. Having generated a homology model, we
extracted a single protomer from the dimeric structure and ran molecular dynamics simulations
to identify equilibrated starting structures. In running initial simulations we discovered that
as a monomer, the first 21 residues appear disordered, in agreement with sequence predictions
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(Fig. D.1A) but in contrast to their behavior in the dimeric structure (Fig. D.1C). As a result,
we choose to also model these residues as fully disordered. A single starting seed conformation
was used for all dimerization-CTD simulations.
Excluded volume (EV) simulations were performed using the same setup, but with a modified
Hamiltonian under which solvation, attractive Lennard-Jones, and polar (charge) interactions
are scaled to zero, as described previously [329].
Molecular dynamics simulations
All molecular dynamics simulations of SARS-CoV-2 nucleoprotein were performed with Gro-
macs 2019 using the AMBER03 force field with explicit TIP3P solvent [143, 146, 501]. Sim-
ulations were prepared by placing the starting structure (PDB ID: 6VYO) in a dodecahedron
box that extends 1.0 Å beyond the protein in any dimension. The system was then solvated
(29125 atoms), and energy minimized with a steepest descents algorithm until the maximum
force fell below 100 kJ/mol/nm using a step size of 0.01 nm and a cutoff distance of 1.2 nm for
the neighbor list, Coulomb interactions, and van der Waals interactions. For production runs,
all bonds were constrained with the LINCS algorithm and virtual sites were used to allow a 4
fs time step [226,228]. Cutoffs of 1.1 nm were used for the neighbor list with 0.9 for Coulomb
and van der Waals interactions. The Verlet cutoff scheme was used for the neighbor list. The
stochastic velocity rescaling (v-rescale) thermostat was used to hold the temperature at 300
K [224]. Conformations were stored every 20 ps.
The FAST algorithm was used to enhance conformational sampling and quickly explore the
dominant motions of nucleoprotein [35, 42]. FAST-pocket simulations were run for 6 rounds,
with 10 simulations per round, where each simulation was 40 ns in length (2.4 µs aggregate
simulation). The FAST-pocket ranking function favored restarting simulations from states with
large pocket openings. Additionally, a similarity penalty was added to the ranking to promote
conformational diversity in starting structures, as has been described previously [278]. The
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FAST dataset was clustered using a k-centers algorithm based on RMSD between frames using
backbone heavy atoms (C, Cα, Cβ, N, O) to generate 1421 discrete states, which were then
launched on the distributed computing platform Folding@home [37, 403].
Furthering conformational sampling and enhancing statistics, Folding@home produced 500
µs of aggregate simulation. A final k-centers clustering was performed with the combined
Folding@home and FAST data using Enspara (https://github.com/bowman-lab/enspara) [39].
This clustering was performed the same as described above and generated 200 discrete states
that capture maximal diversity in nucleoproteins’ conformational ensemble. These states were
then used as the basis for CAMPARI simulations.
Sequential MD/MC sampling approach
The NTD and RBD combined are 173 residues of folded and disordered protein, which raises
a significant challenge for all-atom sampling. To address this we leveraged a novel approach
in which we first ran several microsecond of all-atom molecular dynamics simulations of RBD
alone using the Folding@Home platform and the FAST approach for enhanced conformational
sampling [35, 37, 403]. We then identified 200 conformationally distinct states based on these
simulations which we used as “seeds” for the RBD. Using these seeds, we reconstructed the
previously missing NTD and ran all-atom Monte Carlo simulations in which the NTD was fully
sampled, the RBD sidechains are fully sampled, but the RBD backbone dihedral angles are held
fixed. Multiple replicas of each starting conformation were run, giving us a total ensemble of
∼400 K conformations. In parallel, we also ran simulations of the NTD in isolation, enabling
an assessment of the impact of the folded domain.
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Coarse-grained Polymer Simulations
Coarse-grained simulations were performed using the PIMMS software package [338, 402].
PIMMS is a Monte Carlo lattice-based simulation engine in which each bead engages in
anisotropic interactions with every adjacent lattice site. Moves used here were cluster trans-
lation/rotation moves and single-bead perturbation moves. Specifically, every simulation step,
each bead in the system is sampled to move to adjacent sites in random order 503 of times mul-
tiplied by a factor that reflects the length of the chain. Every 100 moves (on average) a cluster
of chains is randomly selected and translated or rotated, where a cluster reflects a collection of
two or more chains in direct contact. This moveset provides changes to the system that reflect
physical movements expected in a dynamical system, allowing us to - for equivalently sized
systems - compare the apparent dynamics of assembly, as has been done previously [502–505].
We repeated the simulations presented using a range of different movesets and, while conver-
gence varied from set-to-set, we always observed analogous results.
All simulations were performed in a 70 x 70 x 70 lattice-site box using period boundary con-
ditions. The results reported are averaged over the final 20% of the simulation to give average
values after equivalent numbers of MC steps. The “polymer” is represented as a 61-residue
polymer with either a central high-affinity binding site or not. The binder is a 2-bead species.
Every simulation was run for 20 x 109 Monte Carlo steps, with four independent replicas. Sim-
ulations were run with 1,2,3,4 or 5 polymers and 50, 75, 100, 125, 150, 175, 200, 250, 300,
400 binders.
If our simulations are run in a way deliberately designed to rapidly reach equilibrium using
enhanced sampling approaches eventually all single-polymer condensates coalesce into one
large multi-polymer condensate. Hence, our simulations are deliberately designed explore a
regime in which single-polymer condensates are metastable.
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D.1.3 Protein expression, purification, and labeling.
Plasmid construct design.
SARS-CoV2 Nucleocapsid protein (NCBI Reference Sequence: YP 009724397.2) including

















GCAACTGCAACAAAGCATGTCAAGCGCCGATAGTACACAGGCGTAA - was cloned into









QQTVTLLPAADLDDFSKQLQQSMSSADSTQA. Site-directed mutagenesis was performed
on the His9-SARS-CoV2 Nucleocapsid pGEX vector to create M1C R68C, Y172C T245C,
and F363C A419C variant N protein constructs. All cloning and site-directed mutagenesis
steps were performed by Genewiz and sequences were verified using sanger sequencing.
Protein Expression and Purification.
Both GST-His9-SARS-CoV2 M1C-R68C and Y172C-T245C Nucleocapsid variants were ex-
pressed recombinantly in BL21 Codon-plus pRIL cells (Agilent). 4L cultures were grown in
LB medium containing carbenicillin (100 ug/mL) to OD600 ∼ 0.6 and induced with 0.2 mM
IPTG for 12 hours at 16ºC. Harvested cells were lysed with sonication at 4ºC in lysis buffer
(50mM Tris pH 8, 500 mM NaCl, 10% glycerol, 10 mg/mL lysozyme, 5 mM BME, cOm-
plete™ EDTA-free Protease Inhibitor Cocktail (Roche), DNAse I (NEB), RNAse H (NEB)).
The supernatant was cleared by centrifugation (37000 rpm for 1 hr) and bound to an HisTrap
FF column (GE Healthcare) in buffer A (50 mM Tris pH 8, 500 mM NaCl, 10% glycerol,
20mM imidazole, 5 mM BME). GST-His9-N protein fusion was eluted with buffer B (buffer A
+ 500 mM imidazole) and dialyzed into cleavage buffer (50 mM Tris pH 8, 50 mM NaCl, 10%
glycerol, 1 mM DTT) with HRV 3C protease, thus cleaving the GST-His9-N fusion yielding
FL N protein with two additional N-term residues (GlyPro). FL N protein was then bound to
an SP sepharose FF column (GE Healthcare) and eluted using a gradient of 0-100% buffer B
(buffer A: 50mM Tris pH 8, 50mM NaCl, 10% glycerol, 5 mM BME, buffer B: buffer A + 1 M
NaCl) over 100 min. Purified N protein variants were analyzed using SDS-PAGE and verified
by electrospray ionization mass spectrometry (LC-MS). Concentrations were determined spec-
troscopically in 50mM Tris (pH 8.0), 500mM NaCl, 10% (v/v) glycerol using an extinction
coefficient = 42530 M−1cm−1
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Both GST-His9-SARS-CoV2 wild-type and F363C A419C Nucleocapsid variants were ex-
pressed recombinantly in Gold BL21(DE3) cells (Agilent). 4 L cultures were grown in LB
medium with carbenicillin (100 ug/mL) to OD600 ∼ 0.6 and induced with 0.2 mM IPTG
for 12 hours at 16ºC. Harvested cells were lysed with sonication at 4ºC in lysis buffer (listed
above). The supernatant was cleared by centrifugation (37000 rpm for 1 hr) and the pellet was
resuspended in 50 mM Tris pH 8, 500 mM NaCl, 10% glycerol, 6 M Urea, 5 mM BME and
incubated at 4ºC for one hour. The resuspension was cleared by centrifugation (37000 rpm for
1hr) and the GST-His9-N protein in the supernatant was bound to a FF HisTrap column (GE
Healthcare) in buffer A (50 mM Tris pH 8, 500 mM NaCl, 10% glycerol, 20 mM imidazole,
5 mM BME) containing 6 M Urea. The column was then washed with buffer A allowing the
protein to refold on the column. The GST-His9-N protein fusion was then eluted with buffer B
(buffer A containing 500 mM imidazole) and dialyzed into cleavage buffer (50 mM Tris pH8,
50 mM NaCl, 10% glycerol, 1 mM DTT) containing HRV 3C protease. FL N protein was then
bound to an SP sepharose FF column (GE Healthcare) and eluted using a gradient of 0-100%
buffer B (buffer A: 50mM Tris pH 8, 50 mM NaCl, 10% glycerol, 5 mM BME, buffer B: buffer
A + 1 M NaCl) over 100 min. Purified N protein variants were analyzed using SDS-PAGE
and verified by electrospray ionization mass spectrometry (LC-MS). Protein concentrations of
stock solutions were determined spectroscopically in 50mM Tris (pH 8.0), 500mM NaCl, 10%
(v/v) glycerol using an extinction coefficient = 42530 M−1cm−1
Fluorescent Dye Labeling.
All Nucleocapsid variants were labeled with Alexa Fluor 488 maleimide (Molecular Probes)
under denaturing conditions in buffer A (50mM Tris pH8, 50mM NaCl, 10% glycerol, 6M
Urea, 1mM DTT) at a dye/protein molar ratio of 0.7/1 for 2 hrs at room temperature. Single la-
beled protein was isolated via ion-exchange chromatography (Mono S 5/50 GL, GE Healthcare
- protein bound in buffer A and eluted with 0-100% buffer B (buffer A + 1 M NaCl) gradi-
ent over 100 min) and UV-Vis spectroscopic analysis to identify fractions with 1:1 dye:protein
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labeling. Single labeled Alexa Fluor 488 maleimide labeled N protein was then subsequently
labeled with Alexa Fluor 594 maleimide at a dye/protein molar ratio of 1.3/1 for 2 hrs at room
temperature. Double labeled (488:594) protein was then further purified via ion-exchange chro-
matography (Mono S 5/50 GL, GE Healthcare - see above).
D.1.4 Single Molecule Spectroscopy
Experimental setup and procedure.
Single-molecule fluorescence measurements were performed with a Picoquant MT200 instru-
ment (Picoquant, Germany). For single-molecule FRET measurements, a diode laser (LDH-D-
C-485, PicoQuant, Germany) was synchronized with a supercontinuum laser (SuperK Extreme,
NKT Photonics, Denmark), filtered by a z582/15 band pass filter (Chroma) and pulsed at 20
MHz for pulsed interleaved excitation (PIE) (Müller et al., 2005) of labeled molecules. Emitted
photons were collected with a 60x1.2 UPlanSApo Superapochromat water immersion objective
(Olympus, Japan), passed through a dichroic mirror (ZT568rpc, Chroma, USA), and filtered by
a 100 µm pinhole (Thorlabs, USA). Photons are counted and accumulated by a HydraHarp 400
TCSPC module (Picoquant, Germany). For FRET-FCS measurements, the same diode laser
was used in continuous-wave mode to excite the donor dye. Photons emitted from the sam-
ple were collected by the objective, and scattered light was suppressed by a filter (HQ500LP,
Chroma Technology) before the emitted photons passed the confocal pinhole (100 mm diame-
ter). The emitted photons were then distributed into four channels, first by a polarizing beam
splitter and then by a dichroic mirror (585DCXR, Chroma) for each polarization. Donor and
acceptor emission was filtered (ET525/50m or HQ642/80m, respectively, Chroma Technology)
and then focused on SPAD detectors (Excelitas, USA). The arrival time of every detected pho-
ton was recorded with a HydraHarp 400 TCSPC module (PicoQuant, Germany).
FRET experiments were performed by exciting the donor dye with a laser power of 100 µW
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(measured at the back aperture of the objective). For pulsed interleaved excitation experiments,
the power used for exciting the acceptor dye was adjusted to match a total emission intensity
after acceptor excitation to the one observed upon donor excitation (between 50 and 70 mW).
Single-molecule FRET efficiency histograms were acquired from samples with protein con-
centrations between 50 pM and 100 pM. Trigger times for excitation pulses (repetition rate 20
MHz) and photon detection events were stored with 16 ps resolution.
For fluorescence correlation spectroscopy (FCS) experiments, acceptor-donor labeled samples
with a concentration of 100 pM were excited by either the 485 nm diode laser or the supercon-
tinuum laser at the powers indicated above. However, in the experiments on protein oligomer-
ization, due to an increase in the fluorescence background upon addition of unlabeled protein
above 1 µM, only the correlations corresponding to direct acceptor excitation (582 nm) have
been considered reliable for the analysis.
For nsFCS, FRET samples of acceptor-donor labeled protein with a concentration of 100 pM
were excited by the same diode laser but in continuum wavelength mode.
All measurements were performed in 50 mM Tris pH 7.32, 143 mM β-mercaptoethanol (for
photoprotection), 0.001% Tween 20 (for surface passivation) and GdmCl at the reported con-
centrations. All measurements were performed in uncoated polymer coverslip cuvettes (Ibidi,
Wisconsin, USA), which significantly decrease the fraction of protein adhering to the surface
(compared to normal glass cuvettes) under native conditions. For comparison, experiments
have been performed also in glass cuvette coated with PEG, which provided analogous results
to the polymeric cuvette.
Each sample was measured for at least 30 min at room temperature (295 ± 0.5 K).
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FRET efficiency histograms.
Fluorescence bursts from individual molecules were identified by time-binning photons in bins
of 1 ms and retaining the burst if the total number of photons detected after donor excita-
tion was larger than 30. Transfer efficiencies for each burst were calculated according to
E = nA/(nA + nD) where nD and nA are the number of donor and and receptor pho-
tons, respectively. Corrections for background, acceptor direct excitation, channel crosstalk,
differences in detector efficiencies, and quantum yields of the dyes were applied (Schuler et al.,





where IDand IA represent the total intensities observed after donor and acceptor excitation and
γPIE provides a correction factor to account for differences in the detection efficiency and laser
intensities. Bursts with stoichiometry corresponding to 1:1 donor:acceptor labeling (in contrast
to donor and acceptor only populations) were selected and finally from the selected bursts a
histogram of transfer efficiencies is constructed. Variations in the selection criteria for the
stoichiometry ratio do not impact significantly the observed mean transfer efficiency (within
experimental errors).
To estimate the mean transfer efficiency and deconvolve multiple populations (e.g for the NTD
construct) from the transfer efficiency histograms, each population was approximated with a
Gaussian peak function. For fitting more than one peak, the histogram was analyzed with a
sum of Gaussian peak functions. For the conversion of transfer efficiency to distances, we used
the value of the Förster radius for Alexa488 and Alexa594 previously determined and reported
in literature, R0 = 5.4 nm [506]. We further correct the value accounting for the dependence
of the Förster radius on the solution refractive index. The changes in refractive index caused
by increasing concentrations of GdmCl or KCl were measured with an Abbe refractometer
(Bausch and Lomb, USA).
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Finally, we estimated a systematic error on transfer efficiency of ± 0.03, based on the variation
of transfer efficiency of the same reference samples after different calibrations of the instrument
over the last two years. Standard deviation of the transfer efficiency for multiple repeats of the
NTD, LINK, and CTD constructs is equal or less than ± 0.01. Since we aim for a comparison
with simulations, here we consider the systematic error as the larger source of error and we
propagate the corresponding effect on all the calculated distances.
Fluorescence lifetimes and anisotropies analysis.
A quantitative interpretation of this transfer efficiency in terms of distance distribution requires
the investigation of protein dynamics. A first method to assess whether the transfer efficiency
reports about a rigid distance (e.g. structure formation or persistent interaction with the RBD)
or is the result of a dynamic average across multiple conformations is the comparison of transfer
efficiency and fluorescence lifetime.The interdependence of these two factors is expected to be
linear if the protein conformations are identical on both timescales (nanoseconds as detected by
the fluorescence lifetime, milliseconds as computed from the number of photons in each burst).
Alternatively, protein dynamics give rise to a departure from the linear relation and an analytical
limit can be computed for configurations rearranging much faster than the burst duration. The
dependence of the fluorescence lifetimes on transfer efficiencies determined for each burst was
compared with the behavior expected for fixed distances and for a chain sampling a broad
distribution of distances. For a fixed distance, R, the mean donor lifetime in the presence of
acceptor is given by
tD(R) = tD0(1− E(R)) (D.2)



















is the time-resolved fluorescence emission intensity following donor excitation. A similar cal-




Donor and acceptor lifetimes at different concentrations of GdmCl were analyzed by fitting
subpopulation-specific time-correlated photon counting histograms after donor and acceptor
excitation, respectively.
Multiparameter detection allows also excluding possible artifacts, such as insufficient rotational
averaging of the fluorophores or quenching of the dyes. Subpopulation-specific anisotropies
were determined for both donor and acceptor of all three constructs for NTD, LINK, and CTD,
and values were found to vary between 0.1 and 0.2 for the donor and between 0.1 and 0.2 for
the acceptor, sufficiently low to assume as a good approximation for the orientational factor
κ2 = 2/3.
Fluorescence Correlation Spectroscopy (FCS) analysis.
In order to determined changes in the hydrodynamic radius (Rh) of the protein, FCS correla-
tions were analyzed assuming 3D diffusion of the molecule across a three dimensional Gaus-
sian profile of the confocal volume (Rigler, Eur Blophys J (1993) 22:169-175). For 1 diffusing
species, and in the absence of photophysical transitions in the time scale of the lag times ana-
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where N is the average number of molecules in the confocal volume, τD is the diffusion time






where D is the 3D translational diffusion coefficient and ωxy is the radius from the center of
the laser beam at which the light intensity decreases e2 times from its maximum value at the
center. α = ωz/ωxy.
Additionally, in order to account for contributions of the photophysics of the fluorophore to the
correlation observed in the µs timescale, we added two triplet terms multiplying the diffusion
correlation term (see for example Krichevsky, Rep. Prog. Phys. 65 (2002) 251–297). The
overall equation that we fit to the FCS traces is then
g(τ) = 1 + (gD(τ)− 1)(1 + cT1 exp(−
τ
τT1




where τT1, τT2, cT1, andcT1, denotes the characteristic times and amplitudes of the contribu-
tions of two triplet states tog(τ). Parameters τD, τT1, τT2, cT1, cT2andN were fitted by least
square nonlinear regression analysis for each concentration of unlabeled protein tested (Fig.
D.13A-B), while α was fixed at a value of 6 determined independently from analysis of fluo-
rescence intensity profiles of fluorescent nanobeads.
Making use of the definition of τD and the Stokes-Einstein equation, we have, for each concen-







where τD0 and Rh0 are the diffusion time and hydrodynamic radius in the absence of unlabeled
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protein, respectively. Error bars in Fig. D.13 B are the standard errors of Rh / Rh0 estimated
from propagation of the standard errors across multiple measurements of the diffusion times
obtained from the fit.
Nanosecond Fluorescence Correlation Spectroscopy.
Autocorrelation curves of acceptor and donor channels and cross-correlation curves between
acceptor and donor channels were calculated with the methods described previously [330,508].
All samples have been measured at a concentration of 100 pM and bursts with a transfer effi-
ciency between 0.3 and 0.8 have been selected to eliminate the contribution of donor only to
the correlation amplitude. Finally, the correlation was computed over a time window of 5 µs
and characteristics timescales were extracted according to:






])(1 + cCD exp[−
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where N is the mean number of molecules in the confocal volume and i and j indicate the
type of signal (either from the Acceptor or Donor channels). The three multiplicative terms
describe the contribution to amplitude and timescale of photon antibunching (AB), chain dy-
namics (CD), and triplet blinking of the dyes (T). τCD is then converted in the reconfiguration
time of the interdye distance τr correcting for the filtering effect of FRET as described previ-
ously [509]. An additional multiplicative CD term has been added only for the donor-donor
correlations to describe the fast decay observed at very short time. Such a decay is not found in
the correlations of other disordered proteins measured on the instrument and we associate the
fast decay with the rotational motion of the overall protein. A fit to this fast decay is about 2
ns.
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Polymer models of distance distributions.
Conversion of mean transfer efficiencies for fast rearranging ensembles requires the assumption
of a distribution of distances. Here, we compared the results of two distinct polymer models:
the Gaussian model and a Self-Avoiding Walk (SAW) model that accounts for changes in the
excluded volume [510]. This second model has been shown to provide a better description
of chain distribution and scaling exponent when compared to distance distributions from MD
simulations [511]. Importantly, both models rely only on one single fitting parameter, the root
mean square interdye distance r = 〈R2〉1/2 for the Gaussian chain and the scaling exponent ν
for the SAW model.





where R is the interdye distance, lc is the contour length of the chain, P (r) represents the
chosen distribution, and E(R)is the Förster equation for the dependence of transfer efficiency






The Gaussian chain distribution is given by:








The SAW model can be expressed as:





































γ =1.1615, and Γ is the Euler Gamma Function, b0=0.55nm is an empirical prefactor [511], N
is the number of residues between the fluorophores, and ν is the scaling exponent.
Finally, when converting the distance from transfer efficiencies, to account for the length of dye
linkers and compare the experimental data with simulations, the root-mean-squared interdye
distance r was rescaled according to
rm,n = |m− n|0.5Idye|m− n+ 2Idye|0.5 (D.17)
with Idye=4.5 (Aznauryan et al., 2016; Hoffmann et al., 2007). Finally, the persistence length
is computed using the Gaussian conversion r2 = 2lplc [348].
Binding of denaturant and folding.
As in previous works [318, 322, 512], we model the chain expansion with the denaturant in
terms of a simple binding model:




Where r0 is the mean square interdye distance at zero denaturant,ρ is a term the captures the
extent of chain expansion with the denaturant compared to r0, and theK is the binding constant,
and c is the concentration of denaturant.
In presence of folded domains, we can imagine the folding/unfolding of the domains can affect
the overall size of the chain because of an increase or decrease of excluded volume due to the
surrounding folded domains (which screen part of the available conformations) or because of
the folding or unfolding of elements in the region between the fluorophores. To account for
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this effect, as in the case of the NTD, we weighed the effect of denaturant on the chain for the
fraction folded ff and unfolded fu accordingly to:




where r0f and r0u are the root mean square interdye distance in presence of folded or unfolded
domains in native buffer,
ff =
exp[−m(c− cm)]
1 + exp[−m(c− cm)]
(D.20)
and fu = 1 − ff , where cm the midpoint concentration and m the denaturant m value, rep-
resenting the dependence of free energy on denaturant concentration. The stability parameter
∆G0 can be computed as ∆G0 = mcm.
Polymer model of electrostatic interactions.
The disordered regions of the N protein are enriched in positive and negative charges. To pro-
vide a term of comparison in the interpretation of protein conformations as function of salt
concentration, we use the polymer theory for polyampholyte solutions developed by Higgs and
Joanny [512, 513], which has been shown previously to capture quantitatively the conforma-
tional changes of unstructured proteins. Briefly, the root mean square interdye distance is equal
to r = N0.5 ∗ l0 ∗ α where N is the number of monomers in the disordered region, l0 is the
length of elementary segment (here 0.36 nm) and α is the ratio between l and l0, with l being a
rescaled segment that accounts for excluded volume and electrostatic interactions.
αis computed according to the equation proposed by Higgs and Joanny [512, 513]:







where v∗ is an effective excluded volume given by the sum of three terms:








Here, v is the excluded volume (accounting for physical excluded volume and positive and
attractive interactions that are not due to electrostatics), f and g are the fraction of positive and
negative residue respectively for considered segment of the protein, k is the Debye screening
length, and lb is the Bjerrum length.
Importantly, when accounting for the fraction of negative charges, we also account for the
contribution of the -2 net charge of each dye at pH 7.3.
Salt dependence of NTD, LINK, and CTD conformations.
In addition to studying the conformations under native buffer conditions, we investigate how
salt affects the conformations of the three disordered regions. We started by testing the effects
of electrostatic interactions on the NTD conformational ensemble. Moving from buffer con-
ditions and increasing concentration of KCl, we observed a small but noticeable shift toward
lower transfer efficiencies, which represents an expansion of the NTD due to screening of elec-
trostatic interactions. This can be rationalized in terms of the polyampholyte theory of Higgs
and Joanny [512, 513] (see Table D.2), where the increasing concentration of ions screens the
interaction between oppositely charged residues (see Fig. D.10).
We then analyzed for comparison the LINK construct. Interestingly, we find a negligible effect
of salt screening on the root mean square distance r172-245 as measured by FRET (see Fig.
D.10). Predictions of the Higgs and Joanny theory for the content of negative and positive
charges within the LINK construct indicates a variation of interdye distance dimension that is
comparable with the measurement error. It has to be noted that in this case the excluded volume
term in the Higgs and Joanny theory will empirically account not only for the excluded volume
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of the amino acids in the chain, but also for the excluded volume occupied by the two folded
domains.
Finally, we test if the addition of salt can provide similar effects than those obtained by GdmCl
on the conformations of the CTD: interestingly, we do not observe any significant variation
either in transfer efficiency or distribution width (Fig. D.10), suggesting that the broadening of
the population observed for the CTD does not originate from electrostatic interactions.
D.1.5 Testing protein oligomerization.
NativePAGE experiments were performed to verify that purified recombinantly expressed SARS-
CoV-2 N protein is capable of forming dimers and oligomers, in analogy to SARS-CoV N pro-
tein, and as shown in more recent work for SARS-CoV-2 [303,306,316]. Indeed, NativePAGE
experiments reveal the existence of multiple bands (Fig. D.13C-D). However, since the low-
est band in the NativePAGE corresponds to an apparent molecular weight of ∼70-80 kDa, we
wanted to verify the oligomeric state of this band.
To test whether the apparent mass is due to a slow mobility of the protein because of its high
positive charge, we performed crosslinking experiments. These experiments confirm the for-
mation of dimers, tetramers, and high oligomeric species, as a function of protein concentration
above 500 nM (Fig. D.13E-F). These oligomeric species are in equilibrium with the monomer,
the smallest species on the denaturing SDS PAGE (which has the expected molecular weight of
∼45 kDa). It has to be noted that, because of the slow reactivity of the crosslinking agent (see
Methods below), the crosslinking experiments do not represent the population of monomeric
and oligomeric species at equilibrium. However, the comparison between the NativePAGE
and the crosslinking experiments supports the fact that the smallest band in the NativePAGE is
indeed the monomer protein.
We finally turned to Fluorescence Correlation Spectroscopy (FCS) to test whether labeled pro-
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tein can form dimers. We measured the CTD construct that carries one labeling position at the
end of the oligomerization domain. When increasing the concentration of unlabeled protein,
we observe a systematic increase in the hydrodynamic radius when compared to the hydrody-
namic radius under native conditions (Fig. D.13A-B). This suggests that the labeled protein
can form higher oligomeric species in a concentration regime comparable to the one observed
in NativePAGE and SDS PAGE experiments and that at 100 pM (the concentration used in
single-molecule experiments), no oligomer is formed. Caution must be used in the interpre-
tation of the oligomeric bound species observed in FCS experiments, since labeling mutation
may have affected the affinity of the dimerization domain. Future experiments will address the
role of mutation on dimerization. Finally, all experiments have been performed at two different
time points, after 1 hour and after 24 hours of incubation of the labeled sample with unlabeled
protein to test any kinetic effect on the measured value. No significative difference has been
observed.
Taken together, NativePAGE crosslinking experiments verify that in smFRET and FCS experi-
ments we are in fact monitoring the behavior of the monomeric SARS-CoV-2 N protein.
D.1.6 Protein Crosslinking Methods.
50 mM disuccinimidyl suberate (DSS) (Thermo Scientific) stock solution was prepared (10 mg
into 540 uL of anhydrous DMSO (Sigma)). All protein samples were prepared in 20 mM NaPi
pH 7.4 (with and without 200 mM NaCl) at the following concentrations: 0.1, 0.5, 1, 5, 10
and 20uM. DSS stock solution was added to each sample to a final concentration of 1.25 mM.
Samples were incubated for 1 hour at room temperature. Samples were then quenched to a
final concentration of 200mM Tris pH 7.4 and allowed to incubate for 15 minutes. Crosslinked
proteins were then analyzed using SDS PAGE and Coomassie staining.
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D.1.7 NativePAGE Methods.
All protein samples were prepared in 20 mM NaPi pH 7.4 (with and without 200 mM NaCl)
at the following concentrations: 0.05, 0.1, 0.5, 1, 5, 10 and 20 uM. Samples were subjected to
NativePAGE (Invitrogen) and protein mobility was analyzed with Coomassie staining.
Development of turbidity in solutions of N protein and poly(rU) was followed through mea-
surements of absorbance at 340 nm in a microvolume spectrophotometer (NanoDrop, Thermo,
USA). Mixtures were prepared in 500 µl plastic reaction tubes by adding 4 µl protein solution
into 3 µl of poly(rU) and absorbance was recorded 45 s – 75 s after mixing. Working solutions
were kept at room temperature during experiments.
Reaction media was 50 mM Tris, pH 7.5 (HCl), 0.002 % v/v Tween20, and NaCl as indicated
in Results.
poly(rU) (Midland Certified Reagent Company, TX, USA, lot number 011805) was reconsti-
tuted into this media from stocks dissolved in RNAse free water. According to the manufac-
turer, the size of poly(rU) molecules is mostly less than 250 nucleotides (nt.) and longer than
200 nt.
Protein stocks (in 50 mM Tris pH 8.0, 500 mM NaCl, 10% v/v glycerol) were buffer exchanged
into the desired buffer through size exclusion chromatography in Zeba Spin 7 k MWCO de-
salting columns (Thermo, USA). poly(rU) concentrations in working dilutions were assessed
through the absorbance at 260 nm employing an extinction coefficient of 9.4 mM−1cm−1
(Michelson, 1959). Protein concentrations were assessed through the absorbance at 280 nm
employing an extinction coefficient of 42.53 mM−1cm−1, computed according to the method
proposed by Pace et al. (Pace et al., 1995).
The limiting concentrations of nucleic acid across which an increase in turbidity was detected
were estimated through interpolation of the data. To this end, an empirical equation, describing
the trends observed at all concentrations, was fitted to the data and then was solved to extract the
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poly(rU) concentrations at which turbidity reaches a limit value above the background signal.
We used a limiting absorbance value of 0.005 units (340 nm, 1 mm path length). We found that
an appropriate function for this end is an exponential of a Gaussian distribution function F (x):









where x denotes poly(rU) concentration andA, µ, σandµ are parameters fitted through weighted
minimum least squares for each protein concentration (solid lines in Fig. 5.5A-B and limiting
value points in panels C-D). To characterize the observed global trends of turbidity, as a func-
tion of both RNA and protein concentration, we determined approximate functional forms of
the dependence on protein concentration of the individually fitted parameters (A(p), β(p), σ(p)andµ(p),
where p is protein concentration). The observed dependencies were increasing linearly for µ(p)
and quadratic for β(p) and σ(p). A was the worst defined parameter and thus displayed the least
clear trend. For the results in absence of added salt we employed an increasing power function
with exponent as a fitting parameter (best fit value was < 1), whereas for the results in presence
of 50 mM NaCl the trend of A(p) was better described by a decreasing exponential function.
We thus used the functional forms A(p), β(p), σ(p) and µ(p) to construct a global function
dependent on both protein and RNA concentration. Global fitting of this equation to the whole
set of turbidity titration curves provided the turbidity contour plots shown in Fig. 5.5C-D (solid




Table D.1: Fit parameters to denaturant binding model.
ρ K (M−1) r0 (Å)
NTD (1 pop) 1.3± 0.2 0.36 ± 0.05
50 ± 2
(fixed)
NTD (2 pop) (shared parameter) (shared parameter) 36 ± 3
LINK 1.1 ± 0.03 0.06 ±0.03
57 ± 2
(fixed)
CTD 0.47 ± 0.02 0.36 ± 0.1
50 ± 2
(fixed)
Table D.2: Fit parameters of Higgs & Joanny theory
v
NTD 4.4 ± 0.1
LINK 5.5 ± 0.3
CTD 8.4 ± 0.9
Table D.3: Scaling exponents
νSAW νsimulation
NTD 0.520 ± 0.009 0.52
LINK 0.538 ± 0.008 0.58
CTD 0.546 ± 0.008 0.49
Table D.4: All-atom simulation summary






NTD-RBD 400 24 20 20,000 399,000
RBD-LINK-DIM 10 66 60 20,000 31,113
DIM-CTD 40 24 20 20,000 40,000
NTD 40 71 66 30,000 64,000
LINK 30 101 80 30,000 66,660
CTD 40 71 66 30,000 64,000
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Figure D.1: Sequence alignment of the coronavirus N-terminal domain (NTD).
Figure D.2: Sequence alignment of the coronavirus RNA binding domain (RBD).
Figure D.3: Sequence alignment of the coronavirus linker (LINK).
Figure D.4: Sequence alignment of the coronavirus dimerization domain.
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Figure D.5: Sequence alignment of the coronavirus C-terminal domain (CTD)
Figure D.6: Histograms of transfer efficiency distributions across denaturant concentrations for
NTD, LINK, and CTD constructs.
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Figure D.7: Dependence of fluorescence lifetime on transfer efficiency. A. NTD construct.
B. LINK construct. C. CTD construct. Black line: linear dependence expected for a rigid
molecule. Green line: the donor lifetime (normalized by the donor lifetime in absence of
FRET: tD/tD0) in the limit of dynamics much faster than the burst duration but slower than
the fluorophore lifetime. Orange line: the acceptor lifetime delay (normalized by the donor
lifetime in absence of FRET. The green and orange contour plots represent the corresponding
distributions of donor lifetime and acceptor lifetime delay as observed in single-molecule ex-
periments under native conditions The green and orange dots represent the mean value of the
measured distributions. A larger overlap between donor and acceptor lifetime populations is
observed for the NTD and CTD, hinting to possible static conformations.
Figure D.8: Mean transfer efficiency and width of NTD, LINK, and CTD across denaturant.
The mean transfer efficiency of the NTD domain exhibits a plateau between 1 and 2 M; at the
same concentration we observe a small but systematic increase in the amplitude of the transfer
efficiency distribution hinting to the coexistence of two populations in slow exchange with very
similar transfer efficiencies. The CTD width also shows a small increase in the width of the
transfer efficiency distribution that may reflect the formation of local structure under native
conditions (e.g. the putative helical binding motif).
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Figure D.9: Fit of NTD construct with two populations. To address the change in amplitude that
occurs from the NTD construct between 1 and 2 M GdmCl, we attempt a fit of the same data
using two populations with a fixed distance equal to average width outside the 1-2 M GdmCl
region (see for comparison Fig. D.8). Upper panel: fit of the transfer efficiency histogram at
1.5 M GdmCl. The white- and gray- shaded areas reflect fits to the “folded RBD” population
and to the “unfolded RBD” population. Central panel: Comparison of transfer efficiencies
with a single fit (solid orange circles, compare Fig. D.8) and from the two populations: gray
solid circles for the “unfolded RBD” population and unfilled circles for the “folded RBD”
population. Lower panel: Fraction folded estimated from the fit with Eq. S7 compared to the
fraction of “folded RBD” obtained from computing the ratio between the area under “folded
RBD” species and the total histogram area.
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Figure D.10: Interdye distances of NTD, LINK, CTD in presence of salt (KCl). Upper panel:
root mean square interdye distance between position 1 and 68. Dashed line: fit according to the
Higgs and Joanny model (Eq. D.21-D.22) predicts a comparable change to the one observed.
Central panel: root mean square interdye distance between position 172 and 245. Dashed
line: fit according to the Higgs and Joanny model (Eq. D.21-D.22) predicts a comparable
change to the one observed. Solid line and shaded area: average value of the root-mean-square
interdye distance across all salt conditions and corresponding standard deviation. The standard
deviation is comparable to the measurement error. Lower panel: root mean square interdye
distance between position 363 and 419. Dashed line: fit according to the Higgs and Joanny
model (Eq. D.21-D.22) does not capture the observed trend. This can be possibly explained
considering the significant predicted population of helical conformations in the CTD. Solid
line and shaded area: average value of the root-mean-square interdye distance across all salt
conditions and corresponding standard deviation. Inset: no variation in the width of the transfer
efficiency population is observed upon addition of KCl.
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Figure D.11: Chain dynamics measured via ns-FCS. Nanosecond FCS measurements for the
NTD, LINK, and CTD constructs provide a measure of the dynamics on the nanosecond
timescale. The donor-donor (green), acceptor-acceptor (red), and donor-acceptor (orange)
correlation are fitted to a global model that accounts for antibunching, FRET dynamic pop-
ulations, and triplet. The acceptor-donor correlation shows a clear anticorrelated change for
NTD and LINK in the signal that reflects the anticorrelated nature of the donor-acceptor en-
ergy transfer as a function of distance: an increase in acceptor reflects a decrease in donor.
The CTD cross-correlation exhibits a flat behavior. Occurrence of a correlation in the donor-
donor and acceptor-acceptor autocorrelations corresponding with a characteristic time tb= 190
± 30 ns suggests the presence of chain dynamics, either through FRET or Photo-induced Elec-
tron Transfer (PET) [331, 332]. Addition of 0.2 M GdmCl, which causes a small decrease in
the transfer efficiency width (Fig. D.8) leads to an anticorrelation in the cross-correlation of
CTD. The correlation decay appears also faster with a tCD= 70 ± 15 ns. All measurements
are normalized to the value measured at 1 µs for highlighting the amplitude relative to the
reconfiguration term.
Figure D.12: Turbidity experiments plotted against RNA/protein ratio. Representative turbidity
titrations with poly(rU) in 50 mM Tris, pH 7.5 (HCl) at room temperature, in absence of added
salt (A) and in presence of 50 mM NaCl (B), at the indicated concentrations of N protein. On
the x-axis, the concentration of poly(rU) is rescaled for the protein concentration. Points and
error bars represent the mean and standard deviation of 2-4 consecutive measurements from the
same sample. Solid lines are simulations of an empirical equation fitted individually to each
titration curve. An inset is provided for the titration at 3.1 µM N protein in 50 mM NaCl to
show the small yet detectable change in turbidity on a different scale. Interestingly, within the
experimental error, we observe a clear alignment of the turbidity curves with a maximum at 20
nucleotides per protein in the absence of added salt (A) and 30 nucleotides per protein in the
presence of 50 mM NaCl (B).
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Figure D.13: Testing SARS-CoV-2 N protein oligomerization. (A-B) Fluorescence Correlation
Spectroscopy (FCS) of full-length SARS-CoV-2 N protein as a function of protein concentra-
tion. (A) FCS traces of 100pM Alexa 488/Alexa 594 N protein labeled at positions 363 and
419 in the absence (blue dots) and the presence (gray dots) of 50 µM unlabeled N protein. (B)
Hydrodynamic radius of SARS-CoV-2 N protein obtained from FCS trace analysis (blue dot:
100pM labeled N protein; gray dot: 100pM labeled N protein + 50µM unlabeled N protein).
(C-D) NativePAGE of full-length SARS-CoV-2 N protein in 20 mM NaPi pH 7.4 as a function
of protein concentration in the presence of 200 mM NaCl (C) and in the absence of added salt
(D). ‘Custom Std’ lane contains Alcohol Dehydrogenase ( * , 150 kDa) and Bovine Serum
Albumin ( ** , 66 kDa). (E-F) SDS PAGE of crosslinked full-length SARS-CoV-2 N protein
in 20 mM NaPi pH 7.4, 1.25mM DSS as a function of protein concentration in the presence of
200mM NaCl (E) and in the absence of added salt (F).
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Figure D.14: Distributions of inter-residue distance from ABSINTH simulations (black) vs.
excluded volume simulations (red). Comparison of simulations with the full ABSINTH Hamil-
tonian (‘normal’, black) against simulations performed in the excluded volume (EV, red) limit
for A. NTD, B. LINK and C. CTD. In all cases the EV simulations report substantially larger
average distances than the ABSINTH simulations, as expected given the absence of any at-
tractive intramolecular interactions. The distances reported from the EV simulations are also
slightly more expanded than under fully denatured conditions, consistent with systems studied
previously (see [496, 514].
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Figure D.15: Scaling maps for IDR-only simulations. Scaling maps report on the normalized
distance between pairs of residues, where normalization is done by the distance expected if
the IDRs behaved as self-avoiding chains in the excluded-volume limit. Scaling maps for IDR-
only simulations of the A. NTD, B. LINK and C. CTD. For each sequence, transient helices are
annotated on the scaling maps. Note that in the LINK we observe interaction between the C-
terminal region of the LINK and H4, while H3 does not interact with any parts of the sequence.
Similarly, in CTD we see extensive intramolecular interactions between H5 and H6.
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Figure D.16: Distributions for the radius of gyration (Rg) of for IDR-only simulations. Rg
distributions for A. NTD, B. LINK and C. CTD. Average Rg for each IDR in isolation is 19.1
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Table E.1: Table S1. X-ray crystallography data collection and refinement statistics for CTX-
M-14 mutant enzymes. *Values in parentheses represent the highest-resolution bin.
P167S/D240G E166A/D240G E166A/P167S/ E166A/D240G- E166A/P167S/ E166A/P167S/
D240G CTX D240G-CTX-1 D240G-CTX-2
PDB ID 6V5E 6V6P 6V6G 6V7T 6V83 6V8V
Data collection
Space group P 41 21 2 P 41 21 2 P 32 2 1 P 21 P 41 21 2 P 32 2 1
a, b, c () 42.2, 42,2, 261.6 41.9, 41.9, 259.2 41.4, 41.4, 231.1 45.1, 107.3, 47.8 42.4, 42.4, 262.7 41.3, 41.3, 231.6
α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 120 90, 99.9, 90 90, 90, 90 90, 90, 120
Resolution Range (Å) 41.70 - 2.30 39.89 - 1.55 35.88 - 1.50 35.48 - 1.34 41.82 - 1.80 32.44 - 1.80
(2.38 - 2.30) (1.61 - 1.55) (1.56 - 1.50) (1.39 - 1.34) (1.84 - 1.80) (1.87 - 1.80)
R-merge (%) 8.4 (12.1) 9.7 (18.7) 5.6 (46.5) 4.7 (11.8) 9.4 (60.6) 8.7 (11.8)
I/sigma 17.4 (9.6) 16.6 (10.3) 30.8 (5.1) 17.1 (8.5) 31.3 (5.4) 11.7 (4.8)
Multiplicity 7.0 (6.4) 11.8 (14.0) 8.4 (10.6) 3.7 (3.7) 16.7 (19.9) 4.8 (2.0)
Completeness (%) 88.3 85.5 98.8 99.4 100 97.9
Wilson B-factor (Å2) 29.4 10.3 12.1 9.1 18.2 14.1
Refinement
Molecules per asymmetric unit 1 1 1 2 1 1
No. of unique reflections 10104 (880) 30051 (2829) 37869 (3494) 99523 (9924) 23526 (2299) 21924 (1871)
R-work/R-free (%) 18.5 / 25.1 16.8 / 19.4 18.3 / 21.7 14.3 / 16.1 17.1 / 20.8 14.9 / 18.9
No. of protein residues 263 263 260 526 261 260
Ramachandran
Favored (%) 98.5 98.1 97.7 98.1 98.5 98.1
Outliers (%) 0 0 0.39 0.38 0 0.39
Average B-factor (Å2) 31 14.2 21.2 14.1 23.3 16.6
Protein 30.8 12.4 19.6 11.7 21.1 14.4
Ligand - 23.4 37.3 18.6 62.2 28.7
Solvent 34.7 29.1 32.1 26.7 36.3 30.2
RMS deviations
Bond length (Å) 0.003 0.011 0.007 0.006 0.006 0.011
Bond angles (°) 0.685 1.16 0.92 0.93 0.96 1.204
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Figure E.1: The β3 loop and Asn104 contact CAZ in the single mutants. Joint distribu-
tions of two hydrogen-bonding distances that capture the contacts between CTX-M and cef-
tazidime (CAZ) in the acyl-enzyme complex: i) Asn104 to the imino group of ceftazidime
and ii) the backbone nitrogen of S237 on the β3 loop to the β-Lactam carbonyl oxygen of
ceftazidime. Distance cutoffs for hydrogen-bonding interactions are marked (dashed lines) to
indicate whether or not an interaction occurs. Distributions are shown for wild type (top left),
D240G (top right), P167S (bottom left), and P167S/D240G (bottom right). Each point repre-
sents a snapshot from the molecular dynamics simulations colored according to its probability
based on a 2D histogram.
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Figure E.2: Ser237 makes contacts with the imino group of ceftazidime. Cumulative distance
distribution of the sidechain oxygen of Ser237 to the carboxylate of the imino group of cef-
tazdime in the acyl-enzyme complex. Distributions are shown for wild type (black), D240G
(blue), P167S (red), and P167S/D240G (purple).
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Figure E.3: MD simulations of the closed conformation of P167S/D240G capture an open
conformation of the Ω-loop. Overlay of the crystal structure of E166A/P167S/D240G/CAZ
(purple, Ser70 colored in green) with a representative conformation from simulation of the
open conformation of the Ω-loop (orange, Ser70 colored in green) sampled from simulations
of the P167S/D240G variant starting from the closed conformation. In both constructs the
catalytic serine that forms the acyl-enzyme complex with the serine that binds ceftazidime
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[45] Guillermo Pérez-Hernández, Fabian Paul, Toni Giorgino, Gianni De Fabritiis, and Frank
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